Development of methods to test drug sensitivity of fish pathogenic Flavobacterium columnare and drug sensitivity thresholds for F. columnare to the antimicrobial florfenicol. by Gieseker, Charles Michael
ABSTRACT 
 
Title of Dissertation:  DEVELOPMENT OF METHODS TO TEST 
DRUG SENSITIVITY OF FISH PATHOGENIC 
FLAVOBACTERIUM COLUMNARE AND DRUG 
SENSITIVITY THRESHOLDS FOR F. 
COLUMNARE TO THE ANTIMICROBIAL 
FLORFENICOL 
Charles Michael Gieseker, Ph.D., 2015 
Dissertation directed by:  Associate Professor, L. Curry Woods III, 
Department of Avian and Animal Sciences 
 
Antimicrobial drugs play a key role in managing the health of fish in aquaculture. 
However, public health concerns about antimicrobial resistance—the ability of 
microorganisms to resist standard antimicrobial treatments—include the potential for 
antimicrobial use in aquaculture to select for resistant bacteria in and around fish farms. 
Recent approval of two antimicrobial drugs to treat farmed freshwater fish with infections 
caused by the aquatic bacteria Flavobacterium columnare and F. psychrophilum created 
an important need for research to monitor these bacteria for changes in antimicrobial 
susceptibility and to decide when the antimicrobials should be used. Therefore three 
studies were conducted. 
The initial study optimized methods for broth microdilution testing F. columnare 
and F. psychrophilum and conducted a multi-laboratory standardization trial that set 
quality control parameters for nine antimicrobials commonly used in aquaculture, thus 
creating the first standardized testing method. In the second study, we constructed 
frequency distributions using minimal inhibitory concentrations determined from testing 
134 F. columnare with the standardized method. Analysis of the distributions determined 
the drug concentration—called an epidemiological cutoff value (ECV)—which separated 
the wild type isolates with no acquired or selected resistance from the non-wild type 
isolates. The ECV indicated 22 of 134 isolates had decreased their susceptibility to at 
least 1 antimicrobial. In addition, we developed a laboratory disease model with juvenile 
channel catfish, Ictalurus punctatus. We compared the virulence of three F. columnare 
isolates with wild type or three isolates with non-wild type florfenicol susceptibility using 
the model. We found that five isolates had similar high level virulence and were not 
affected by differences in florfenicol susceptibility. 
Finally, we studied if decreased non-wild type florfenicol susceptibility affected 
the ability of the approved florfenicol treatment to control F. columnare infections. The 
approved treatment significantly reduced catfish mortality following exposure to an 
isolate with typical wild type florfenicol susceptibility but mortality was not reduced 
following exposure to an isolate with non-wild type susceptibility. Taken together, these 
studies provide methods and research needed to monitor F. columnare for changes in 
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Chapter 1: Introduction 
Antimicrobial resistance is an important health issue due to the continuing rise of 
pathogenic microorganisms (bacteria, fungi, viruses and parasites) that withstand 
standard antimicrobial treatments. Resistance jeopardizes numerous advances made by 
modern human and veterinary medicine since procedures often depend on antimicrobials 
to prevent or treat infection. Drug-resistant microorganisms interrupt an antimicrobial’s 
mode of action often requiring another antimicrobial that works in a different way. 
However, different antimicrobials are not always available, and in addition some 
microorganisms develop resistance to multiple drugs. Therefore, limiting antimicrobial 
resistance requires using these drugs as judiciously as possible. 
Recommendations for judicious use include dispensing the right antimicrobial for 
an illness and at the discretion of a certified health professional who considers the use 
medically necessary (WHO, 2000). The use of antimicrobials to prevent disease, 
especially in food animals, is a concerning practice that can unnecessarily select for 
resistance (WHO, 2000, Leung et al., 2011; WHO 2014). With the goal of limiting the 
selection of resistance on farms, the European Union banned antimicrobial prophylaxis in 
food animals, opting to only allow therapeutic uses with veterinary oversight (Cogliani et 
al., 2011). The United States Food and Drug Administration (FDA) has recently proposed 
to follow suit, asking companies to voluntarily remove all approved indications of 
medically important antimicrobials meant to enhance growth in food animals (FDA, 
2013a/b). In addition, FDA will also require veterinary oversight for all remaining 
therapeutic uses. By requiring veterinary oversight these countries want to ensure animals 
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receive appropriate therapy, i.e. one that provides an effective drug at a concentration and 
duration that inhibits the pathogenic microorganism and achieves a clinical cure in the 
infected patient (Lees and Aliabadi, 2002). Thus, clinicians should know whether or not 
available antimicrobials inhibit the target microorganism as determined by an 
antimicrobial susceptibility test. 
Standard laboratory protocols for testing antimicrobial susceptibility are a key 
component in strategies to reduce antimicrobial resistance (Leung et al., 2011). 
Standardized testing provides laboratories with the same procedures and quality controls 
to certify results. By generating consistent results across multiple laboratories, datasets 
can be generated so criteria can be set to monitor for microorganisms that have developed 
resistance or to facilitate judicious use. Analysis of how frequently a particular 
microorganism has a certain antimicrobial susceptibility determines cutoff points in the 
test scale that define if the microorganism has decreased its susceptibility to a given 
antimicrobial (i.e., antimicrobial resistance). Monitoring trends in the prevalence of 
microorganisms with decreased susceptibility can then be compared over time and across 
different locations. Susceptibility tests are also compared to outcomes of clinical therapy 
and drug pharmacology so categories can be defined to predict the likely outcome of 
treatment. Clinicians use the categories to help decide when to prescribe an approved 
antimicrobial, facilitating prudent use of antimicrobials. 
While all microorganisms (bacteria, fungi, viruses and parasites) can develop 
resistance, drug-resistant bacteria have created the most concern (WHO, 2014). Bacteria 
have very short life cycles with relatively fast mutational and/or selective processes that 
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allow them to quickly adapt to changes in their environment. Antimicrobials act on 
bacteria by inhibiting the synthesis of nucleic acids, proteins or cell walls, disrupting 
metabolic pathways, or altering cell membranes. Bacteria decrease their susceptibility to 
antimicrobials with enzymes that destroy drugs, efflux pumps that remove the drugs from 
the bacterial cell, modified cellular sites that drugs target and/or altered metabolic 
pathways (Tenover, 2006). Some bacteria intrinsically resist certain classes of 
antimicrobial drugs; however, resistance is often associated with mutated genes or new 
genes transferred from other bacteria. Although genetic mutation and gene transfer are 
natural processes, the overuse and misuse of antimicrobials in medicine and agriculture 
has influenced the emergence and spread of antimicrobial resistance (Leung et al., 2011). 
As with other animal agriculture sectors, antimicrobial use in aquaculture selects 
for bacteria with decreased antimicrobial susceptibility (Aoki et al., 1974; Kim et al., 
1993; Ho et al., 2000; Michel et al., 2005; Dung et al., 2008; Rhodes et al., 2008; Clark et 
al., 2009; Ishida et al., 2010). Uneaten medicated feed or treatment in open water also 
releases antimicrobials directly into the environment creating concerns that drug residues 
in sediment could alter the susceptibility of environmental bacteria (Samuelsen et al., 
1991, 1992; Coyne et al., 1994; Rigos et al., 2004). Hence, the most important risk from 
aquaculture with regard to antimicrobial resistance is the potential for bacteria to become 
resistant in and around fish farms, and transfer their resistance genes to other bacteria that 
infect humans (Sørum et al., 2003; FAO/OIE/WHO, 2006; Maki et al., 2008; Verner-
Jefferys et al., 2009). 
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The FDA recently approved the antimicrobials florfenicol (Aquaflor®) and 
oxytetracycline dihydrate (Terramycin®) for use in freshwater-reared finfish to control 
infections caused by the aquatic bacteria Flavobacterium columnare and Flavobacterium 
psychrophilum (Federal Register, 2007a/b, 2008, 2012, 2014). These bacteria are 
nutritionally fastidious gram-negative bacteria that are ubiquitous in freshwater infecting 
a wide range of wild and cultured freshwater fishes. The new drug approvals are an 
important improvement for U.S. aquaculture as F. columnare and F. psychrophilum are 
two of the most economically important diseases in the industry. In addition, Aquaflor® 
is the first new antimicrobial approved in U. S. for aquaculture in the last 20 years. 
Unfortunately, a standardized antimicrobial susceptibility test for these bacteria was not 
available or required during drug approval process. My first goal in this research was to 
standardize a susceptibility test for these fastidious bacteria.  
My second goal, once I had a standardized test was to develop interpretive criteria 
for F. columnare. These criteria are integral to the test since they are the cutoff points that 
indicate whether isolates of the bacterium 1) have decreased susceptibility to an 
antimicrobial, or 2) will likely be controlled by treatment with an antimicrobial. I used 
the standardized test to determine the antimicrobial susceptibility patterns of F. 
columnare against antimicrobials used to treat columnaris disease as well as other 
antimicrobials commonly used in global aquaculture. Using the susceptibility distribution 
for each antimicrobial, I determined the cutoff that divides the isolates based on their 
susceptibility. Finally, I developed an infection model in channel catfish, Ictalurus 
punctatus, and studied whether F. columnare with decreased florfenicol susceptibility as 
indicated by the in vitro test can resist an actual in vivo treatment with Aquaflor
®
. This is 
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a key component needed to use the standard susceptibility test as a predictor of treatment 
so Aquaflor
®
 can be judiciously used by the aquaculture industry.  
In this chapter I provide background information about F. columnare and F. 
psychrophilum, their diagnostic characteristics and previous antimicrobial susceptibility 
testing of both species. In addition, I describe the process followed by the Clinical 
Laboratory Standards Institute (CLSI) to standardize antimicrobial susceptibility test 
methods and to develop interpretive criteria.  
1.1 Flavobacterium columnare 
Flavobacterium columnare was first described by Davis (1922) from a variety of 
different species of diseased freshwater fishes with gill and skin lesions. He consistently 
observed dirty-white or yellowish areas on some part of the fish’s body (particularly on 
the fins) that rapidly increased in size. Once lesions emerged, the fish rapidly died. Slide 
scrapes immersed in a drop of water from the actively growing margin of lesions were 
exclusively composed of long, slender, flexible rod-shaped bacteria. Although Davis 
(1922) could not grow the bacteria, the easily recognizable nature of the disease with 
well-defined lesions and bacteria strongly suggested the bacterium caused the disease. He 
named the bacterium Bacillus columnaris because it forms columns or haystacks seen in 
wet preparations of gill or skin lesions. 
Ordal and Rucker (1944) were the first to isolate the bacterium, renamed as 
Chondrococcus columnaris, on a low-nutrient medium, and identified it as a 
myxobacterium since they observed fruiting bodies and microcysts. Myxobacteria are 
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long thin gram-negative rods that move by a creeping or flexing motion and that have a 
life cycle composed of vegetative cells, fruiting bodies and/or microcysts (Bullock et al., 
1986). However, Garnjobst (1945) quickly proposed changing the name to Cytophaga 
columnaris because stars/clusters formed in liquid media rather than fruiting bodies. 
Later on, Leadbetter (1974) proposed naming the bacterium Flexibacter 
columnaris and also suggested that the Flexibacter genus also include Cytophaga 
psychrophila (syn. – F. psychrophilum). Bernardet and Grimont (1989) confirmed 
Leadbetter’s proposal using DNA relatedness and phenotypic tests and also proposed 
changing the name of C. psychrophila to Flexibacter psychrophilus. However, they 
recognized the entire Cytophaga-Flexibacter-Flavobacterium phylogenetic branch had to 
be reorganized before their proposals could be accepted. Subsequently, Bernardet et al. 
(1996) studied the phylogenetic relationships of the entire group and determined based on 
DNA-rRNA hybridization that some Cytophaga and Flexibacter species, including F. 
columnare and F. psychrophilum, grouped with the Flavobacteria. The genus now 
includes all 3 species that infect fish (Flavobacterium columnare, F. psychrophilum and 
F. branchiophilum). 
Fish illness from Flavobacterium columnare, columnaris disease (Davis, 1922; 
Ordal and Rucker, 1944), has become one of the most economically important bacterial 
diseases in the commercial production of channel catfish, Ictalurus punctatus, in the 
United States (Wagner et al., 2002). The disease is also a major problem for a wide range 
of other cultured fish as well as wild fish worldwide (Fish and Rucker, 1945; Borg, 1960; 
Wakabayaski and Egusa, 1966; Bullock et al., 1986; Bernardet, 1989). Most freshwater 
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fish from cold- to warmwater are susceptible to the disease usually when the fish are 
stressed by environmental conditions (Wakabayashi, 1991; Durburow et al., 1998). The 
disease remains a major problem throughout many freshwater aquaculture industries 
(Decostere and Haesebrouck, 1999; Pulkkinen et al., 2010) and continues to emerge for 
example in the US trout industry (Evenhuis et al., 2014). 
Flavobacterium columnare infections are typically limited to the external surfaces 
(fins, gills and skin) of fish although highly virulent isolates cause mortality with no 
tissue damage (Pacha and Ordal, 1967). Lesions are white or yellowish patches on the 
gills or skin but commonly begin on the fins (Davis, 1922). Fin lesions spread out at the 
base of the fin. Initially, skin lesions appear as dull areas where the mucus is eroded 
(Durburow et al., 1998); the leading edge (margin) can be light red from inflamed skin 
(Bullock et al., 1986). Initial skin lesions are small but increase rapidly in size as the 
bacteria grows in spreading patches which can cover large portions of the body. On the 
dorsum, the lesions can have a characteristic saddleback appearance (Durburow et al., 
1998). More chronic skin lesions have gray-blue or yellow-brown ulcerated centers 
where the infection has progressed through the dermis and caused muscle necrosis 
(Bullock et al, 1986; Durburow et al., 1998). Gill lesions appear as white or yellow 
eroded patches where the bacteria cause necrosis, hyperplasia and fusion of the secondary 
lamellae, congestion of blood vessels and/or edema (Foscarini, 1989). Systemic 
infections occur with limited internal pathology although the bacterium can be readily 
cultured from organs (Bullock et al., 1986). Reported kidney lesions from experimental 
infections in salmon were limited to enlargement of the Bowman’s capsule in glomeruli 
(Pacha and Ordal, 1967).  
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1.2 Flavobacterium psychrophilum 
As with F. columnare, Davis (1946) also first described F. psychrophilum 
infections in rainbow trout, Oncorhynchus mykiss, after observing sick juvenile trout in a 
West Virginia hatchery in 1941 and 1945 that had “peduncle disease”. Beginning at the 
adipose fin, the trout would develop white discolored lesions that would gradually 
encompass the entire peduncle and caudal fin, destroying the muscles and fin in severe 
infections. Material scraped from the lesions always had long rod-shaped bacteria which 
gave “little doubt” of the lesion’s cause although the bacterium could not be cultured. 
Shortly afterwards in 1948, an epizootic occurred among hatchery raised fingerling silver 
(coho) salmon, Oncorhynchus kisutch, in Washington State (Borg, 1960). Severe losses 
occurred despite low water temperatures (6-10 °C). These fish had lesions similar to 
those described by Davis (1946) with a long rod-shaped bacterium. Borg (1960) was able 
to grow the bacterium on low nutrient media and grouped them based on growth and 
biochemical characteristics. With pathogenicity tests Borg (1960) fulfilled Koch’s 
postulates finding that the slow-growing low temperature group isolated from the kidneys 
of sick fish was the primary cause of the disease, naming it Cytophaga psychrophila (syn. 
-  Flavobacterium psychrophilum). Infections were induced in fish held at 10 to 18 °C.  
The disease is known as “Bacterial Coldwater Disease” (BCWD) since most 
epizootics occur at water temperatures below 15 °C (Wood, 1974). Reports of the disease 
were only from North American salmonids until about the mid-1980s when similar 
disease condition occurred in Rainbow trout fry in Europe and Japan (Cipriano and Holt, 
2005; Wakabayashi, 1991; Wakabayashi et al., 1994). This form of the disease is 
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commonly called Rainbow Trout Fry Syndrome (RTFS, Austin and Stobie, 1991; 
Lorenzen et al., 1991) but it’s also called fry anemia or myxobacterial infection. RTFS is 
usually an internal infection of fry weighing ≤ 1 gram grossly observed as weakness, pale 
gills, swollen abdomen, exophthalmia and/or dark coloration (Bernardet et al., 1988; 
Lorenzen et al., 1991; Santos et al., 1992). The fry usually have severe anemia, 
accumulation of fluid in the peritoneal cavity (ascites), enlarged spleens, and liver 
discoloration. Long rod-shaped F. psychrophilum are found in smears of the spleen, liver, 
kidney, and blood and can be readily cultured on cytophaga agar.  
BCWD and RTFS cause extensive losses in salmonid aquaculture worldwide 
(Nematollahi et al., 2003). Although the disease occurs most frequently amongst 
salmonids, it also occurs in other freshwater fish (Cipriano and Holt, 2005). 
1.3 Growth and Identification 
As described by Bernardet and Grimont (1989), Flavobacterium columnare are 
long, slender, flexible gram negative rods that are 3 to 10 μm long and 0.3 to 0.5 μm wide 
although, some cells can be grow up to 10 to 25 μm long. In wet preparations the cells 
clearly glide with pivoting and bending. The bacterium can tolerate up to 0.5% NaCl and 
temperatures between 10 to 33°C (some tolerate 37°C) although optimal growth is from 
20 to 25°C. A wider optimal temperature range for F. columnare is more likely as others 
have reported a higher optimum temperature, for instance, Garnjobst (1945) listed 
optimal growth as 25 to 30°C. On agar, the bacterium forms yellow colonies that strongly 
adhere. The colonies appear flat, dry, and spreading. In liquid cultures, the bacterium 
forms aggregates that adhere to the sides of the container. The yellow-orange color of 
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these bacteria is mainly derived from non-diffusible flexirubin pigment (Reichenbach et 
al., 1974).  
Flavobacterium psychrophilum is a nonsporulating, gram-negative rod that ranges 
in size from 1-5 µm long by 0.3-0.5 µm wide (Bernardet and Grimont, 1989). The cells 
glide very slowly requiring prolonged observation, however some strains glide faster. 
The bacterium tolerates up to 0.5% NaCl and temperatures between 10 to 20°C. Optimal 
growth occurs at 15 to 18 °C with growth slowing dramatically at 6 and 22-25 °C. On 
agar colonies are circular with regular edges and do not adhere; however, some strains 
produce colonies with spreading margins. Colonies appear yellow with a smooth glossy 
texture. 
Flavobacterium columnare and F. psychrophilum do not grow well on standard 
media such as trypticase soy, tryptic soy or brain heart infusion (Bernardet and Grimont, 
1989; Daskalov et al., 1999; Cain and LaFrentz, 2007) requiring media low in nutrients. 
Anacker and Ordal (1955) developed one of the first recipes often referred to as 
“cytophaga” or “Anacker and Ordal” media. Other alternatives are tryptone yeast extract 
(TYE) (Fujihara and Nakatani, 1971), Shieh (Shieh, 1980) and tryptone yeast extract salts 
(TYES) (Holt et al., 1993). The bacteria generally grow better on media that contain salts 
such as Shieh and TYES (Song et al.,1988; Holt et al., 1993). Often liquid media is used 
to grow F. columnare since it adheres strongly to agar (Garnjobst, 1945). 
The growth of F. columnare and F. psychrophilum varies a lot between isolates; 
therefore, researchers have modified the media in order to improve isolation. To prevent 
spreading and adherence of F. columnare, a specialized media was developed called 
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Flavobacterium columnare growth medium (FCGM), (Farmer, 2004). To improve 
growth of F. psychrophilum, the tryptone level is commonly increased (Wakabayashi and 
Egusa, 1974). Other improvements for F. psychrophilum include adding certain sugars, 
skimmed milk, horse serum or trace elements (Daskalov et al., 1999; Michel et al., 1999:  
Cepeda et al., 2004). Some have also simplified recipes (i.e. modified Shieh) to limit the 
number of necessary trace elements (LaFrentz and Klesius, 2009). 
Several selective media use the antimicrobials polymyxin B, neomycin and/or 
tobramycin to selectively isolate F. columnare (Fijan, 1969; Decostere et al., 1997). 
Selective cytophaga medium uses neomycin (5 μg/ml) and polymyxin B (200 IU/ml) 
(Hawke and Thune, 1992), and selective Shieh medium uses tobramycin (1 μg/ml) 
(Decostere et al., 1997). Hsu- Shotts media incorporates gelatin along with neomycin (4 
μg/ml; Bullock et al., 1986). 
Many biochemical traits further characterize these bacteria (Bernardet and 
Grimont, 1989). However in order to speed identification, several PCR assays were 
developed based on specific 16S rRNA gene sequences for F. columnare (Toyama et al., 
1996; Bader and Shotts, 1998; Bader et al., 2003; Darwish et al., 2004) and F. 
psychrophilum (Toyama et al., 1994; Urdaci et al., 1998). However, only the set 
developed by Darwish et al. (2004) is truly specific for F. columnare since the earlier sets 
were based on a standard strain later found to be Flavobacterium johnsoniae (ATCC 
43622). Sensitivity and specificity were improved upon with primers that amplify the F. 
columnare 16S-23S intergenic spacer region (Welker et al., 2005).  Similarly, primers 
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specific to the gyrase B gene improved detection of F. psychrophilum (Izumi and 
Wakabayashi, 2000). 
1.4 Development of a standard susceptibility test 
The standardized methods either described or developed  within this dissertation 
followed the guidelines of the Clinical Laboratory Standards Institute (CLSI). The CLSI 
is a world renowned leader in developing clinical laboratory standards and guidelines. 
Each subject area has an expert CLSI committee that develops and approves new 
methods or criteria, and updates existing methods using an international consensus 
process.  
1.4.1 Standard Methods 
The CLSI recommends 3 standardized antimicrobial susceptibility testing (AST) 
methods: disk diffusion, broth dilution, and agar dilution. The disk diffusion technique 
places a paper disk over a standardized amount of the bacterium spread on the surface of 
an agar plate (Bauer et al., 1966). The disk is infused with a known concentration of the 
antimicrobial that diffuses through the agar as the bacterium grows. Disk diffusion 
identifies the diameter of the inhibited growth zone (zone of inhibition) around the disk. 
The dilution techniques grow the bacteria on agar plates or in broth tubes (macro) or 
wells (micro) that have different drug concentrations. Each plate, well or tube 
incorporates a separate antimicrobial concentration in a stepwise dilution series. A 
standardized amount of bacterial cells are applied to the agar surface or in the broth. 
Growth is assessed at a set temperature after a defined incubation period. The dilution 
techniques identify the minimum concentration of the antimicrobial that inhibits visible 
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growth of the bacterium, known as the minimal inhibitory concentration (MIC). MICs 
can be directly compared to the kinetics of the drug in the animal whereas inhibitory zone 
diameters cannot.  However, zone diameters can be correlated to MICs using statistical 
methods (Metzler and DeHaan, 1974; Brunden et al., 1992; Bradford and Sanders, 1992).  
The original set of reference protocols developed for AST of aquatic bacteria 
included all 3 methods described above (Alderman and Smith, 2001). These protocols 
brought together the standard methods developed by CLSI with modifications for aquatic 
bacteria. The intent was to begin developing standardized, quality controlled methods for 
testing the antimicrobial susceptibility of fish pathogenic bacteria so laboratories could 
better share data to facilitate judicious use of antimicrobials in aquaculture. Subsequent 
standardization trials created the first standardized disk diffusion and broth dilution 
susceptibility testing methods for non-fastidious aquatic bacteria that grow on normal 
testing media (Miller et al. 2003, 2005; CLSI 2006 a/b).  The guidelines also grouped 
fastidious aquatic bacteria together based on similar growth requirements and 
recommended modifications for susceptibility testing. The recommendations give 
laboratories a basis to develop standard methods for the fastidious groups. 
1.4.2 AST of F. columnare and F. psychrophilum 
The CLSI testing guidelines for aquatic bacteria suggests Mueller-Hinton (MH) 
media diluted 3g/L supplemented with 5% horse or fetal calf serum for disk diffusion and 
broth dilution testing the fish pathogenic Flavobacteria: F. columnare, F. psychrophilum 
and F. branchiophilum (CLSI, 2006 a/b). This recommendation is based on a disk 
diffusion test developed for F. columnare (Hawke & Thune, 1992). Although some 
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researchers have used this media for disk diffusion of F. columnare (Hawke & Thune, 
1992; Thomas-Jinu & Goodwin, 2004; Gaunt et al., 2010) other media are also used, 
particularly cytophaga (Wakabayashi & Egusa, 1966; Amin et al., 1988; Michel et al., 
2002; Suomalainen et al., 2006; Kubilay et al., 2008). Alternatively, some researchers 
have used the agar dilution technique for F. columnare but on a very limited basis with 
cytophaga or Shieh media at different growth conditions (Soltani et al., 1995; Decostere 
et al., 1998). 
Growing F. columnare on solid agar is a major drawback to both disk diffusion 
and agar dilution, since the bacterium prefers to grow in broth media (Garnjobst, 1945). 
Moreover, the gliding of F. columnare can distort the margins of the inhibitory zone in 
disk diffusion (Farmer, 2004) or can result in isolates spreading over adjacent isolates on 
the agar dilution plate. In order to have a more consistent method to test the susceptibility 
of F. columnare, Darwish et al. (2008) adapted the broth microdilution technique using 
dilute (4 g/L) Mueller-Hinton broth. This method uses a slightly more concentrated broth 
compared to CLSI’s recommendation (3 g/L). 
To test the antimicrobial susceptibility of F. psychrophilum researchers 
consistently use dilute Mueller-Hinton (MH) media supplemented as described by Hawke 
and Thune (1992) for disk diffusion and agar dilution testing. Incubations conditions 
have varied with most researchers testing at 15-18 °C and determining results at 72-96 
hours (Schmidt et al., 2000; Bruun et al., 2000; Michel et al., 2003; Izumi & Aranishi, 
2004; Kum et al., 2008). When compared to modified cytophaga, the growth of F. 
psychrophilum on dilute MH appeared altered in disk diffusion tests as very little growth 
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was observed for some isolates (Michel et al., 2003). However, the same study only 
observed slightly lower MICs with diluted MH when the 2 media were compared with 
agar dilution tests. 
Some researchers have tested F. psychrophilum with broth microdilution although 
the methods have not been consistent. The broth media ranged between modified 
cytophaga, diluted Mueller-Hinton and full strength cation-adjusted Mueller-Hinton with 
temperature at 15-18 °C and incubation at 72-168 hours (Rangdale et al., 1997; Hesami et 
al., 2010; Del Cerro et al., 2010). As with F. columnare, F. psychrophilum readily grows 
in broth making broth dilution an attractive option for susceptibility testing; however, a 
standard procedure was needed. Another advantage to using broth dilution was the 
existing standardized method for non-fastidious aquatic bacteria. Updating the current 
CLSI guideline would be less labor intensive than standardizing agar dilution methods 
which do not have existing standard methods for aquatic bacteria. Therefore, the first 
objective of this research was to standardize similar broth microdilution methods for F. 
columnare and F. psychrophilum using dilute (4 g/L) Mueller-Hinton broth. The same 
testing technique was used since the bacteria have similar nutritional requirements.  
1.4.3 Special considerations for AST of F. columnare and F. psychrophilum 
Pure cultures of F. columnare or F. psychrophilum often clump together making it 
hard to get cell suspensions with a consistent concentration of 5 x 10
5
 colony-forming 
units/mL required for broth microdilution testing (CLSI, 2006b; Wiegand et al., 2008). 
Laboratories typically grow F. columnare and F. psychrophilum in broth while stirring or 
shaking to get consist cell suspensions for susceptibility testing (Darwish et al., 2008, 
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Bruun et al., 2000). However, suspensions can be made by swabbing colonies off agar 
plates or diluting static broth cultures. Since some fish health laboratories may not have 
equipment to shake or stir during incubation, methods were needed so consistent 
suspensions could be made from static cultures. 





 since these cations improve the growth of bacteria to better estimate the in vivo 
activity of antimicrobials (D’Amato et al., 1975; Nanavaty et al., 1998). Previous 
research suggested cations maybe unnecessary for broth dilution testing of F. columnare 
(Darwish et al., 2008). However, it was unknown if cations were necessary for broth 
dilution testing of F. psychrophilum. In addition, no one had investigated if diluting the 
cations will significantly affect antimicrobial susceptibility. If media with dilute cations 
could be used, then laboratories could simply dilute commercially prepared full strength 
cation-adjusted MH broth without having to replenish the cations. Therefore, the effect of 
different cation levels on the antimicrobial susceptibility of F. columnare and F. 
psychrophilum had to be characterized. In addition, the effect supplementing the broth 
with serum also had to be characterized since the CLSI recommends 5% serum for 
susceptibility testing these bacteria (CLSI, 2006). 
An incubation temperature and period already existed for broth dilution testing of 
F. columnare (Darwish et al., 2008). However, no consistent incubation temperature or 
period existed for broth dilution testing of F. psychrophilum, but the growth conditions 
used with agar dilution provided a good reference (15-18 °C, 72-96 hours). Although F. 
psychrophilum grows optimally at 15 °C, the generation time at 18 °C is very similar 
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(Holt et al., 1989). Therefore, 18 °C was chosen for incubation since the existing quality 
control (QC) bacteria standardized for testing non-fastidious aquatic bacteria at 22 and 28 
°C would grow better at the higher temperature. These bacteria are known to have stable 
antimicrobial susceptibility; however, we needed to test their stability at the new test 
conditions. Developing a Flavobacterium QC strain would have taken considerable effort 
to find strain with reliable susceptibility at 2 very different incubation temperatures. A 
better alternative was to develop the existing QC strains to be used with local 
Flavobacterium sp. strains developed by individual laboratories. 
1.4.4 QC ranges 
Standard antimicrobial susceptibility tests use QC bacteria to monitor 
performance. The QC bacteria are standard strains with stable susceptibility at the test 
conditions taken from a recognized source such as the American Type Culture 
Collection, ATCC (CLSI, 2008). These standard strains are tested along with target 
bacteria. Test performance is verified when the test results of the standard strain(s) falls 
within the predetermined range set for a certain antimicrobial. Out-of-range results 
indicate the test plates were not made with the correct drug concentrations or the operator 
made a mistake in the method. The cause of QC failures must be investigated and tests 
repeated. 
QC ranges (or limits) are set with data from multi-laboratory testing trials where 
each lab tests the QC bacteria at a certain number of repetitions with the same media lots, 
drug lots and protocol. The CLSI has a guideline that clearly outlines the requirements 
for establishing acceptable QC ranges for susceptibility testing of veterinary bacterial 
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pathogens (CLSI, 2008). At least 7 laboratories from different institutions should 
participate in the standardization trial with at least one veterinary diagnostic laboratory. 
After the trial, the data are compiled and provisional QC ranges determined. The CLSI 
Veterinary Antimicrobial Susceptibility Testing (VAST) subcommittee reviews the 
ranges for addition into the guidelines. An approved range should include at least 95% of 
the data centered on the mode. The VAST committee has the authority to expand or 
shrink the ranges based on distribution of the data. QC ranges should be relatively close 
to the test scale cutoffs used to interpret the test, either for resistance monitoring or for 
predicting treatment outcome. Thus to standardize the susceptibility testing method, a 
standardization trial was needed whereby laboratories tested the quality control bacteria 
at the test conditions multiple times.  
1.5 Criteria to interpret AST to monitor for drug resistance monitoring and 
to predict the success of drug treatments 
Antimicrobial susceptibility tests are interpreted by separating the MIC or zone 
diameter results into categories denoted by certain cutoff points in the MIC or zone 
diameter scale. Two categories, wild type (WT) or non-wild type (NWT), divide the 
isolates based on whether they have acquired antimicrobial resistance mechanisms 
(Kahlmeter et al., 2003). Three categories, susceptible, intermediate or resistant, called 
clinical breakpoints predict the likely outcome of an antimicrobial treatment (CLSI, 
2008). 
Scientists track antimicrobial resistance by monitoring the prevalence of bacteria 
that have acquired resistance. This requires setting an MIC or zone diameter, called an 
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epidemiological cutoff value (ECV), which separates the WT isolates that have no 
resistance mechanisms from the NWT isolates (Kahlmeter et al., 2003). ECVs are 
determined from testing isolates of a single bacterium species. Histograms of the MIC or 
zone diameter distributions are then inspected for breaks that define where the WT 
isolates end and the NWT isolates begin (Turnidge et al., 2006). However, this 
convention does not work well if the WTand NWT isolate distributions overlap with no 
clear separation. Fortunately, statistical approaches fit curves to distribution of WT 
isolates so the ECV can be mathematically estimated (Kronvall, 2003; Turnidge et al., 
2006).  
An ECV is also used to determine clinical breakpoints; however, for this purpose 
it is called a “wild type cutoff”.  Other cutoffs are also considered that define what 
isolates are controlled in actual treatments (clinical cutoff) and what isolates should be 
controlled based on how the animal’s body affects the drug, and how the drug affects the 
body and the bacteria (pharmacokinetic/pharmacodynamics – PK/PD – cutoff). The WT 
and clinical cutoffs are compared to determine the susceptible breakpoint with the PK/PD 
cutoff used as a weighing factor (CLSI, 2008). The susceptible (S) category means the 
antimicrobial will likely control an infection caused by the isolate. A susceptible 
breakpoint can include more or less than the natural distribution of WT isolates. For 
instance, a defined dosage regime of the antimicrobial may still control infections caused 
by isolates that have mechanisms that confer a low level of resistance; therefore, the 
susceptible breakpoint would include some of these NWT isolates. 
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Once the value of the susceptible breakpoint is determined, further evaluations are 
used to define intermediate and resistant categories (CLSI, 2008). The intermediate (I) 
category indicates treatment will only be successful if the antimicrobial concentrates at 
the infection site or, if available, that a higher dosing regimen is needed. Treatment of 
infections caused by isolates in the resistant (R) category will likely fail because the 
antimicrobial does not concentrate at the infection site to a level that inhibits the 
bacterium. A bacterial species that has not acquired drug resistance will only have 
susceptible isolates. As the bacterial population develops resistance, intermediate and 
resistant breakpoints are added to a particular bacterium/antimicrobial combination. 
However, most new antimicrobial indications for fish are existing drugs used elsewhere 
in veterinary and human medicine; therefore, target bacteria may already have developed 
or acquired resistance mechanisms. 
Diagnostic laboratories use the S, I, R breakpoints to advise veterinarians in 
prescribing treatment, fostering judicious use of antimicrobials. Currently for aquatic 
bacteria, ECVs and clinical breakpoints only exist for the bacterium Aeromonas 
salmonicida (CLSI, 2010). Aquaculture needs more ECVs and clinical breakpoints for 
bacteria, such as F. columnare, that cause major diseases in aquaculture so changes in 
antimicrobial susceptibility can be more effectively monitored and so antimicrobials can 
be more effectively used. 
1.6 Setting criteria to monitor F. columnare susceptibility changes or predict 
florfenicol treatment 
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Setting a WT cutoff (ECV) for clinical breakpoints requires testing a minimum of 
100 isolates of a bacterium with a standard MIC generating susceptibility test (broth 
dilution or agar dilution; CLSI, 2008). The isolates should be from diverse sources to get 
as good a geographical and temporal separation as possible. Although no minimum 
requirements exist for setting an ECV, it is possible to estimate the value from as little as 
30 bacterial isolates (CLSI, 2011) tested with a standard MIC or disk diffusion test. 
Therefore the standardized broth microdilution test satisfied requirements for both ECVs 
and clinical breakpoints. However research was needed on the in vitro susceptibility 
patterns of at least 100 F. columnare against antimicrobials approved for columnaris 
disease and other potential unapproved antimicrobial treatments. The resulting MIC 
frequency distributions and ECVs tested the null hypothesis that there are no isolates of 
F. columnare that have decreased susceptibility to antimicrobials commonly used in 
aquaculture.   
In addition to WT cutoffs, clinical and PK/PD data are needed to set clinical 
breakpoints for florfenicol treatment of columnaris disease. Fortunately, the conditional 
approval process used to get florfenicol approved for columnaris disease created 
opportunities that make establishing clinical breakpoints achievable. First, 
pharmacokinetics of florfenicol in channel catfish was recently studied to support 
converting the approval from a conditional to an official status (Gaunt et al., 2012, 2013; 
Federal Register, 2012). The same research group is also considering pharmacodynamics 
studies on how florfenicol affects F. columnare (Gaunt, personal communication). 
Second, a columnaris disease model generated part of the substantial evidence for the 
conditional approval of Aquaflor® (florfenicol) to control columnaris disease in channel 
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catfish (Gaunt et al., 2010; Federal Register, 2007a). The model provides an alternative 
way to enhance the limited clinical data available from the field. Therefore, a similar 
disease model facilitated studying the ability of the approved florfenicol dose to control 
F. columnare infections. Disease could be induced with F. columnare isolates that have 
different antimicrobial susceptibilities near potential clinical breakpoints to test the null 
hypothesis that infections in channel catfish caused by an isolate with decreased 
susceptibility can be controlled by the approved florfenicol treatment. 
A variety of different methods have been used to experimentally induce 
columnaris disease. In channel catfish, some columnaris disease models use a cutaneous 
abrasion in conjunction with a bath exposure to a single infectious F. columnare strain 
(Bader et al., 2003, 2006; Darwish and Mitchell, 2009; Darwish Et al., 2009a/b). 
Abrasion techniques found to effectively induce columnaris disease include rubbing a 
cotton gauze pad (Bader et al., 2003, 2006), branding with a hot wire (Bader et al., 2006) 
or scrubbing with an adhesive pad (Darwish and Mitchell, 2009; Darwish Et al., 
2009a/b). However, other researchers have induced disease without a cutaneous abrasion, 
using only a bath exposure (Thomas-Jinu & Goodwin, 2004; Soto et al., 2008; 
Shoemaker et al., 2008; Gaunt et al., 2010). A very reproducible model was needed to 
induce disease with different strains of F. columnare therefore an abrasion had to be 
evaluated. Another important factor for the disease model was the occurrence of 
mortality. Most of the mortalities induced by Gaunt et al. (2010) occurred on days 3-5 
which gave the fish time to eat at least some of the medicated florfenicol feed. In other 
columnaris disease models, most mortality occurred within 48 hours. 
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The ideal disease model needed to induce consistent infections in channel catfish 
without an abrasion that began 2 to 5 days after exposure so the fish get at least 2 to 3 
florfenicol doses prior to onset of morbidity. The level of infection should be similar 
between the different F. columnare isolates we want to study. Once developed, the model 
can be used to test the null hypothesis that F. columnare isolates with decreased 
florfenicol susceptibility do not induce disease as effectively as isolates with typical 
susceptibility. These experiments were needed prior to experiments on whether the 
approved florfenicol treatment can control F. columnare infections.  
1.7 Summary 
Setting standard methods to test the antimicrobial susceptibility of F. columnare 
and F. psychrophilum will provide a considerable improvement to how aquaculturists use 
antimicrobials against these very important fish pathogens. Proficiency will increase 
between laboratories since everyone can use the same methods and quality assessment 
parameters. Thus, test results collected from local regions will be more comparable 
facilitating greater coverage in monitoring antimicrobial resistance patterns. By focusing 
on a test that generates an MIC, data will be more easily compared to clinical outcomes 
and drug kinetics facilitating the development of clinical breakpoints. This will give 
veterinarians more reliable data to base their decisions on when to use antimicrobials. 
Focusing on interpretive criteria for F. columnare will standardize a test for a 
leading pathogen that continues to emerge in new aquaculture sectors. Effective use of 
florfenicol for this bacterium will contribute to reducing the reservoir of resistance 
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bacteria in the environment thereby limiting risks to public health and keeping 
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Chapter 2: Development and precision testing of broth microdilution 
methods to determine the antimicrobial susceptibility of Flavobacterium 
columnare and Flavobacterium psychrophilum. 
 
Gieseker, C M, Crosby, T C, Mayer, T D, Bodeis, S M and Stine, C B. In Preparation. 
 
2.1 Abstract 
Flavobacterium columnare and F. psychrophilum are major fish pathogens that 
may require antimicrobial therapy. Choice of appropriate treatment is dependent upon 
determining antimicrobial susceptibility which requires validated testing methods. This 
paper reports on methods optimized for broth microdilution testing of F. columnare and 
F. psychrophilum. We developed specialized methods to make reproducible broth 
inoculums, and confirmed the proper incubation time and media composition. We tested 
the stability of potential quality control bacteria and the precision of the method. 
Supplementing the broth with horse serum did not improve growth which was in log 
phase at 48 hours for F. columnare and 72-96 hours for F. psychrophilum confirming the 
test should be incubated at 28°C for approximately 48 hours and at 18°C for 
approximately 96 hours, respectively. The most consistent susceptibility results were 
achieved with plain 4 g/L dilute Mueller-Hinton broth (CAMHB) supplemented with 
dilute calcium and magnesium. The quality control strains Escherichia coli (ATCC 
25922) and Aeromonas salmonicida subsp. salmonicida (ATCC 33658), yielded stable 
minimal inhibitory concentrations (MIC) against all 7 antimicrobials tested after 30 
passes at 28°C and 15 passes at 18°C. In precision tests, most MICs of the isolates agreed 
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100% within in one drug dilution for ampicillin, florfenicol and oxytetracycline. The 
agreement was lower with the ormetoprim/sulfdimethoxine combination with at least 
75% agreement for all but 1 isolate. A multi-laboratory standardization trial used these 
methods to determine quality control limits for testing F. columnare and F. 
psychrophilum establishing a standardized antimicrobial susceptibility testing method for 
these nutritionally fastidious aquatic bacteria. 
2.2 Introduction 
Major advances have been made in the development of standard laboratory 
methods to determine the antimicrobial susceptibility of bacterial pathogens of fish. 
Miller et al. (2003 and 2005) conducted two multi-laboratory standardization trials to 
determine quality control (QC) parameters for standard disk diffusion and broth dilution 
testing, at 22°C and 28°C, of non-fastidious bacteria isolated from aquatic animals.  
Results of these trials were used to draft two Clinical and Laboratory Standards Institute 
(CLSI) guidelines (CLSI, 2006a, 2006b). These guidelines provide reference methods, as 
well as QC parameters for testing some antimicrobials used in aquatic animal medicine. 
Recently a multi-laboratory standardization trial established QC parameters for 
broth microdilution testing of the fish pathogenic fastidious gliding bacteria 
Flavobacterium columnare and F. psychrophilum (Gieseker et al., 2012). These bacteria 
are major pathogens of farmed fish that may require antimicrobial therapy based on 
susceptibility test results. Therefore, reliable susceptibility testing methods are needed to 
help guide clinical therapy and to monitor for changes in antimicrobial susceptibility 
patterns. This paper describes methods optimized to test F. columnare and F. 
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psychrophilum by broth microdilution. The methods were developed to facilitate a 
standardization trial so that a reference method could be created.  
The distinctive growth features of fastidious bacteria present challenges that 
dictate which in vitro susceptibility testing method (disk diffusion, broth dilution and 
agar dilution) should be used. Although agar dilution has been used to test F. 
psychrophilum (Bruun et al., 2000; Michel et al., 2003; Schmidt et al., 2000), some F. 
columnare isolates glide overtop adjacent isolates spotted on the agar. In addition, the 
gliding rhizoid growth of F. columnare also disrupts Kirby-Bauer disk diffusion 
distorting the inhibitory zones (Farmer, 2004). Therefore, the broth dilution technique is 
the best option for testing both of these Flavobacteria, especially since they both grow 
well in liquid media. We choose to focus on the broth microdilution method since it is 
already standardized for non-fastidious aquatic bacteria (Miller, 2005; CLSI, 2006b). 
The CLSI suggests Mueller-Hinton broth (MHB) diluted 1:7 (3 g/L) 
supplemented with 5% horse or fetal calf serum for broth dilution testing of fish 
pathogenic Flavobacteria (CLSI, 2006b). This recommendation was based on the work 
of Hawke and Thune (1992). However, recent research has determined plain MHB 
diluted 4 g/L is better for broth microdilution testing of F. columnare and that calcium 
and magnesium cations, typically added to MHB for broth dilution susceptibility testing, 
may not be needed (Farmer, 2004; Darwish et al., 2008). Calcium and magnesium cations 
are usually added to MHB since they improve the growth of bacteria to better estimate 
the in vivo activity of antimicrobials (D’Amato et al., 1975; Nanavaty et al., 1998). In 
preliminary testing, F. psychrophilum grew well in 4 g/L cation-adjusted Mueller-Hinton 
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broth (CAMHB) without serum (authors, unpublished results). However, further tests 
were needed to determine the effect of serum and cations on the growth and susceptibility 
of F. columnare and F. psychrophilum.   
The low temperature requirement of F. psychrophilum presents another challenge 
since selected QC strains must also grow under the same test conditions. In preliminary 
tests, we found the two QC strains used for susceptibility testing of non-fastidious aquatic 
bacteria (CLSI, 2006a, 2006b), Escherichia coli ATCC 25922 and Aeromonas 
salmonicida subsp. salmonicida ATCC 33658, grow in diluted 4 g/L CAMHB at 18°C 
(authors, unpublished results). Flavobacterium psychrophilum grows well at 15-20°C 
with relatively fast generation times (Pacha, 1968; Holt et al., 1989). To verify if these 
strains can function as QC organisms, their susceptibility to antimicrobials needed to be 
assessed to show they are stable. 
With the goal of developing a standard broth microdilution test for F. columnare 
and F. psychrophilum, we optimized the method of preparing a standard cell suspension, 
incubation times and required media supplements. Additionally, we evaluated the test 
results for the existing aquatic QC strains under the modified test conditions and also 
performed an intra-laboratory testing trial to compare the precision of the methods among 
four separate operators.  
2.3 Materials and Methods 
2.3.1 Bacterial isolates, culture conditions and antimicrobials 
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Table 1 lists the 11 F. columnare and 13 F. psychrophilum isolates used in the 
described experiments. All of the isolates were obtained from diseased fish and were 
donated from laboratories in the USA, France, Netherlands, Australia, Chile and the 
American Type Culture Collection (ATCC). The identity of the isolates was confirmed 
with species-specific PCR (Darwish et al., 2004; Toyama et al., 1994). Two QC strains 
for standardized susceptibility testing of non-fastidious aquatic bacteria, Eshcerichia coli 
ATCC 25922 and Aeromonas salmonicida subsp. salmonicida ATCC 33658 were used in 
all experiments that tested antimicrobial susceptibility with laboratory prepared broth 
microdilution plates. 
The florfenicol (FFN) and oxytetracycline (OTC) antimicrobials used to test the 
effect of cations on susceptibility were purchased from Sigma-Aldrich (St. Louis, 
Missouri, USA) and MP Biomedicals (Santa Ana, California, USA), respectively. All 
antimicrobials except ormetoprim/sulfadimethoxine, used for stability testing of the 
potential quality control strains and for the intra-laboratory testing trial were purchased 
from Sigma-Aldrich (St. Louis, Missouri, USA). Stock concentrations of ormetoprim 
(1000 µg/mL) and sulfadimethoxine (1520 µg/mL) were purchased from Trek Diagnostic 
Systems, Inc. (Cleveland, Ohio, USA).   
2.3.2 Effect of horse serum supplementation and incubation time on growth 
Spread plate enumerations were used to evaluate F. columnare and F. 
psychrophilum growth in CAMHB diluted 4 g/L with or without 5% horse serum (Donor 
Equine Serum, Hyclone Laboratories, Logan, Utah, USA). CAMHB diluted 4 g/L was 
prepared by removing 8.9 mL CAMHB from commercially-prepared 11 mL CAMHB 
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tubes (Trek Diagnostics, Cleveland, Ohio, USA) and replacing the broth with 8.9 mL of 
sterile demineralized water, or replacing the broth with 8.35 mL sterile water and 0.55 
mL horse serum. 
Ten F. columnare isolates and 10 F. psychrophilum isolates were cultured from 
pure cryopreserved samples. Each isolate was subcultured twice in tryptone yeast extract 
salts (TYES) broth (Holt et al., 1993) incubated at 28°C for 24 hours (F. columnare) and 
18°C for 72 hours (F. psychrophilum). Turbidity suspensions (0.5 McFarland) of each 
isolate were prepared from the second subculture. Each suspension was vortexed and the 
clumps were allowed to settle for 1-3 minutes. The upper, more homogeneous fraction 
(~2 mL) was removed, and adjusted as needed to a turbidity equivalent to a 0.5 
McFarland. Fifty-five µL of this fraction was added to 11 mL of CAMHB diluted 4 g/L 
with or without 5% horse serum to target a bacterial concentration of 5 x 10
5
 colony-
forming units (CFU)/mL. After vortexing, the inoculated dilute CAMHB was emptied 
into a sterile reservoir trough, and 100 µL was pipetted into each well of a sterile 96-well 
plate. A separate 96-well plate was inoculated for each isolate and broth combination. 
Flavobacterium columnare plates were incubated at 28°C, while F. psycrhophilum plates 
were incubated at 18°C. 
Three replicate wells were sampled (100 µL) from each 96-well plate at 0, 24, 48, 
72 and 96 hours for F. columnare isolates and at 0, 24, 48, 72, 96, 120 and 144 hours for 




) were prepared. A 100 µL 
aliquot of each 10-fold dilution was spread on TYES agar and incubated at 28°C for 48 
hours (F. columnare) and at 18°C for 96 hours (F. psychrophilum). Viable cell 
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concentrations (CFU/mL) were compared to determine whether serum supplementation 
improved growth and the optimal incubation time to target the log growth phase. 
2.3.3 Turbidity level and inoculum volume for final target cell concentration in the test 
broth 
To determine the McFarland turbidity and volume required to reliably achieve 5 x 
10
5
 CFU/mL bacterial concentrations in the broth microdilution plate wells, viable cells 
were enumerated directly from inoculated broth. Individual turbidity suspensions of 10 F. 
columnare isolates (0.5 McFarland) and 10 F. psychrophilum isolates (0.5 and 1.0 
McFarland) were prepared from the second subculture as described above. Fifty-five µL, 
110 µL and 165 µL were removed from each cell suspension and added to a 
corresponding tube of 11 mL CAMHB diluted 4 g/L. A 1:1000 dilution was prepared 
from each tube in sterile saline and 100 µL was spread on 3 replicate TYES agar plates. 
The plates were incubated at 28°C for 24 hours (F. columnare) and 18°C for 72 hours (F. 
psychrophilum). Afterwards, plates were counted and CFU/mL calculated. 




 supplementation on susceptibility 
We compared minimal inhibitory concentrations (MIC) determined with dilute 
broth supplemented with different levels of calcium and magnesium cations in order to 
confirm if cations were needed for testing and to compare MICs between dilute and full 
strength cation levels. The susceptibility of F. columnare (n=6), F. psychrophilum (n=6), 
E. coli ATCC 25922 and A. salmonicida subsp. salmonicida ATCC 33658 to florfenicol 
and oxytetracycline was tested in 4 g/L MHB supplemented with full cations (20 mg/L 
Ca
++
; 2 mg/L Mg
++
) as suggest by the CLSI for full strength CAMHB, in 4 g/L MHB 
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supplemented with dilute cations (4 mg/L Ca
++
; 2 mg/L Mg
++
) and in plain 4 g/L MHB 
with no cations (CLSI, 2006b). 
In-house broth microdilution 96-well plates were prepared with FFN (32-0.015 
µg/mL) or OTC (16-0.008 µg/mL) following CLSI guidelines (CLSI, 2006b). Mueller-
Hinton broth was prepared from dehydrated media (BD Diagnostic Systems, Sparks, MD, 









/mL) of calcium chloride and magnesium chloride (Acros, Fair Lawn, New 
Jersey, USA). Separate plates were made for each drug in each broth. 
To make the custom 96-well plates, the highest final drug concentration was 
prepared in broth media at twice the target concentration in a 50 mL centrifuge tube by 
adding calculated amounts of stock drug solutions (1280 µg/mL). To allow for 
subsequent 2-fold dilutions, double the volume needed to fill the first column of the 96-
well plates was made. The highest drug concentration was then serially diluted 2-fold 11 
times in the same broth media in 50 mL centrifuge tubes. Fifty µL of the appropriate 
concentration was added to the appropriate column of sterile 96-well plates using a 
multichannel pipette. The final 2 wells in the last row of the well plates were filled with 
plain broth; one to be left un-inoculated as a negative control and the other inoculated 
with cell suspension as a positive control. Plates were stored at ≤ -70°C in sterile plastic 
bags until used within 2 months.  
Minimal inhibitory concentrations were determined using CLSI guidelines for 
broth microdilution testing with adaptions developed here for making Flavobacteria cell 
suspensions (CLSI, 2006b). Each isolate was subcultured twice in TYES broth (F. 
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columnare and F. psychrophilum) or on a blood agar plate (BAP; E. coli and A. 
salmonicida). Broth and agar plates were incubated at 28°C for 24 hours (F. columnare) 
and 18°C for 72 hours (F. psychrophilum). Separate E. coli ATCC 25922 and A. 
salmonicida ATCC 33658 cultures were subcultured alongside the Flavobacterium 
isolates at each incubation temperature. Five replicate cell suspensions (0.5 McFarland 
turbidity) were made for each isolate. Suspensions were diluted 1:50 (Flavobacteria) or 
1:100 (E. coli and A. salmonicida) in separate 5 mL aliquots of the 3 broths.  Fifty µL of 
each inoculated broth was added to a row of a FFN and OTC broth microdilution plate 
made with the corresponding broth; one row for each isolate tested. Each plate was 
inoculated with all 6 F. columnare or F. psychrophilum isolates, E. coli and A. 
salmonicida. Cell density was monitored in the broth supplemented with dilute cations 
with colony counts as described from 3 replicates of each bacterium using TYES 
(Flavobacteria) or BAP (QC bacteria) agar plates. The broth microdilution and colony 
count plates were incubated 28°C for 48 hours (F. columnare) and 96 hours at 18°C (F. 
psychrophilum). After incubation the broth microdilution plates were read and MIC 
results determined (CLSI, 2006b).  
2.3.5 Stability of ATCC strains under test conditions 
The susceptibility of E. coli ATCC 25922 and A. salmonicida subsp. salmonicida 
ATCC 33658 was tested after multiple consecutive subcultures to examine the stability 
under culture conditions developed for testing F. columnare and F. psychrophilum. Both 
strains were subcultured every 24 hours at 28°C and every 72-96 hours at 18°C. 
Susceptibility to enrofloxacin (2-0.001 µg/mL), erythromycin (128-0.06 µg/mL), 
florfenicol (16-0.008 µg/mL), flumequine (8-0.004 µg/mL), gentamicin (8-0.004 µg/mL), 
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oxytetracycline (32-0.015 µg/mL) and oxolinic acid (4-0.002 µg/mL) was examined with 
in-house prepared broth microdilution plates as described at 28 °C after 5, 10, 15, 20, 25 
and 30 subcultures; and at 18 °C after 5, 10 and 15 subcultures. 
2.3.6 Intra-laboratory precision testing 
To test the precision of the F. columnare and F. psychrophilum broth 
microdilution methods, four operators each tested three separate bacterial suspensions of 
6 F. psychrophilum isolates at 18°C, and three separate bacterial suspensions of 6 F. 
columnare isolates at 28°C. Tests of three separate bacterial suspensions of E. coli ATCC 
25922 and A. salmonicida subsp. salmonicida ATCC 33658 were also included at each 
temperature. Susceptibility to ampicillin (0.015-32 µg/mL), oxytetracycline (0.015-32 
µg/mL), florfenicol (0.008-16 µg/mL) and ormethoprim/sulfadimethoxine (0.002/0.04–
4/76 µg/mL) were assayed. Custom frozen broth microdilution plates were prepared and 
used as described previously. All bacterial suspensions were prepared and tested on the 
same day. 
2.4 Results 
2.4.1 Broth and incubation time for optimal growth and antimicrobial susceptibility 
testing 
Five percent horse serum did not improve the growth of F. columnare or F. 
psychrophilum in 4 g/L CAMHB (Figure 1 and 2). The number of viable cells for most of 
the isolates was higher at each time point in plain 4 g/L CAMHB. Most of the F. 
columnare isolates (6 of 9) appeared to be in log-phase growth by 48 hours. These 
isolates either had a rapid increase in cell number that peaked at 72 hours, or rapid 
47 
increase at 48 hours that remained in a relative plateau. The growth of another isolate 
(36413) peaked at 24 hours and stayed relatively constant. The last 2 isolates (33971 & 
36417) grew slowly without a noticeable increase until 96 hours. An isolate (36434) did 
not grow when initially subcultured therefore it had to be excluded from the experiment. 
All of the F. psychrophilum isolates grew in plain 4 g/L CAMHB but some did 
not grow in the serum supplemented broth. The number of viable cells for most of the 
isolates peaked at 96 hours in plain 4 g/L CAMHB then declined; however growth 
peaked at 72 hours for 2 isolates (36393 & 36394). 
2.4.2 Inoculum volumes for final target cell concentration in the test broth 
Table 2 lists the mean cell concentration (CFU/mL) and standard deviations of 10 
F. columnare and 10 F. psychrophilum isolates at different McFarland cell suspensions 
and inoculum volumes used to prepare broth for microdilution testing. Dilute CAMHB 
(11mL) inoculated with either 110 μL or 165 μL of a 0.5 McFarland F. columnare 
suspension most closely achieved the initial target cell concentration of 5.0 x 10
5
 
CFU/mL. Dilute CAMHB inoculated with 55 μL of a 0.5 McFarland F. psychrophilum 
suspension or 55 μL of a 1.0 McFarland suspension most closely achieved 5.0 x 10
5
 






Without cations the MICs of the F. columnare were consistently 1-2 dilutions 
below the MICs determined using cations (Table 3). Most of the MICs agreed between 
the 2 cation levels; however, some F. columnare did not grow in the unsupplemented 
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broth or in the presence of full-strength cations. All of the isolates grew in the broth 
supplemented with dilute cations. 
Most of the F. psychrophilum isolates did not grow in the unsupplemented broth; 
however, all of the isolates grew in the cation-supplemented broths. The MICs 
determined for each isolate from the 2 supplemented broths agreed within 1 dilution. 
The MICs of the QC bacteria agreed across the drugs and cation levels at both 
incubation temperatures. The cation levels had a dose-dependent effect on the 
oxytetracycline MICs of A. salmonicida subsp. salmonicida ATCC 33658 at 28°C and E. 
coli ATCC 25922 at 18°C. 
2.4.4 QC stability 
All MIC results for each drug agreed within 1 dilution for both bacteria at 28°C 
up to 30 subcultures and at 18°C up to 15 subcultures. Ampicillin and the 2 sulfonamide 
drugs were not tested because of the stability observed in the first 7 drugs tested. E. coli 
ATCC 25922 and A. salmonicida subsp. salmonicida ATCC 33658 had consistent MIC 
results against ampicillin and ormetoprim/sulfadimethoxine during intra-laboratory 
precision testing. 
2.4.5 Intra-laboratory precision testing 
 All of the F. columnare MICs agreed between the operators within 1 dilution of 
the mode for florfenicol and oxytetracycline (Table 4). Except for one isolate, all of the 
ampicillin MICs also agreed. The MIC results were more variable with the potentiated 
sulfonamide.  Four of the 6 isolates agreed within a dilution but the remaining 2 isolates 
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only agreed 75 % and 50 %. Both E. coli ATCC 25922 and A. salmonicida subsp. 
salmonicida ATCC 33658 had stable MICs at the conditions for testing F. columnare. 
 We observed a similar trend for F. psychrophilum. At least 91 % of MICs agreed 
between the operators within a dilution of the mode for florfenicol and oxytetracycline. 
Likewise most of ampicillin MICs agreed for 5 of the 6 isolates. Agreement was lower 
with the potentiated sulfonamide but was at least 75 %. The tested QC strains also had 
stable MICs at the F. psychrophilum test conditions. 
2.5 Discussion 
The broth microdilution testing procedures presented in this paper use the same 
test media for both F. columnare and F. psychrophilum. Supplementing the broth media 
with 5% horse serum was not necessary as with agar dilution and disk diffusion tests 
(Bruun et al., 2000; Hawke and Thune, 1992; Michel et al., 2003; Schmidt et al., 2000). 
Both QC bacteria currently used for non-fastidious aerobic aquatic bacteria grew well at 
the test conditions and had very precise MIC results similar to the QC MIC ranges 
established in full strength Mueller-Hinton broth (Miller et al., 2005; CSLI, 2006b). In 
addition, the methods proved reliable when compared between different operators.  
By allowing a few minutes for the aggregated cells to settle out of suspension, we 
were able to make standardized cell suspensions at the standard turbidity level from 
statically grown cultures of F. columnare. Compared to standard procedures for other 
organisms (CLSI, 2006b) more of this suspension had to be added to the broth (1:100 
dilution) to get the target cell concentration (5 x 10
5
 CFU/mL), presumably because F. 
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columnare cells are relatively large compared to other bacteria. With this approach, we 
consistently prepared broth inoculums that approximated the correct number of cells. 
Alternatively, cultures grown while continually mixing can likely improve the 
consistency of the cell suspensions. Laboratories that test F. columnare and F. 
psychrophilum susceptibility commonly use mixing to grow the primary cultures (Bruun 
et al., 2000; Darwish et al., 2008). Mixing may also improve cell viability considering 
cultures of F. psychrophilum can include many dead cells (Michel et al., 1999). 
Therefore, when testing these Flavobacteria, laboratories should first experiment with 
their methods to prepare the broth inoculums. 
Unfortunately, F. psychrophilum isolates differ greatly from each other in growth 
rate making it hard to consistently prepare inoculums with similar cell concentration. In 
this study, the broth inoculum averaged the target cell concentration most closely when 
the suspensions at the standard turbidity were diluted in broth at the standard rate (1:200). 
However, in preliminary testing, we found the broth inoculums should be made in the 
same way as F. columnare. The lower dilution rate resulted in more consistent cultures, 
preventing better against excessively low cell numbers of slow growing isolates. 
The growth of F. columnare sharply increased through 48 hours then slowed 
suggesting, as previously established, that susceptibility tests of F. columnare should be 
incubated for 48 hours at 28°C (Darwish et al., 2008). Flavobacterium psychrophilum 
growth peaked at 96 hours then sharply declined suggesting a longer incubation could 
impair testing results. Although the cells were growing in log phase by 72 hours, we 
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chose to incubate our broth microdilution tests for 96 hours to better account for slow-
growing isolates. 
We tested F. psychrophilum at 18°C since its generation time at this temperature 
is very similar to the established in vitro optimum of 15°C (Holt et al., 1989).  In 
addition, existing QC bacteria would presumably grow better, therefore no new QC 
bacteria would be needed. As such, we found that drug susceptibility of both existing QC 
bacteria (CLSI, 2006b) were stable at both 28 and 18°C in the dilute media.   
Supplementing the broth with calcium and magnesium cations works best for 
broth dilution testing F. columnare and is required for testing of F. psychrophilum. 
Cations diluted at a level similar to the dilute broth provide MIC results similar to results 
from test conducted in media containing full strength cations; therefore, commercially 
available CAMHB diluted to 4 g/L can be used. Commercial broth gives laboratories the 
convenience of not having to make media as well as possibly easier storage conditions 
and extended shelf-life. 
Although full strength CAMHB was recently used for broth microdilution testing  
of F. psychrophilum (Hesami et al., 2010), we chose dilute media to have similar 
methods for testing both F. columnare and F. psychrophilum and to be in line with 
suggested media recommendations (CLSI, 2006b; Alderman and Smith, 2001). The 
procedures and growth conditions developed in this study along with the recently 
developed QC limits (Gieseker et al., 2012) provide the first standardized antimicrobial 
susceptibility testing method for these fastidious bacteria. We hope this method will 
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improve the monitoring for antimicrobial resistance and promote the judicious use of 
antimicrobials approved to control the fish diseases caused by these bacteria. 
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Table 2-1.  Flavobacterium columnare and F. psychrophilum isolates used to develop 
















22650 503-435 Channel catfish 2003 USA Dr. Tim Santucci + + +
22655 503-517 Channel catfish 2003 USA Dr. Tim Santucci + +
22683 94-060 Channel catfish 1994 USA Dr. John Hawke + + +
33677 94-082 Channel catfish 1994 USA Dr. John Hawke + +
33970 ATCC 49512 Brown trout n/a France ATCC + + +
33971 ATCC 49513 Black bullhead n/a France ATCC + +
36413 CVI unknown unknown 1991 Netherlands Dr. Olga Haenen + +
36417 CVI 04017018 Koi 2004 Netherlands Dr. Olga Haenen + + +
36422 ALG 92-491-C Channel Catfish 1992 USA Dr. Joseph Newton + + +
36434 JIP 07/02 Koi 2002 France Dr. Jean-Francois Bernardet +
36445 M08-26807 Koi n/a USA Dr. Hui-Min Hsu + +
F. psychrophilum
22645 ATCC 49418 Coho salmon n/a USA ATCC + + +
36391 FLPS 70 Coho salmon 1981 USA Dr. Douglas Call
36393 FLPS 79 Coho salmon 1990 USA Dr. Douglas Call + +
36394 FLPS 80 Rainbow trout 1990 USA Dr. Douglas Call + +
36395 FLPS 85 Rainbow trout 1985 USA Dr. Douglas Call + + +
36396 FLPS 96 Ayu 1988 Japan Dr. Douglas Call +
36400 FLPS 69 Coho salmon 1981 USA Dr. Douglas Call + + +
36403 FLPS 74 Coho salmon 1989 USA Dr. Douglas Call
36408 FLPS 99 Coho salmon 1991 USA Dr. Douglas Call + +
36410 AU0205 Atlantic Salmon 2006 Chile Dr. Ruben Avendano + + +
36411 AU2706 Rainbow trout 2006 Chile Dr. Ruben Avendano + +
36429 LVDI 5/I Common carp 1992 France Dr. Jean-Francois Bernardet + + +





Figure 2-1. Growth of F. columanre (n=9) in 4 g/L dilute cation-adjusted Mueller-Hinton 





























































































Figure 2-2.  Growth of F. psychrophilum (n=10) in 4 g/L dilute cation-adjusted Mueller-



































































































Table 2-2.  Mean number of cells (CFU/mL) and standard deviations of 10 F. columnare 
and 10 F. psychrophilum isolates at different McFarland cell suspensions and inoculum 











F. columnare 0.5 55 3.5E+05 1.1E+05
0.5 110* 7.4E+05 6.2E+05
0.5 165 7.5E+05 2.6E+05
F. psychrophilum 0.5 55 6.3E+05 2.6E+05
0.5 110 1.1E+06 4.8E+05
0.5 165 1.5E+06 4.9E+05
1 55 8.5E+05 2.2E+05
1 110 1.6E+06 4.2E+05
1 165 2.0E+06 6.6E+05  
* 1 isolate had an unusually high cell concentration due most likely to technician error. 







Table 2-3. Minimal inhibitory concentrations (µg/mL) of F. columnare, F. 
psychrophilum, A. salmonicida subsp. salmonicida ATCC 33658 and E. coli ATCC 
25922 from broth microdilution testing in 4 g/L cation-adjusted Mueller-Hinton broth 
supplemented with difference levels of calcium and magnesium cations.  
 
Isolate NC DC FC NC DC FC
F. columnare , 28°C
22650 0.03 0.06-0.12 no growth 0.5-1 2 no growth
22683 0.03 0.12 0.12 0.12-2 2 2
33970 0.03 0.12 0.12-0.5 0.5 2 2
36417 2 8 8 0.5 1-2 1
36422 0.06 0.12 0.12 1-2 1 1-2
36445 no growth 0.06-0.12 no growth no growth 1 no growth-0.25
A. salmonicida  ATCC 
33658
0.12 0.25-0.5 0.5 2 1 1
E. coli  ATCC 25922 0.5 1 1 8-16 8 8
F. psychrophilum , 18°C
22645 no growth 0.12 0.12-0.25 no growth 1 1
36395 no growth-0.03 0.06 0.12 1 1 1
36396 no growth 0.12 0.12-0.25 no growth 1-2 2
36400 no growth 4 4-8 no growth 1 1-2
36410 no growth 8 16 no growth 2 1-2
36429 no growth 0.12 0.25 no growth 1 1-2
A. salmonicida  ATCC 
33658
0.12 0.12 0.5 2 1 1-2
E. coli ATCC 25922 0.25 0.5 1 16-32 16 16-32





Table 2-4. Percent agreement between 4 operators in broth microdilution testing of 6 F. 
columnare, 6 F. psychrophilum and 2 potential QC strains with specialized conditions 
develop for these nutritionally fastidious Flavobacteria.  
 
Isolate AMP FFN OTC PRI
28°C, 48 hours
F. columnare  22650 100 100 100 100
22655 100 100 100 100
22683 100 100 100
b
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E. coli  ATCC 25922 100 100 100 100













36396 100 100 91
b
83











36410 100 100 100 75
36429 92 100 100
b
75
E. coli  ATCC 25922 100 100
e
92 100
A. salmonicida  ATCC 33658 92 100 92 100
a
 AMP = ampicillin, FFN = florfenicol, OTC = oxytetracycline, PRI = ormetoprim - sulfadimethoxine.
b
 Average of 11 replicates since the bacteria did not grow in one replicate.
c
 All MIC results were above the highest drug concentration tested.
d
 Some isolates had MIC at lower limit or less, presumed to agree within a dilution.
e
 Some isolates had MIC at upper limit or greater, presumed to agree within a dilution.  
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Chapter 3: Determination of quality control ranges to nine 
antimicrobials for broth microdilution susceptibility testing of 
Flavobacterium columnare and Flavobacterium psychrophilum. 
 
Gieseker, C M, Mayer, T D, Crosby, T C, Carson, J, Dalsgaard, I, Darwish, A M, Gaunt, 
P S, Gao, D X, Hsu, H-M, Lin, T L, Oaks, J L , Pyecroft, M, Teitzel, C, Somsiri, T and 
Wu, C C. Published in Diseases of Aquatic Organisms 101:207-215, 2012. 
 
3.1 Abstract 
A multi-laboratory broth microdilution method trial was performed to standardize 
the specialized test conditions required for the fish pathogens Flavobacterium columnare 
and F. psychrophilum. Nine laboratories tested the quality control (QC) strains 
Escherichia coli (E. coli) ATCC 25922 and Aeromonas salmonicida subsp. salmonicida 
(A. salmonicida) ATCC 33658 against 10 antimicrobials (ampicillin, enrofloxacin, 
erythromycin, florfenicol, flumequine, gentamicin, ormetoprim / sulfadimethoxine, 
oxolinic acid, oxytetracycline and trimethoprim / sulfamethoxazole) in diluted (4 g/L) 
cation-adjusted Mueller-Hinton broth incubated at 28 and 18 ºC for 44-48 and 92-96 
hours, respectively. QC ranges were set for 9 of the 10 antimicrobials. Most of the 
minimal inhibitory concentration (MIC) distributions (16 of 18, 9 drugs at both 
temperatures) for A. salmonicida ATCC 33658 were centered on a single median MIC ± 
1 two-fold drug dilution resulting in a QC range that spanned three dilutions. More of the 
E. coli ATCC 25922 MIC distributions (7 of 16) were centered between two MIC 
dilutions requiring a four dilution QC range. A QC range could not be determined for E. 
62 
coli ATCC 25922 against 2 antimicrobials at the low temperature. These data and their 
associated QC ranges have been approved by the Clinical and Laboratory Standards 
Institute (CLSI), and will be included in the next edition of the CLSI’s M49-A Guideline. 
This method represents the first standardized reference method for testing fish pathogenic 
Flavobacterium spp. 
3.2 Introduction 
The nutritionally fastidious aquatic gliding bacteria Flavobacterium columnare 
(F. columnare) and F. psychrophilum represent an important group of fish pathogens that 
need standard antimicrobial susceptibility testing (AST) methods. They are major fish 
pathogens that cause significant disease losses in freshwater aquaculture worldwide 
(Wakabayaski and Egusa, 1966; Bernardet, 1989; Holt et al., 1993; Wagner et al., 2002; 
Nematollahi et al., 2003; Pulkkinen et al., 2010). The Clinical and Laboratory Standards 
Institute (CLSI) provides 2 consensus-approved guidelines with reference methods and 
quality control (QC) criteria for disk diffusion and broth dilution susceptibility testing of 
non-fastidious aquatic bacteria (CLSI, 2006 a, b) based on the work of Miller et al. (2003, 
2005). CLSI groups fastidious aquatic bacterial pathogens with similar growth condition 
requirements, and offers potential media and incubation modifications; however, no 
standard reference methods or QC criteria have been developed to date. 
In general, three AST methods can be developed as standard CLSI reference 
methods: disk diffusion, broth dilution, and agar dilution. Dilution techniques (agar and 
broth) are preferable to disk diffusion since these tests yield a minimal inhibitory 
concentration (MIC) that can be directly compared to the pharmacokinetics of the drug in 
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the animal. However, disk diffusion is popular among fish disease diagnosticians because 
the method is inexpensive, easy to perform and better suits laboratories that test only a 
small number of isolates infrequently. Disk diffusion is not as practical for testing the fish 
pathogenic Flavobacteria, in particular F. columnare, since the gliding motility of the 
bacterium distorts the margin of the inhibitory zone (Farmer, 2004). Alternatively agar 
dilution, the gold standard method, has been used to test F. psychrophilum (Bruun et al., 
2000; Schmidt et al., 2000; Michel et al., 2003), but the method is fairly labor intensive 
and does not lend itself nicely to ad hoc testing. Therefore, we determined that broth 
dilution, specifically broth microdilution, was the best option to develop as a standard 
reference AST method. 
CLSI’s broth dilution testing guideline for aquatic bacteria (M49-A) suggests 
using diluted Mueller-Hinton broth (MHB) (3 g/L) for testing F. columnare, F. 
psychrophilum and F. branchiophilum. The guide also suggests that F. psychrophilum 
and F. branchiophilum may need additional supplements of 5% horse or fetal calf serum, 
and/or NaCl (CLSI, 2006b). These recommendations were partly based on the disk 
diffusion methods developed by Hawke and Thune (1992) for testing F. columnare. 
However, more recent research has determined that only diluted MHB (4 g/L) is needed 




, typically added 
to MHB for broth dilution susceptibility testing, may not be needed (Farmer, 2004; 
Darwish et al., 2008). Preliminary work at the Food and Drug Administration, Center for 
Veterinary Medicine, Office of Research found diluted MHB (4 g/L) yielded consistent 
MICs for F. columnare and F. psychrophilum isolates, as well as for both QC strains 
referenced in CLSI’s M42-A and M49-A guidelines. We had too few isolates to test F. 
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branchiophilum adequately. We also found that Ca
++
 (4 mg/L) and Mg
++ 
(2 mg/L) were 
needed for testing F. psychrophilum, and serum supplementation was not necessary for 
testing of F. columnare or F. pyschrophilum. Sodium chloride supplementation was not 
considered since F. columnare and F. psychrophilum generally do not grow in media 
containing more than 0.5% NaCl (Bernardet and Grimont, 1989). Ultimately, we found 
diluted MHB (4 g/L) with Ca
++
 (4 mg/L) and Mg
++ 
(2 mg/L) was a good medium for 
broth dilution testing of both F. columnare and F. psychrophilum isolates. 
Optimal incubation conditions for F. columnare and F. psychrophilum also 
needed to be established. We found that incubating F. columnare at 28°C for 44-48 h as 
recommended by the CLSI (2006b) and Darwish et al. (2008) worked well. In contrast, a 
slightly higher incubation temperature (18°C) and longer incubation time (96 h) than 
recommended by the CLSI was needed for F. psychrophilum (Gieseker et al., in prep.). 
Although 18°C is just above the recommended growth temperature of 15°C for F. 
psychrophilum (CLSI, 2006b), the bacterium grows similarly at both temperatures (Holt 
et al., 1989). A longer incubation time is needed as the shorter incubation times of 44-72 
h, as recommended by the CLSI, yielded misleadingly low MICs in preliminary testing 
(Gieseker et al., unpublished). 
To establish a standard AST method for fish pathogenic Flavobacteria, drug 
susceptibility testing ranges were needed for the QC strains under the altered test 
conditions optimized for these bacteria. Herein, we report the results of a multi-laboratory 
standardization trial that established MIC QC ranges of 9 antimicrobials for the QC 
strains, Escherichia coli (E. coli ATCC 25922; NCIMB 12210) and Aeromonas 
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salmonicida subsp. salmonicida (A. salmonicida, ATCC 33658; NCIMB 1102). CLSI’s 
Subcommittee on Veterinary Antimicrobial Susceptibility Testing (VAST) – Aquaculture 
Working Group analyzed the data and proposed QC ranges to the VAST Subcommittee. 
The ranges presented here were unanimously accepted for inclusion in the next edition of 
CLSI’s M49-A Guideline. These QC ranges and testing methods provide the first 
standard AST reference methods for the important fish pathogens F. columnare and F. 
psychrophilum. 
3.3 Materials and Methods 
The design of this study was based on CLSI guideline M37-A3 (CLSI, 2008). The 
QC strains, E. coli (ATCC 25922; NCIMB 12210) and A. salmonicida (ATCC 33658; 
NCIMB 1102), were tested by nine laboratories using broth microdilution methods 
developed for testing Flavobacterium psychrophilum and F. columnare (Darwish et al., 
2008; Gieseker et al., in prep). Both QC strains were tested at 18°C (92-96 h) and 28°C 
(44-48 h) using three different lots of diluted (4 g/L) cation-adjusted Mueller-Hinton 
broth (CAMHB). All laboratories repeated each test 10 times. Each replicate had 3 panels 
(media lots 1, 2, & 3) (3 panels x 10 replicates = 30 replicates/laboratory for each 
drug/strain/temperature combination). 
3.3.1 Participating Laboratories 
Nine laboratories participated in the standardization trial. The laboratories were 
the Food and Drug Administration, Center for Veterinary Medicine, Office of Research, 
Laurel, Maryland, USA (FDA/CVM/OR); Animal Health Laboratory, Department of 
Primary Industries, Parks, Water & Environment, Launceston, Tasmania, Australia; 
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National Veterinary Institute, Technical University of Denmark, Frederiksberg, 
Denmark; Harry K. Dupree Stuttgart National Aquaculture Research Center, Stuttgart, 
Arkansas, USA; Mississippi State University, College of Veterinary Medicine, 
Stoneville, Mississippi, USA; University of Wisconsin Veterinary Diagnostic Laboratory, 
Madison, Wisconsin, USA; Washington Animal Disease Laboratory, Pullman, 
Washington, USA; Inland Aquatic Animal Health Research Institute, Department of 
Fisheries, Kasetsart University Campus, Jaktujak, Bangkok, Thailand; Animal Disease 
Diagnostic Laboratory, Purdue University, West Lafayette, Indiana, USA. All 9 
laboratories completed testing for the trial. The data presented are based on 8 laboratories 
for E. coli, ATCC 25922 and 7 labs for A. salmonicida ATCC 33658. One laboratory 
admitted making mistakes on their MIC interpretations; therefore, the data from that 
laboratory were excluded from the analysis. In addition, another laboratory could only 
test E. coli due to import restrictions against A. salmonicida.   
3.3.2 Broth microdilution panels and test media 
Custom, commercially prepared dry-form 96-well broth microdilution panels 
were purchased from Trek Diagnostic Systems (Cleveland, Ohio, USA). Each well had 
dried residue of a separate two-fold dilution of one of 10 antimicrobials. Ten dilutions 
were tested for each of the following antimicrobials: ampicillin (0.03 – 16 μg/mL), 
enrofloxacin (0.001 – 0.5 μg/mL), erythromycin (0.25 – 128 μg/mL), florfenicol (0.12 – 
64 μg/mL), flumequine (0.004 – 2 μg/mL), oxolinic acid (0.002 – 1 μg/mL), 
oxytetracycline (0.015 – 8 μg/mL) and ormetoprim / sulfadimethoxine (0.008/0.15 – 4/76 
µg/mL). Seven dilutions were tested of gentamicin (0.03 – 2 μg/mL) and trimethoprim / 
sulfamethoxazole (0.008/0.15 – 0.5/9.5 µg/mL). 
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Three separate lots of broth were made from dehydrated powders manufactured 
by BBL™ (212322, lot 7331751) and Difco™ (275710, lot 8127115) (Becton-Dickinson, 
Sparks, Maryland, USA), and Oxoid (CM0405, lot 597351; Basingstoke, Hampshire, 
United Kingdom). 11-mL aliquots of each broth were prepared by Trek Diagnostics 
Systems. Calcium (4 mg/L) and magnesium (2 mg/L) cations were added by CLSI 
guidelines if the prepared media were not already supplemented. 
3.3.3 Test bacteria and test conditions 
American Type Culture Collection (ATCC, Manassas, Virginia, USA) reference 
strains of Escherichia coli ATCC 25922 and Aeromonas salmonicida ATCC 33658 were 
incubated at 18°C for 92-96 h and 28°C for 44-48 h in diluted (4 g/L) CAMHB. 
3.3.4 Broth microdilution susceptibility testing 
Tests were conducted in each laboratory over a minimum of three days with a 
maximum of four replicates per day. Each laboratory (besides one mentioned above) 
tested 10 replicates of each strain at both temperatures. Each replicate consisted of three 
96-well panels; one panel for each lot of broth.  
Prior to each test day, strains were subcultured twice on tryptic soy agar 
supplemented with 5% sheep blood. On each test day a single suspension was prepared of 
each strain to a predetermined turbidity measured by colorimeter (0.5 McFarland), 
spectrophotometer (0.08 to 0.13 at OD625) or turbidimeter (20-30 NTUs). 
Fifty-five µL of the cell suspension were added to each 11 mL aliquot of broth 
(1:200 dilution). Each 11 mL aliquot of broth was used to inoculate into a 96-well broth 
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microdilution panel. One hundred (100) µL of the inoculated broth was added to each 
well using a Sensititre® autoinoculator (Trek Diagnostic Systems, 3 labs) or a 
multichannel pipette (6 labs). To prevent contamination and dehydration, plastic adhesive 
seals were immediately attached to the panels covering the top of the wells. Within 15 
minutes of inoculation, the panels were placed in their respective incubators. No more 
than 4 panels were stacked together to achieve a uniform temperature across the panels.  
Actual cell densities were determined using a colony count procedure where two 
panels on each test day were arbitrarily chosen for each QC strain (one each at 18°C and 
28°C).  Ten µL were removed from the positive control well and placed in 10 mL sterile 
saline (1:1000 dilution). A 100 µl aliquot was evenly spread on a tryptic soy agar plate 
supplemented with 5% sheep blood. Colony count plates were incubated under the same 
conditions (temperature and time) as the 96-well panels, and colony-forming units 
(CFUs) were counted at the same time MICs were determined. Mean CFU/mL and 
standard deviations (SD) were calculated for each drug/strain/temperature combination 
across all replicates. 
After the appropriate incubation period, the panel seal was removed to read 
panels. Panels were examined for growth in the wells, either as a pellet or turbidity. The 
MIC was the first well in the dilution series without growth. When interpreting results in 
wells with the bacteriostatic sulfonamides, growth < 80% of the pellet density in the 
positive control well was recorded as growth limited, indicative of a bacteriostatic effect 
evident as a trailing endpoint. Where this occurred, the MIC was established by 
identifying the well with 50% growth when compared with the positive control well. The 
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next highest dilution well adjacent to the 50% growth well was assumed to have 
approximately 80% growth; therefore the concentration in the well with 50% growth 
inhibition was considered the MIC. 
3.3.5 Data Analysis 
The data were pooled into frequency distributions by broth lot, and also by 
laboratory. Each drug/strain/temperature combination was analyzed separately for MIC 
mean, mode, median, minimum, maximum, and range. 
All MIC data were entered into RangeFinder; a specialized Excel spreadsheet 
program that analyzes antimicrobial susceptibility testing data from CLSI standardization 
trials (Turnidge & Bordash, 2007). RangeFinder calculated a QC range, number of 2-fold 
dilutions in the range, and the percent of observations captured by the calculated range. 
Frequency distributions and histograms for each drug/strain/temperature 
combination were used to also determine QC ranges using the median method developed 
by Gavan et al. (1981). Ideally, the QC ranges encompassed 95% of the observations, and 
spanned 3 drug concentrations centered on the mode of the distribution. If data were 
skewed in one direction, where the MIC frequency at the 2-fold dilution immediately 
adjacent to the mode was greater than or equal to 60% of MIC frequency at the mode, an 
additional 2-fold dilution was added to the final proposed QC range. The CLSI’s VAST – 
Aquaculture Working Group compared the QC ranges estimated by the Gavan and 
RangeFinder methods to determine proposed QC ranges for each drug/strain/temperature 
combination. Both methods use arbitrary limits that require expert opinion.  
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3.3.6 Confirmation of the drug concentration on the custom dry-form broth 
microdilution panels 
One laboratory (FDA/CVM/OR) followed the same procedures used in the 
standardization trial to test five subcultures of E. coli ATCC 25922 and five subcultures 
of A. salmonicida ATCC 33658 in undiluted CAMHB to confirm the potency of the 
drugs on the panels. The testing was repeated three times and each replicate was prepared 
on a separate day. Tests were conducted at 22°C and 28°C according to CLSI M49-A 
guideline. Spread plate colony counts were also prepared identically as described 
previously to confirm cell densities on each day testing was conducted. Drug potencies 
were considered acceptable if MIC test results from the two QC strains on the custom 
dry-form panels were within the acceptable ranges listed in the M49-A guideline. 
3.4 Results and Discussion 
3.4.1 Standardization trial 
Using standard AST methods makes it easier for laboratories to reliably share 
data, monitor development of drug resistance and provide consistent clinical 
recommendations. Proper QC procedures with expected test results are required to 
confirm method performance. Miller et al., (2003, 2005) established the first standard 
reference disk diffusion and MIC testing methods for non-fastidious aquatic bacterial 
pathogens (CLSI, 2006a, b). These organisms include members of Enterobacteriaceae 
and Vibrionaceae, and A. salmonicida, A. hydrophila and other mesophilic aeromonads, 
Pseudomonas spp., Plesiomonas shigelloides, and Shewanella spp.  Many fastidious 
aquatic bacteria are also important fish pathogens. In particular, the pathogenic gliding 
bacteria, F. columnare and F. psychrophilum cause disease and major economic loss for a 
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wide variety of freshwater aquaculture industries. Recent approval of antimicrobials in 
the United States to control mortality of fish infected with F. columnare and F. 
psychrophilum have further fueled a need for standard AST methods for these fastidious 
organisms. Our research directly addresses this issue and reports the results of a 
standardization trial to set MIC QC ranges for testing F. columnare and F. 
psychrophilum. 
The proposed QC ranges determined by the CLSI VAST – Aquaculture Working 
Group  were presented to the VAST subcommittee and accepted with minor revisions to 
be included in the next edition of the M49-A guideline for dilution susceptibility testing 
of bacteria isolated from aquatic animals (CLSI, 2006b). Table 1 demonstrates the lot-by-
lot comparison of the MIC results from our standardization trial. No laboratory was 
consistently different although in some cases a laboratory had some MIC results outside 
of the majority (~95%) of the data distribution. A visual analysis comparing data by broth 
lot showed that all lots consistently agreed across the laboratories. Tables 2-5 summarize 
the MIC results and QC limits approved by the CLSI VAST Subcommittee for E. coli 
ATCC 25922 and A. salmonicida ATCC 33658. Most of the MICs observed at both 
temperatures for A. salmonicida ATCC 33658 were centered on a single median MIC ± 1 
two-fold drug dilution (e.g., Fig. 1). In two cases, enrofloxacin at 18°C  and 
ormetoprim/sulfadimethoxine at 18°C (Fig. 2), a 4 two-fold dilution range was approved 
since the MIC distribution was asymmetric, and had a frequency adjacent to the median 
that was >60% of the frequency of the median MIC. More of the approved QC ranges for 
E. coli ATCC 25922 were 4 dilutions. This was the case at 28°C for 4 of the 9 drugs, and 
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at 18°C for 3 of 7 drugs; in addition, because of inadequate data, QC ranges could not be 
established for enrofloxacin and ormetoprim/sulfadimethoxine at 18°C. 
No MIC QC ranges could be set for gentamicin since a majority of laboratories 
observed MICs below the test range (≤0.03 µg/mL). When compared to frozen-form 
panels with the same drug format (performed by one laboratory, FDA/CVM/OR), 
gentamicin MICs from the dry-form panels were still observed to be below the test 
concentration range (data not shown). However, gentamicin MIC results were in range 
when both QC strains were tested with the dry-form panels in full strength CAMHB in 
this study (below) and by the manufacturer. We opted to use dry-form panels since these 
panels could withstand potentially longer transit times, and were shown to perform well 
in a similar standardization trial (Miller et al., 2005). Miller et al. (2005) also found that 
MIC results on dry-form and frozen-form broth microdilution panels agreed for the same 
QC strains. 
Colony count data tracking approximated the final target concentration of 
approximately 5 x 10
5
 CFU/mL bacteria as recommended by the CLSI (2006b). The 
mean CFU/mL (SD) for A. salmonicida ATCC 33658 was 4.0 x 10
5
 CFU/mL (1.8 x 10
5
) 
at 18°C and 4.3 x 10
5
 CFU/mL (1.7 x 10
5
) at 28°C. The mean CFU/mL (SD) for E. coli 
ATCC 25922 was 3.3 x 10
5
 CFU/mL (1.9 x 10
5
) at 18°C and 4.5 x 10
5
 CFU/mL (1.6 x 
10
5
) at 28°C. No trends were observed between MIC results and low/high cell densities 
indicating the variability in the cell densities did not markedly affect MIC results. 
3.4.2 Validation of drug concentrations with undiluted CAMHB 
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The established QC ranges from the M49-A CLSI guideline (CLSI, 2006b) for 
broth microdilution testing in full strength CAMHB of A. salmonicida ATCC 33658 and 
E. coli ATCC 25922 at 22°C (24 & 48 h) and 28°C (24 h) were used to validate the drug 
concentrations of the custom dry-form broth microdilution panels. All the MIC results at 
22°C, were within the accepted QC ranges, and were in agreement among the replicates 
within ± 1 two-fold dilution except for erythromycin results for A. salmonicida. At 24 
hours, 9 of 15 erythromycin test results were out of the accepted parameters, but by 48 
hours only 2 of 15 were out of range. 
All of the 28°C A. salmonicida erythromycin MIC results were in the QC range, 
but were concentrated at the lowest MIC.  However, in the standardization trial the 
median erythromycin MIC data in diluted CAMHB for A. salmonicida at 18°C (96 h) 
was very similar to 28°C (48 h; Tables 4 & 5). At least 99.5% of the MIC data was within 
the same two-fold dilution range with the same median at both temperatures. 
The data from this validation experiment were presented to the CLSI VAST 
committee concurrently with the standardization trial and the results confirmed that drug 
concentration ranges were valid on the dry-form panels used in the standardization trial.  
3.5 Conclusions 
Consistent MIC results across the laboratories showed that E. coli ATCC 25922 
and A. salmonicida ATCC 33658 are reliable QC strains for broth microdilution testing at 
18°C and 28°C in diluted CAMHB (4 g/L). These strains can be used for QC testing of 
clinical isolates of Flavobacterium columnare and Flavobacterium psychrophilum.  
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CLSI testing guidelines are intended to be living documents that are continually 
updated as new methods and approaches are developed. This newly standardized AST 
method for Flavobacteria and the MIC QC ranges provided in Table 6 will be included in 
the next edition of CLSI’s M49-A guideline. We hope that this work as well as the work 
of Miller et al. (2003, 2005) will serve as helpful resources to aid in continued 
development of more standardized AST methods for other important aquatic bacterial 
pathogens. 
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Table 3-1. Comparison by broth lot of MIC results across each laboratory: Escherichia 
coli ATCC 25922 incubated at 18°C for 92-96 hours. The grey shaded area denotes the 
CLSI-approved QC range.  
Lab 1 Lab 2 Lab 3 Lab 4 Lab 5 Lab 6 Lab 7 Lab 8 All Labs





0.25 2 4 4 2 2 1 2 2 8 6 3 10 8 7 7 2 6 39 18 19
0.5 6 10 10 2 8 6 6 8 10 5 7 8 8 10 8 2 4 7 2 3 3 8 4 32 57 56
1 2 3 2 3 3 1 8 3 3
2 1 2 2 1 2 2
4
8
N 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 10 80 80 80
Geomean 0.50 0.50 0.50 0.54 0.66 0.76 0.38 0.44 0.50 0.54 0.62 0.50 0.44 0.50 0.44 0.29 0.33 0.41 0.25 0.29 0.31 0.31 0.44 0.33 0.39 0.45 0.45
mode 0.5 0.5 0.5 0.25 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.25 0.25 0.5 0.25 0.25 0.25 0.25 0.5 0.25 0.25 0.5 0.5
min 0.25 0.5 0.5 0.25 0.5 0.5 0.25 0.25 0.5 0.25 0.5 0.25 0.25 0.5 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25
max 1 0.5 0.5 2 2 2 0.5 0.5 0.5 1 1 1 0.5 0.5 0.5 0.5 0.5 0.5 0.25 0.5 0.5 0.5 0.5 0.5 2 2 2
range 3 1 1 4 3 3 2 2 1 3 2 3 2 1 2 2 2 2 1 2 2 2 2 2 4 4 4
All lab median = 0.5




Table 3-2. MIC results for Escherichia coli ATCC 25922 incubated at 28 ± 2°C for 44-48 
hours in diluted (4 g/L) CAMHB against 9 antimicrobials.  
Antimicrobial Testing Range # of % within
agent (ug/mL) Inter-Laboratory Median CLSI-approved dilutions in QC range
range QC range QC range (n=239)
Ampicillin 0.03–16 1–4 2 1-4 3 100.0
Enrofloxacin 0.001–0.5 0.004–0.015 0.008 0.002-0.015 4 100.0
Erythromycin 0.25–128 4–64 32 16-64 3 94.6
Florfenicol 0.12–64 1–8 4 2-8 3 99.6
Flumequine 0.004–2 0.12–0.5 0.25 0.06-0.5 4 100.0
*Ormetoprim/Sulfadimethoxine 0.008/0.15-4/76 0.06/1.19-0.5/9.5 0.25/4.75 0.12/2.38-0.5/9.5 3 97.1
Oxolinic Acid 0.002–1 0.06–0.25 0.06 0.03-0.12 3 99.6
Oxytetracycline 0.015–8 0.12–1 0.5 0.12-1 4 100.0
**Trimethoprim/Sulfamethoxazole 0.008/0.15-0.5/9.5 0.015/0.30-0.06/1.19 0.06/1.19 0.015/0.30-0.12/2.38 4 100.0 ***
 
 *First value indicates concentration of ormetoprim; second value concentration of sulfadimethoxine





Table 3-3. MIC results of Escherichia coli ATCC 25922 incubated at 18 ± 2°C for 92-96 
hours in diluted (4 g/L) CAMHB against 9 antimicrobials.  
Antimicrobial Testing Range # of % within
agent (ug/mL) Inter-Laboratory Median CLSI-approved dilutions in QC range
range QC range QC range (n=240)
Ampicillin 0.03–16 0.25–>16 4 2-8 3 95.8
Enrofloxacin 0.001–0.5 ≤0.001–0.015 0.002 No ranges proposed
Erythromycin 0.25–128 2-32 8 4-16 3 97.5
Florfenicol 0.12–64 ≤0.12–32 8 4-32 4 97.9
Flumequine 0.004–2 ≤0.004–0.5 0.12 0.06-0.25 3 96.3
*Ormetoprim/Sulfadimethoxine 0.008/0.15-4/76 0.015/0.30-1/19 0.5/9.5 Ranges not accepted
Oxolinic Acid 0.002–1 0.015–0.12 0.06 0.03-0.12 3 97.1
Oxytetracycline 0.015–8 0.25–2 0.5 0.12-1 4 97.9
**Trimethoprim/Sulfamethoxazole 0.008/0.15-0.5/9.5 ≤0.008/0.15–0.12/2.38 0.03/0.59 0.015/0.30-0.12/2.38 4 97.5
 
 *First value indicates concentration of ormetoprim; second value concentration of sulfadimethoxine





Table 3-4. MIC results of Aeromonas salmonicida subsp. salmonicida ATCC 33658 
incubated at 28 ± 2°C for 44-48 hours in diluted (4 g/L) CAMHB against 9 
antimicrobials.  
Antimicrobial Testing Range # of % within
agent (ug/mL) Inter-Laboratory Median CLSI-approved dilutions in QC range
range QC range QC range (n=210)
Ampicillin 0.03–16 0.12–16 0.12 0.06-0.25 3 99.0
Enrofloxacin 0.001–0.5 0.008–0.015 0.008 0.004-0.015 3 100.0
Erythromycin 0.25–128 1–16 8 4-16 3 99.5
Florfenicol 0.12–64 0.5–2 0.5 0.25-1 3 99.5
Flumequine 0.004–2 0.015–0.06 0.03 0.015-0.06 3 100.0
*Ormetoprim/Sulfadimethoxine 0.008/0.15-4/76 0.06/1.19-0.5/9.5 0.12/2.38 0.06/1.19-0.25/4.75 3 99.5
Oxolinic Acid 0.002–1 0.008–0.06 0.015 0.008-0.03 3 99.5
Oxytetracycline 0.015–8 0.12–0.5 0.12 0.06-0.25 3 99.5
**Trimethoprim/Sulfamethoxazole 0.008/0.15-0.5/9.5 ≤0.008/0.15–0.12/2.38 0.06/1.19 0.03/0.59-0.12/2.38 3 99.5
 
 *First value indicates concentration of ormetoprim; second value concentration of sulfadimethoxine




Table 3-5. MIC results of Aeromonas salmonicida subsp. salmonicida ATCC 33658 
incubated at 18 ± 2°C for 92-96 hours in diluted (4 g/L) CAMHB against 9 
antimicrobials. 
Antimicrobial Testing Range # of % within
agent (ug/mL) Inter-Laboratory Median CLSI-approved dilutions in QC range
range QC range QC range (n=210)
Ampicillin 0.03–16 0.12–1 0.12 0.06-0.25 3 98.1
Enrofloxacin 0.001–0.5 0.004–0.015 0.008 0.004-0.03 4 100.0
Erythromycin 0.25–128 4–16 8 4-16 3 100.0
Florfenicol 0.12–64 0.5–2 0.5 0.25-1 3 99.5
Flumequine 0.004–2 0.03–0.12 0.03 0.015-0.06 3 98.1
*Ormetoprim/Sulfadimethoxine 0.008/0.15-4/76 0.06/1.19-0.25/4.75 0.06/1.19 0.03/0.59-0.25/4.75 4 99.5
Oxolinic Acid 0.002–1 0.008–0.06 0.015 0.008-0.03 3 99.5
Oxytetracycline 0.015–8 0.12–1 0.12 0.06-0.25 3 99.5
**Trimethoprim/Sulfamethoxazole 0.008/0.15-0.5/9.5 0.015/0.30–0.06/1.19 0.03/0.59 0.015/0.30-0.06/1.19 3 100.0
 
 *First value indicates concentration of ormetoprim; second value concentration of sulfadimethoxine







Figure 3-1. MIC frequency distribution of Aeromonas salmonicida subsp. salmonicida 
ATCC 33658 against oxolinic acid, incubated at 18 °C for 96 hours. Black arrows 
























Aeromonas salmonicida subsp. salmonicida ATCC 33658




Figure 3-2. MIC frequency distribution of Aeromonas salmonicida ATCC 33658 against 
ormetoprim/sulfadimethoxine, incubated at 18 °C for 96 hours. Black arrows indicate the 
CLSI-approved MIC QC range. A 4-dilution MIC range was approved since the number 




















Aeromonas salmonicida subsp. salmonicida ATCC 33658
Ormetoprim/Sulfadimethoxine @ 18°C 96 hours
75%
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Table 3-6. Summary of CLSI approved MIC QC ranges (µg/mL) for broth dilution 
susceptibility testing in dilute 4 g/L CAMHB.  
  
Antimicrobial 
agent 28 °C, 44-48 h 18 °C, 92-96 h 28 °C, 44-48h 18 °C, 92-96 h
Ampicillin 1 - 4 2 - 8 0.06 - 0.25 0.06 - 0.25
Enrofloxacin 0.002 - 0.015 No ranges proposed 0.004 - 0.015 0.004 - 0.03
Erythromycin 16 - 64 4 - 16 4 - 16 4 - 16
Florfenicol 2 - 8 4 - 32 0.25 - 1 0.25 - 1 
Flumequine 0.06 - 0.5 0.06 - 0.25 0.015 - 0.06 0.015 - 0.06
*Ormetoprim/Sulfadimethoxine 0.12/2.38 - 0.5/9.5 Ranges not accepted 0.06/1.19 - 0.25/4.75 0.03/0.59 - 0.25/4.75
Oxolinic Acid 0.03 - 0.12 0.03 - 0.12 0.008 - 0.03 0.008 - 0.03
Oxytetracycline 0.12 - 1 0.12 - 1 0.06 - 0.25 0.06 - 0.25
**Trimethoprim/Sulfamethoxazole 0.015/0.3 - 0.12/2.38 015/0.3 - 0.12/2.38 0.03/0.59 - 0.12/2.38 0.015/0.3 - 0.06/1.19
 *First value indicates concentration of ormetoprim; second value concentration of sulfadimethoxine
**First value indicates concentration of trimethoprim; second value concentration of sulfamethoxazole
Escherichia coli ATCC 25922 Aeromonas salmonicida  ATCC 33658
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Chapter 4: Wild-type cutoff values calculated using a standardized 
broth microdilution susceptibility testing method for Flavobacterium 
columnare 
 
Gieseker, C M, Crosby, T C, Woods, L C. In Preparation. 
 
4.1 Abstract 
The gliding aquatic bacterium Flavobacterium columnare causes columnaris 
disease, a common problem for wild and farmed freshwater fish worldwide. Recently, a 
broth microdilution method was standardized to test the susceptibility of F. columnare 
against antimicrobials commonly used in aquaculture. We used the new method to 
generate minimal inhibitory concentrations (MICs) for 134 F. columnare isolates using 
commercial frozen broth microdilution plates with diluted (4 g/L) cation-adjusted 
Mueller-Hinton broth at 28°C for 44-48 hours. We constructed MIC frequency 
distributions to calculate epidemiological cutoff values (ECVs) for 10 antimicrobials, 
which separate the wild type (WT) isolates from the non-wild type (NWT) isolates that 
have acquired or selected antimicrobial resistance. ECVs were calculated for ampicillin, 
enrofloxacin, erythromycin, florfenicol, flumequine, gentamicin, ormetoprim-
sulfadimethoxine, oxolinic acid, oxytetracycline, and trimethoprim-sulfamethoxazole. 
We observed a clear bimodal division in the MIC frequency distribution of ampicillin, 
florfenicol, flumequine, and oxytetracycline. The distributions of enrofloxacin, 
erythromycin, and oxolinic acid were right-skewed toward higher MICs suggesting the 
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NWT isolates overlapped the WT isolates. Twenty-two isolates with apparent resistance, 
as indicated by decreased drug susceptibility relative to estimated cutoff values, were 
found for ampicillin, enrofloxacin, erythromycin, florfenicol, flumequine, oxolinic acid, 
and oxytetracycline. Of these isolates, 13 had decreased susceptibility to a single drug 
class, 3 isolates to 2 drug classes, and 6 isolates to 3 or more drug classes. These MIC 
frequency distributions and provisional ECVs provide data needed to set epidemiological 
cutoff values to monitor for the development of drug resistance among F. columnare. 
4.2 Introduction 
Flavobacterium columnare is a gram negative gliding bacterium ubiquitous in 
freshwater environments that belongs to the family Flavobacteriaceae in the bacterial 
phylum group Cytophaga-Flavobacterium-Bacteroides (Bernardet et al., 2002). The 
bacterium causes columnaris disease in a large array of wild and cultured freshwater fish 
throughout the world (Wakabayaski and Egusa, 1966; Bernardet, 1989; Pulkkinen et al., 
2010). Columnaris disease starts as dull whitish or yellowish patches on the gills or skin 
that rapidly expand (Davis, 1922). Biopsies or scrapes of the lesions show golden long, 
slender, flexible rod-shaped bacterial cells that aggregate into columns or piles. The 
disease was first discovered from freshwater fishes in the Midwestern United States by 
Davis (1922) followed by isolation of the bacterium by Ordal and Rucker (1944). As 
commercial aquaculture has grown, so have losses from F. columnare, for example, the 
bacterium is a leading disease problem in United States (U. S.) catfish (Wagner et al., 
2002) and Finnish trout industries (Pulkkinen et al., 2010). 
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In response to columnaris disease, researchers have identified potential 
antimicrobial treatments by testing certain F. columnare isolates for their susceptibility to 
various antimicrobials (Wakabayashi and Egusa, 1966; Amin et al., 1988; Hawke and 
Thune, 1992; Soltani et al., 1995; Decostere et al., 1998; Michel et al., 2002; Thomas-
Jinu and Goodwin, 2004b; Suomalainen et al., 2006; Kubilay et al., 2008; Gaunt et al., 
2010). Generally, F. columnare have decreased susceptibility to aminoglycosides and 
polymyxins while they are generally susceptible to penicillins, macrolides, phenicols, 
tetracyclines, and nitrofurans. Against folate inhibitors, F. columnare range widely in 
their susceptibility. Unfortunately, these generalizations are based on a low number of 
isolates tested with a wide variety of methods that differed in media, temperature, and/or 
incubation conditions. Moreover, no consistent method has been used to interpret the 
isolates’ susceptibility test results.  
Recently, a broth microdilution method for antimicrobial susceptibility testing of 
F. columnare was standardized to improve the ability of veterinarians to effectively treat 
columnaris disease and for researchers to monitor the emergence of antimicrobial 
resistance (Gieseker et al., 2012). The method uses the broth dilution technique since F. 
columnare grows better in liquid media (Garnjobst, 1945). Broth dilution tests determine 
the minimal inhibitory concentration (MIC) of a particular antimicrobial against the 
targeted bacteria. Expected quality control (QC) MIC ranges were established so tests 
could be validated (CLSI, 2014). 
Now that a standard susceptibility test exists for F. columnare, criteria, called 
epidemiological cutoff values (ECVs), are needed so that the test can be interpreted 
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correctly and used to monitor the development of antimicrobial resistance. The first step 
in setting an ECV for a broth dilution test is to construct MIC frequency distributions for 
each bacterium-antimicrobial combination (Turnidge and Paterson, 2007; CLSI, 2011). 
Analysis of the distributions, with visual inspection and/or statistics (Kronvall et al., 
2003; Turnidge et al., 2006;), determines the MIC that separates the wild-type (WT) 
isolates from the non-wild-type (NWT) isolates with acquired or selected antimicrobial 
resistance mechanisms.  
Our purpose here was to develop provisional ECVs using MIC frequency 
distributions of F. columnare, using the new standard broth microdilution technique. We 
collected over 100 F. columnare isolates from different locations, times, and fish species 
and tested them against 10 antimicrobials. These antimicrobials include drugs approved 
for F. columnare and unapproved drugs that may be used illegally or in countries with 
limited regulatory oversight. We then used a specialized Excel spreadsheet program 
(ECOFFinder) to analyze the frequency distribution to determine wild-type cutoff valves 
based on the methods developed by Turnidge et al. (2006).  
4.3 Materials and Methods 
4.3.1 Bacterial isolates and antimicrobials 
One hundred and thirty-four F. columnare isolates were donated from laboratories 
in the United States, France, Netherlands, Singapore, and Belgium (Table 1). The 134 
isolates represent 120 unique isolate numbers with 14 duplicate numbers that probably 
derived from the same bacterial clone (2 numbers repeated 3 times; 10 numbers repeated 
2 times). The identity of the isolates was confirmed by polymerase chain reaction (PCR) 
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of the 16S rRNA gene using the methods and species-specific primers described by 
Darwish et al. (2004). The QC strains Escherichia coli ATCC 25922 and Aeromonas 
salmonicida subsp. salmonicida ATCC 33658 were used to validate the antimicrobial 
susceptibility testing results. 
4.3.2 Antimicrobial susceptibility testing 
All broth microdilution tests followed CLSI guideline VET04-A2 (CLSI, 2014). 
The susceptibility of F. columnare against 10 antimicrobials was determined using 
commercially prepared, custom frozen broth microdilution plates (Trek Diagnostic 
Systems, Cleveland, Ohio). Each round bottom 96-well plate was filled with 50 µL of 
one drug at double the final test concentration or left empty as a positive control for cell 
growth. The wells were pre-filled with 10 two-fold dilutions of antimicrobials: ampicillin 
(0.06-32 µg/mL), enrofloxacin (0.002-1 µg/mL), erythromycin (0.5-256 µg/mL), 
florfenicol (0.25-128 µg/mL), flumequine (0.015-8 µg/mL), oxytetracycline (0.06-32 
µg/mL), oxolinic acid (0.008-4 µg/mL), and ormetoprim/sulfadimethoxine (0.015/0.03-
8/152 µg/mL), or 7 two-fold dilutions of gentamicin (0.12-8 µg/mL) and 
trimethoprim/sulfamethoxazole (0.015/0.3-1/19 µg/mL). The last 2 wells in the final row 
were left empty, filled only with the bacterial inoculum (positive control). Plates were 
received frozen and stored at ≤ -70° C until used. Seven rounds of testing were done to 
test each F. columnare isolate once. The QC strains E. coli ATCC 25922 and A. 
salmonicida subsp. salmonicida ATCC 33658 were tested in each round. 
Prior to testing, each F. columnare isolate was subcultured twice in tryptone yeast 
extract salts (TYES) broth (Holt et al., 1993) starting from a frozen culture stored at ≤ -
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70° C. Frozen E. coli ATCC 25922 and A. salmonicida subsp. salmonicida ATCC 33658 
were also subcultured twice on tryptic soy agar plates with 5% sheep blood. Broth and 
agar plates were incubated at 28°C for 24 hours. A single suspension was prepared of 
each isolate using the second subculture. Cultures of F. columnare were vortex mixed 
and held from 1-3 minutes to allow bacterial clumps to settle. The upper, more 
homogeneous fraction (approximately 2 mL) was removed, and adjusted as needed with 
sterile saline to a standard turbidity (0.5 McFarland) using a colorimeter (Hach Company, 
Loveland, Colorado, USA). Separate suspensions of E. coli ATCC 25922 and A. 
salmonicida subsp. salmonicida ATCC 33658 were prepared as specified by CLSI 
(CLSI, 2014). Each bacterial suspension was diluted in 11 mL 4 g/L cation-adjusted 
Mueller-Hinton broth (CAMHB); 1:200 (F. columnare) and 1:100 (E. coli ATCC 25922 
and A. salmonicida subsp. salmonicida ATCC 33658). Fifty µL of inoculated CAMHB 
was pipetted into each well, a separate plate for each isolate. Prior to sealing and 
incubating the plates, 10 µL of inoculum was removed from a positive control, diluted 
1:1000 in sterile saline and 100 µL of the dilution was spread on TYES (F. columnare) or 
BAP agar plate (E. coli, A. salmonicida subp. salmonicida) to monitor for a targeted cell 
density of approximately 5 x 10
5
 colony-forming units (CFU)/mL. The broth 
microdilution and colony count plates were incubated at 28°C for 44-48 hours. Broth 
microdilution plates and colony count plates were read and MICs determined as specified 
in CLSI VET04 (CLSI, 2014). MICs were defined as the lowest drug concentration that 
prevented visible growth (or a growth reduction of ≥ 80% for sulfonamides) of the 
bacteria. 
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We retested F. columnare isolates that had an MIC below the original dilution 
range tested for erythromycin (n=58) and oxytetracycline (n=35).  Frozen broth 
microdilution 96-well plates were prepared with 11 dilutions of erythromycin (0.002-2 
µg/mL) or oxytetracycline (0.002-2 µg/mL) following CLSI guidelines (CLSI, 2014) 
with 4 g/L CAMHB (Becton, Dickinson and Company, Sparks, Maryland). Separate 
plates were made for each drug. 
The highest final drug concentration was prepared in broth media at twice the 
target concentration. To allow for subsequent 2-fold dilutions, double the volume needed 
to fill the first column of the 96-well plates was made in a 50 mL centrifuge tube. The 
highest drug concentration was then serially diluted 2-fold 11 times in the same broth 
media in 50 mL centrifuge tubes. Fifty microliters of the appropriate concentration was 
added to the appropriate column of sterile 96-well plates using a multichannel pipette. 
The wells in the last column (1 positive control/isolate) and the lowest well in the second 
to last column (negative control) were only filled with broth. Plates were stored at ≤ -
70°C until used. A multichannel pipette was used to inoculate each row with a separate 
isolate. Multiple plates were used to test each F. columnare isolate once. Every plate had 
6 F. columnare isolates and the 2 quality control bacteria. 
We tabulated the MIC data by concentration into frequency distributions for each 
antimicrobial in a format similar to DeClercq et al. (2013) to facilitate comparison, and 
also calculated MIC median and geomean. Our work here and that of DeClercq et al. 
(2013) are the only 2 studies that have tested the susceptibility of a relatively large and 
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diverse isolate population of F. columnare. Declercq et al. (2013) used 3 g/L CAMHB, 
whereas we used 4 g/L (CLSI, 2014). 
4.3.3 Determination of provisional ECVs 
The MIC count data was entered into ECOFFinder; a specialized Excel 
spreadsheet program that fits a log-normal distribution to MIC frequency distributions in 
order to determine ECVs (Turnidge et al., 2006). ECOFFinder calculated 4 ECVs that 
include 95.0, 97.5, 99.0, and 99.9 % of the isolates in the susceptible population. The 
ECV is the highest MIC of the WT population of a bacterial species that has typical 
antimicrobial susceptibility. Any isolates with an MIC above the ECV presumably have 
developed decreased susceptibility and are termed NWT. 
4.4 Results 
Both QC strains, Escherichia coli ATCC 25922 and Aeromonas salmonicida 
subp. salmonicida ATCC 33658, produced MICs within the approved ranges for all 
antimicrobials tested except gentamicin, for which no QC ranges exist (Chapter 4: 
Gieseker et al., 2012). 
MICs of most F. columnare isolates were grouped together in the distribution at 
the lower range (Table 2). A few NWT isolates had higher MICs that skewed the 
distribution to the right for all drugs except gentamicin and the sulfonamides. The 
geomean for each drug was typically higher than the median due to the right-skewed 
distribution. The isolate MICs were more widely distributed for both potentiated 
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sulfonamides, with MICs concentrated in 4 drug concentrations that had a relatively even 
unimodal MIC distribution out to 5 and 7 drug concentrations.  
A few isolates were clearly less susceptible to the drugs ampicillin, florfenicol, 
flumequine, and oxytetracycline with MICs separated from the WT population by at least 
1 two-fold dilution. In comparing the different ECVs (Table 3), the 99.9% cutoff value 
most clearly separated the less susceptible WT isolates. The primary population 
overlapped the less susceptible isolates in the enrofloxacin, erythromycin, and oxolinic 
acid MIC distributions; therefore, we used the 99.9% cutoff value to identify the less 
susceptible isolates (Table 2). 
Table 4 lists the NWT F. columnare isolates with decreased antimicrobial 
susceptibility. Twenty-two of the 134 isolates had elevated MICs for at least 1 of the 
antimicrobials. Three of these isolates exhibited decreased susceptibility to 2 drug classes 
and 6 isolates to 3 or more drug classes. The majority of these NWT isolates from 
channel catfish (50%) or koi (27%). 
4.5 Discussion 
We studied the antimicrobial susceptibility patterns of F. columnare against 10 
antimicrobials with a broth microdilution method that used 4 g/L dilute cation-adjusted 
Mueller-Hinton broth. Our results provide MIC frequency distributions and provisional 
ECVs to be considered by CLSI’s Subcommittee for Veterinary Antimicrobial 
Susceptibility Testing to set official ECVs. The MIC distributions clearly show some F. 
columnare isolates have decreased susceptibility to antimicrobials commonly used in 
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aquaculture. In general, our results agree with the work of Darwish et al. (2008) and 
DeClercq et al. (2013) who also studied the antimicrobial susceptibility patterns of F. 
columnare using similar, but non-standardized broth microdilution methods. 
To our knowledge, this is the first report of F. columnare isolates with elevated 
MICs against florfenicol. These isolates were clearly separated from the majority of wild-
type isolates suggesting the isolates have decreased susceptibility to florfenicol (Turnidge 
and Paterson, 2007). An ECV of ≤ 4 µg/mL best separated the NWT isolates from the 
main WT isolate group. This ECV agrees with recent reports, since all F. columnare 
tested had florfenicol MICs ≤ 2 µg/mL (Darwish et al., 2008; Declercq et al., 2013).  
Declercq et al. (2013) found two F. columnare isolates with elevated MICs to 
chloramphenicol which is in the same class as florfenicol. We did not test 
chloramphenicol; however, our work together with DeClercq et al (2013) suggests some 
F. columnare could exhibit decreased susceptibility to both drugs. Bacteria with the 
enzyme chloramphenicol acetyltransferase selectively inactivates only chloramphenicol 
(Schwarz et al., 2004), whereas the floR gene mediates the specific efflux of both 
chloramphenicol and florfenicol (Butaye et al., 2003). Less specific multidrug efflux 
proteins also export chloramphenicol and/or florfenicol.  All of our phenicol-tolerant 
isolates with decreased phenicol susceptibility and those reported by Declercq et al. 
(2013) had elevated MICs against multiple drugs suggesting a non-specific resistance 
mechanism that could include both phenicols; however, the mechanism needs to be 
investigated. 
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We also found multiple F. columnare with decreased susceptibility to ampicillin 
and erythromycin, with MICs above the provisional ECVs. The WT and NWT isolates 
were clearly separated for ampicillin, but overlapped for erythromycin. Some isolates had 
decreased susceptibility to only ampicillin while others included multiple drugs. All 
NWT isolates with respect to erythromycin also had decreased susceptibility to other 
drug classes. Therefore, some of these isolates appear to have a single resistance 
mechanism specific to beta-lactams while others have non-specific or multiple 
mechanisms. Although previous broth microdilution testing found F. columnare with 
elevated MICs against ampicillin or erythromycin (Darwish et al., 2008; DeClercq et al., 
2013), this is the first definitive report of multiple F. columnare isolates from various 
sources with elevated MICs against these antimicrobials.  
As recently reported by Declercq et al. (2013), we also observed individual 
isolates with decreased susceptibility to some or all of the three quinolones and/or 
oxytetracycline (DeClercq et al., 2013). The WT and NWT MIC distributions overlapped 
for enrofloxacin and oxolinic acid. The provisional ECVs split the bimodal distributions 
of flumequine and oxytetracycline MICs. As is common practice in setting MIC 
breakpoints, these provisional ECVs may need adjustment or additional testing so they 
can most accurately delineate the WT isolate population (Turnidge and Paterson, 2007). 
We also found unimodal distributions for the aminoglycoside gentamicin and the 
2 folate inhibiting combinations suggesting the isolates have not acquired resistance. 
These distributions are comparable to those reported by DeClercq et al. (2013) using a 
similar broth microdilution method. However, disk diffusion and agar dilution testing 
95 
suggests some F. columnare have decreased susceptibility to aminoglycosides and/or 
folate inhibitors (Wakabayashi and Egusa, 1966; Hawke and Thune, 1992; Soltani et al., 
1995; Decostere et al., 1998; Michel et al., 2002; Thomas-Jinu and Goodwin, 2004b; 
Suomalainen et al., 2006; Kubilay et al., 2008). It is unclear whether these previous 
reports are indeed true. Experimental infections using two F. columnare isolates (PB-02-
41 & AL-94-203) which showed decreased susceptibility (based on disk diffusion tests) 
to the ormetoprim/sulfadimethoxine (Romet®) were controlled by 50 mg/kg Romet®  
fed once daily for 15 days prior to bacterial challenge (Thomas-Jinu and Goodwin, 2004 
a/b). Therefore, the particular disk diffusion method used to test isolates PB-02-41 and 
AL-94-203 did not appear to accurately predict resistance or, the decreased susceptibility 
indicated by the disk diffusion test was still within a level that the treatment could cure.  
Our results confirm that some ornamental fish species are a source of NWT F. 
columnare with decreased susceptibility to multiple drugs (Declercq et al., 2013); 
however, channel catfish grown for food also carry these organisms. All three NWT 
channel catfish isolates were collected in the same year from the same region. 
Preliminary pulse-field gel electrophoresis with an adapted method for F. columnare 
(Soto et al., 2008) showed two of the three catfish isolates were clonal. 
Our testing results and provisional ECVs provide the necessary data to allow the 
establishment of official ECVs for this pathogen. Although they provide a general 
indication of susceptibility, ECVs should not be used to guide therapy since they are 
based solely on in vitro data and do not consider in vivo effects. However, ECVs do 
define the MIC distribution of WT isolates that are integral, along with 
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pharmacokinetic/pharmacodynamic data and clinical outcome data, to setting clinical 
breakpoints (CLSI, 2008, 2011). Therefore, our results in combination with existing 
pharmacokinetic data (Gaunt et al., 2012, 2013), data generated on pharmacodynamics, 
and on treatment outcomes will help foster clinical breakpoints for F. columnare. 
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Table 4-1. Flavobacterium columnare isolates used for broth microdilution antimicrobial 
susceptibility testing. 
Isolate Host Year Isolated Collection Location Source
ATCC 23463 Chinook salmon n/a USA ATCC
S03-423 Channel catfish 2003 USA Tim Santucci
S03-427 Channel catfish 2003 USA Tim Santucci
S03-435 Channel catfish 2003 USA Tim Santucci
S03-439 Channel catfish 2003 USA Tim Santucci
S03-480 Channel catfish 2003 USA Tim Santucci
S03-517 Channel catfish 2003 USA Tim Santucci
S03-521 Channel catfish 2003 USA Tim Santucci
S03-523 Channel catfish 2003 USA Tim Santucci
S03-531 Channel catfish 2003 USA Tim Santucci
S03-532 Channel catfish 2003 USA Tim Santucci
S03-554B Channel catfish 2003 USA Tim Santucci
S03-559 Channel catfish 2003 USA Tim Santucci
S03-574 Channel catfish 2003 USA Tim Santucci
S03-578 Channel catfish 2003 USA Tim Santucci
S03-579 Channel catfish 2003 USA Tim Santucci
88-173 Channel catfish 1988 USA John Hawke
94-060 Channel Catfish 1994 USA Mark Lawrence
94-081 Channel Catfish 1994 USA Attila Karsi
94-082 Channel catfish 1994 USA John Hawke
94-141 Channel catfish 1994 USA John Hawke
94-147 Channel catfish 1994 USA John Hawke
95-132 Channel catfish 1995 USA John Hawke
96-511 Rainbow trout 1996 Unknown John Hawke
97-376 Hybrid striped bass 1997 USA John Hawke
ATCC 49512 Brown trout 1987 France ATCC
ATCC 49513 Black bullhead 1987 France ATCC
3-5-1991 Unknown 1991 Neatherlands Olga Haenen
CVI 08012761 Barramundi 2008 Neatherlands Olga Haenen
CVI 07014696 Koi 2007 Neatherlands Olga Haenen
L90-640 Channel Catfish 1990 USA Priscilla Barger
L90-629 Channel Catfish 1990 USA Priscilla Barger
L90-629 Channel Catfish 1990 USA Attila Karsi
ALG 92-491-C Channel Catfish 1992 USA Priscilla Barger
Dickerson 1 Channel Catfish 1995 USA Priscilla Barger
Evans Channel Catfish 1995 USA Mark Lawrence
143-94 Channel Catfish 1994 USA Priscilla Barger
155-94 Channel Catfish n/a Unknown Priscilla Barger
JIP 02/06 (1) Betta 2006 Singapore Jean-Francois Bernardet
M09-35447 Cisco 2009 USA Hui-Min Hsu
M08-26807 Koi 2008 USA Hui-Min Hsu
M08-26885 Bluegill 2008 USA Hui-Min Hsu
080925-1-26fcF Chinook salmon 2008 USA Thomas Loch
081016-1-7fcM Coho salmon 2008 USA Thomas Loch
20075A Splake n/a USA Hui-Min Hsu
CVI 04017018 Koi 2004 Neatherlands Olga Haenen
09013931 Koi 2009 Neatherlands Olga Haenen
10009061-1 Koi 2010 Belgium Olga Haenen
10012931 Koi 2010 Neatherlands Olga Haenen
10012573-2 Koi 2010 Neatherlands Olga Haenen
S06-258 Catfish 2006 USA Pat Gaunt
S06-251 Channel catfish 2006 USA Pat Gaunt
S06-337 Channel catfish 2006 USA Pat Gaunt
S07-889 Catfish 2007 USA Pat Gaunt
S07-684 Catfish 2007 USA Pat Gaunt  
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S07-685 Catfish 2007 USA Pat Gaunt
S08-520 Catfish 2008 USA Pat Gaunt
S08-541 Catfish 2008 USA Pat Gaunt
S08-543 Catfish 2008 USA Pat Gaunt
S09-158 Channel catfish 2009 USA Pat Gaunt
S09-162 Channel catfish 2009 USA Pat Gaunt
S09-382 Channel catfish 2009 USA Pat Gaunt
S10-239 Hybrid catfish 2010 USA Pat Gaunt
S09-319 Catfish 2009 USA Pat Gaunt
PB02-41 Koi 2002 USA Andy Goodwin
n/a Channel catfish n/a USA Pat Gaunt
LDA39 H4927 Black bullhead 1998 France Jean-Francois Bernardet
JIP 17/01 Koi 2001 France Jean-Francois Bernardet
JIP 14/00 Neon tetra 2000 Singapore Jean-Francois Bernardet
90-059 Channel Catfish n/a n/a Mark Lawrence
1191-B Channel Catfish n/a n/a Mark Lawrence
C003133K Channel Catfish 2003 USA Mark Lawrence
C91-20 Channel Catfish 1991 n/a Mark Lawrence
091006-1-9fcF Chinook salmon 2009 USA Thomas Loch
101007-1 5 Fc Male Chinook salmon 2010 USA Thomas Loch
101007-1 49 Fc Chinook salmon 2010 USA Thomas Loch
101012-1 55 Fc Chinook salmon 2010 USA Thomas Loch
111005-1 30 Fc Male Chinook salmon 2011 USA Thomas Loch
111025-1 34 Fc Male Chinook salmon 2011 USA Thomas Loch
111025-1 6 Fc Female Chinook salmon 2011 USA Thomas Loch
120210-1 FHM-URCF Fathead minnow 2012 USA Thomas Loch
90-106 Channel Catfish 1990 USA Attila Karsi
92-002 Channel Catfish 1992 USA Attila Karsi
94-078 Channel Catfish 1994 USA Attila Karsi
S09-157 Channel catfish 2009 USA Pat Gaunt
S09-177 Channel Catfish 2009 USA Attila Karsi
S09-194 Channel Catfish 2009 USA Attila Karsi
C-066 Channel Catfish 2010 USA Attila Karsi
C-068 Channel Catfish 2010 USA Attila Karsi
C-069 Channel Catfish 2010 USA Attila Karsi
C-074 Channel Catfish 2010 USA Attila Karsi
CB10-151 Steelhead Trout 2010 USA Attila Karsi
S13-814 Channel catfish 2013 USA Pat Gaunt
S07-452 Channel catfish 2007 USA Pat Gaunt
S07-455 Channel catfish 2007 USA Pat Gaunt
S07-457 Channel catfish 2007 USA Pat Gaunt
S09-108 Channel catfish 2009 USA Pat Gaunt
S09-153 Channel catfish 2009 USA Pat Gaunt
S10-302 Channel catfish 2010 USA Pat Gaunt
S10-502 Channel catfish 2010 USA Pat Gaunt
S11-222 Channel catfish 2011 USA Pat Gaunt
S11-311 Channel catfish 2011 USA Pat Gaunt
S11-492 Channel catfish 2011 USA Pat Gaunt
S12-598 Channel catfish 2012 USA Pat Gaunt
S13-109 Channel catfish 2013 USA Pat Gaunt
S13-182 Channel catfish 2013 USA Pat Gaunt
S13-492 Channel catfish 2013 USA Pat Gaunt
S13-517 Channel catfish 2013 USA Pat Gaunt
S13-529 Channel catfish 2013 USA Pat Gaunt
S13-533 Hybrid catfish 2013 USA Pat Gaunt
S13-541 Channel catfish 2013 USA Pat Gaunt
S13-543 Hybrid catfish 2013 USA Pat Gaunt
S13-549 Hybrid catfish 2013 USA Pat Gaunt
S13-554 Channel catfish 2013 USA Pat Gaunt
S13-562 Hybrid catfish 2013 USA Pat Gaunt
Bio-Med Channel catfish 1996 USA Cova Arias
Grizzle Channel catfish 2000 USA Cova Arias
ALM-05-53 Channel catfish 2005 USA Cova Arias
ALM-05-39 Threadfin shad 2005 USA Cova Arias
ALM-05-28 Blue catfish 2005 USA Cova Arias
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Table 4-2. Frequency distributions, median, geomean and number of the 134 isolates with 
on-scale MICs. Red numbers are the isolates with an MIC above the 99.9 % cutoff value 
listed in Table 3. * MIC values given are only the ormetoprim or trimethoprim 
concentrations. Erythromycin and oxytetracycline have wider MIC ranges due to re-















































































































































































































































































































































































































Table 4-3. ECVs estimated with the program COFinder (Turnidge et al., 2006) using the 
frequency distributions in Table 2. 
Antimicrobial 95.0% 97.5% 99.0% 99.9%
Ampicilin 0.25 0.25 0.25 0.25
Enrofloxacin 0.03 0.03 0.03 0.03
Erythromycin 1 2 2 4
Florfenicol 2 2 2 4
Flumequine 0.12 0.12 0.12 0.12
Gentamicin 4 8 8 16
Oxolinic acid 0.25 0.25 0.25 0.25
Oxytetracycline 0.12 0.12 0.12 0.12
Sulfadimethoxine / ormetoprim 1 2 2 4
Sulfamethoxazole / trimethoprim 0.5 1 1 2




Table 4-4. NWT Flavobacterium columnare isolates with decreased antimicrobial 
susceptibility based on provisional ECVs. 
Isolate Number Fish Host Origin Year Isolated Phenotype
S03-554B Catfish United States 2003 Amp, Enro, Ery, Flor, Flum, Otc, Oxo
S03-559 Catfish United States 2003 Amp, Enro, Ery, Flor, Flum, Otc, Oxo
CVI 07014696 Koi Netherlands 2007 Amp, Enro, Ery, Flor, Flum, Otc, Oxo
3-5-1991 Unknown Netherlands 1991 Amp, Enro, Ery, Flor, Flum, Oxo
S03-517 Catfish United States 2003 Amp, Ery, Flor, Flum, Otc, Oxo
JIP 14/00 Neon Tetra Singapore 2000 Amp, Enro, Flum, Otc, Oxo
CVI 08012761 Barramundi Netherlands 2008 Enro, Flum, Otc, Oxo
10009061-1 Koi Belgium 2010 Enro, Flum, Otc, Oxo
10012931 Koi 2010 Enro, Flum, Otc, Oxo
S03-480 Catfish United States 2003 Enro, Flum, Oxo
09013931 Koi Netherlands 2009 Enro, Flum, Oxo
S13-814 Channel Catfish United States 2013 Enro, Oxo
S07-455 Channel Catfish United States 2007 Flum, Oxo
95-132 Catfish United States 1995 Amp
S09-194 Channel Catfish United States 2009 Amp
111025-1 6 Fc Female Chinook salmon United States 2011 Flum
Dickerson 1 Channel Catfish United States 1995 Flum
CVI 04017018 Koi Netherlands 2004 Otc
M09-35447 Cisco United States 2009 Otc
JIP 17/01 Koi France 2001 Otc
155-94 Channel Catfish Unknown 1994 Oxo
ALM-05-28 Blue catfish United States 2005 Oxo






Chapter 5: Development of a columnaris disease model and comparison 
of infectivity among F. columnare isolates that differ in their florfenicol 
susceptibility. 
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, 
C B, Rodriguez, L R, 
Reimschuessel, R, Woods, L C. In Preparation. 
 
5.1 Abstract 
We exposed channel catfish Ictalurus punctatus to Flavobacterium columnare to 
develop a laboratory model of columnaris disease. Fish were immersed in a static water 
bath of approximately 10
6
 colony-forming units of F. columnare for 2 or 4 hours at 28 
°C. Afterwards, the fish were held in observation tanks with a constant water flow at 26 
°C where the fish were fed and observed for disease signs. An initial experiment 
compared the ability of 3 abrasion techniques to induce infections. We induced consistent 
infections without abrasion, using only crowding and bath immersion. Additional 
experiments compared the effect of different exposure times, fish densities, bacterial 
concentrations, temperatures and ammonia levels in the bath immersion on the onset and 
intensity of infection. Shorter exposure times reduced the intensity of the infections but 
did not slow onset. Lowering the bacterial exposure delayed onset slightly; however, 
lowering the density had no effect. Neither exposing at 26 °C instead of 28 °C nor 
binding ammonia slowed onset or reduced intensity of the infections. Once optimized, we 
used the model to compare the ability of 6 different F. columnare isolates to induce 
infections. Five of the six isolates induced a cumulative percent mortality ≥ 87%. The 
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remaining isolate did not induce any infection. The model and virulent F. columnare 
isolates provide materials and methods needed to study whether in vitro florfenicol 
susceptibility can accurately predict if an approved florfenicol dose can control the 
disease. 
5.2 Introduction 
Death due to columnaris disease caused by the nutritionally fastidious gliding 
bacterium Flavobacterium columnare is a major problem in many freshwater aquaculture 
industries (Davis, 1922; Fish and Rucker, 1945; Bernardet, 1989). In the United States 
(U.S.), columnaris disease is a leading pathogen in the channel catfish industry and is 
emerging in the rainbow trout industry (Wagner et al., 2002; Evenhuis et al., 2014). The 
importance of the disease to the U.S. industry motivated the development of drugs for 
this disease that resulted in the recent approval of the antimicrobials florfenicol 
(Aquaflor®) and oxytetracycline (Terramycin®) to control mortality in freshwater-reared 
fish (Federal Register, 2007, 2008, 2012). Because of these approvals and concern about 
aquaculture’s role in antimicrobial resistance following antimicrobial use 
(FAO/OIE/WHO, 2006), a testing procedure was standardized to determine the 
antimicrobial susceptibility of F. columnare (Chapter 4: Gieseker et al., 2012). With a 
standard susceptibility testing protocol, all laboratories can use the same methods to 
monitor the development of antimicrobial resistance or to recommend antimicrobials for 
treatment. 
In order to appropriately use susceptibility test results when prescribing treatment, 
veterinarians need clinical breakpoints. These breakpoints are particular drug 
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concentration cutoffs that define categories which predict the likely outcome of an 
approved antimicrobial treatment. Setting clinical breakpoints requires field effectiveness 
and susceptibility testing data that correlate the antimicrobial susceptibility of the 
bacterial isolate causing the infection with the treatment outcome. Unfortunately, limited 
field effectiveness data is available for columnaris disease. However, a laboratory study 
on the effectiveness of florfenicol to control experimentally induced F. columnare 
infections generated substantial evidence for the recent approval of Aquaflor® in the U.S. 
(Gaunt et al., 2010). 
A model similar to that used by Gaunt et al. (2010) would be a good way to 
enhance the effectiveness data needed to set clinical breakpoints. The model induced F. 
columnare infections by crowding catfish in a bath exposure to a single infective isolate 
of F. columnare. About half of the untreated fish developed infections and died mostly 3 
to 5 days after exposure to the bacterium. Another columnaris disease model causes a 
similar time course of mortality, but with lower survival (≤ 20 %) since they abraded the 
catfish prior to exposure (Darwish and Mitchell, 2009; Darwish et al., 2009). When 
compared, abrasion clearly lowers survival of catfish exposed to F. columnare; however, 
significant mortality was still induced without abrasion with a time course within 2 days 
(Bader et al., 2003, 2006). Abrasion or mucus removal also makes channel catfish more 
vulnerable to infection by different isolates (Soto et al., 2008). Therefore an abrasion may 
be necessary to get consistent infections between different F. columnare isolates to study 
the ability of the approved florfenicol treatment to control infections caused by isolates 
with susceptibility near potential breakpoints. 
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This report describes 6 experiments to develop a columnaris disease model in our 
laboratory. We used methods similar to Gaunt et al. (2010) to compare 3 types of 
abrasion techniques to induce infections. We also tested the effect of different exposure 
duration, fish density, bacterial concentration, temperature and ammonia level in the bath 
immersion on the onset and intensity of infection.  Lastly, we compared the ability of 6 
different F. columnare isolates to induce infections under the model’s conditions. The 
isolates varied in their susceptibility to the antimicrobial florfenicol. 
5.3 Materials & Methods 
5.3.1 Bacteria and culture conditions 
Table 1 lists the F. columnare isolate used in experiments (1-4) to develop the 
disease model and in the disease induction experiments (5-6). All experiments to develop 
a F. columnare infection model in our laboratory used a single F. columnare isolate 
(Postive control) supplied by Dr. Patricia Gaunt (Mississippi State University). Gaunt et 
al. (2010) used this isolate to study the effectiveness of florfenicol (Aquaflor®, Merck 
Animal Health) to control F. columnare infections induced in channel catfish, Ictalurus 
punctatus. Our experiments to compare the ability of different F. columnare isolates to 
induce disease were supplied by Dr. Mark Lawrence and Dr. Tim Santucci (Mississippi 
State University). The 3 F. columnare isolates with typical wild type susceptibility have 
been compared to other F. columnare isolates in laboratory challenges of juvenile 
fingerling channel catfish (Soto et al., 2008). Isolate WT-3 induced low mortality and 
grouped with other non-virulent isolates based on pulsed-field gel electrophoresis 
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(PFGE). Isolate WT-1 and WT-2 cause high mortality and grouped with other virulent 
isolates.  
The identity of the isolates was confirmed by PCR of the 16S rRNA gene using 
the methods and species-specific primers described by Darwish et al. (2004). Prior to 
each disease model or infection induction experiment, each F. columnare isolate was 
subcultured twice in Shieh broth (Shieh, 1980) starting from a frozen culture kept at ≤ -70 
°C in 20% glycerol. The second subculture was used to make suspensions adjusted with 
sterile saline to a 1.0 McFarland turbidity measured with a colorimeter (Hach Company, 
Loveland, Colorado, U.S.). Fifteen milliliters of the suspension was inoculated into sterile 
flasks containing 2 L of Shieh broth. The flasks were incubated at 28°C for 
approximately 72 hours while stirring at 100 rpms. Afterwards, the flasks were stirred 
and amount of inoculum specified by the experiment (see below) removed. While still 









 dilutions (100 µL) were spread on separate Shieh 
agar plates incubated at 28°C and colonies counted after 44-48 hours. 
5.3.2 Fish and rearing conditions 
Channel catfish (3-4 inch) were purchased from a commercial catfish farm (Osage 
Beach, Missouri) for experiments 1 to 3 and 2-3 inch channel catfish were obtained from 
the USDA Catfish Genetics Unit (Stoneville, Mississippi) for experiments 4 to 6. Gross 
necropsy, skin scrapes, gill biopsies and histopathology were conducted on 5 fish to 
assess their health status at the time of arrival. Afterwards the catfish were reared in our 
laboratory under standard procedures in 240 L aquaria constantly supplied with 
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supplemental aeration and 26±1 °C conditioned well water flowing at approximately 1-2 
L/min. The fish were fed commercial catfish feed (Zeigler Bros., Gardners, 
Pennsylvania) at 2% body weight once daily 5 days/week and grown to approximately 20 
g prior to each experiment.  
All of the experiments used aquaria supplied with conditioned freshwater from a 
50 gallon head tank and supplemental aeration. A digital temperature controller (Love 
Controls®, Michigan City, Indiana) maintained the temperature in the head tank. The 
aquarium systems consisted of four 240 L (60 gallon) tanks or eight 80 L (20 gallon) 
tanks. The 80L aquarium systems housed the fish prior to the exposure for acclimation 
and after the exposure for observation. Water flowed at 26±1 °C at a rate of 
approximately 500 mL/min. 
The bath exposure tanks were individual 240 L or 80 L aquaria located in a 
separate systems from those used for acclimation and observation. Each tank was divided 
into 3 equal compartments with a slotted acrylic divider that allows the compartments to 
share water. Water flowed into the tank at approximately 28 °C.  After all of the fish were 
moved into the exposure tank, the water flow was stopped and temperature maintained 
with 100 or 200 watt aquarium heaters (Aquarium Systems, Sarrebourg, France). Each 
exposure started when the water flow was stopped, water level lowered, heater turned on 
and broth inoculum added.  
A water quality monitoring system continuously recorded the pH, DO and 
temperature in representative 240 L and 80 L tanks. Water samples collected from the 
exposure tanks and from the observation tanks were tested for ammonia and nitrite using 
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the Nessler and Diazotization spectrophotometric methods, respectively (Hach Inc., 
Loveland, Colorado). Water samples were taken from the exposure tanks both before and 
after exposure. 
5.3.3 Acclimation 
Fish were placed in the observation tanks at least 2 weeks prior to each disease 
model or disease induction experiment to acclimate to the tank conditions. Groups of 10 
fish were moved from the holding tanks into the observations tanks. The fish were fed 
commercial catfish feed (Cargill, Inc., Franklinton, Louisiana or, Zeigler Bros., Gardners, 
Pennsylvania) at 2% body weight once daily 7 days/week. A commercial laboratory 
found no detectable levels (limit of detection) of the antimicrobial oxytetracycline (< 5.68 
ppm) in the Cargill feed (Central Analytical Laboratories, Eurofins Scientific, Metairie, 
Louisiana). No detectable levels of the antimicrobials florfenicol (< 0.001 ppm), 
chloramphenicol (<0.0003 ppm), thiamphenicol (< 0.001 ppm), oxytetracycline (< 0.1 
ppm), sulfadimethoxine (< 0.01 ppm) and ormetoprim (< 0.01 ppm) were found in the 
Zeigler feed. The same lot of feed used during acclimation was used in the corresponding 
experiment. 
5.3.4 Development of the disease model 
5.3.4.1 Experiment 1: comparison of abrasion techniques 
We compared the effect of 3 abrasion techniques on inducing F. columnare 
infections on channel catfish using methods similar to Gaunt et al. (2010). This 
experiment used 90 fish acclimated in nine 80 L observation tanks (10 fish/tank). The 
observation tanks were randomly assigned to an abrasion technique (3 tanks/technique). 
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Working with 1 observation tank at a time, the fish were removed and anaesthetized 
individually in 1 g tricaine methanesulfonate (Western Chemical, Ferndale, Washington) 
in approximately 6 L tank water (~20 ppt). Once sedated, the fish were either abraded 
with a motorized tool (Gieseker et al., 2006), dental cotton (Bader et al., 2003) or not 
abraded (Gaunt et al., 2010). Fish abraded with the motorized tool were lightly scraped 
similar to a close shave above the lateral line between the posterior margin of the dorsal 
fin and the anterior margin of the adipose fin. The abrasion width was approximately 1 
cm wide from two passes from back to front, and approximately 3 to 4 cm in length 
following the procedure. Fish abraded with sterile dental cotton were lightly rubbed in the 
same area above the lateral line as with the tool abrasion. The cotton was passed twice 
back to front using the end of the dental cotton. The cotton was turned over between 
passes. The fish (including those not abraded) were allowed to recover from anesthesia 
(in fresh water) before being placed in the exposure tank. To minimize variations in the 
procedure, only one person performed all of the abrasions. 
All of the fish were exposed in one 240 L exposure tank in a separate 
compartment for each abrasion technique at 28 °C. After adding all of the fish, the water 
was lowered to 60 L and sampled (5 mL) for a bacterial count. 300 mL of an 
approximately 72 hour F. columnare broth culture was added spread evenly across the 3 
compartments. The exposure ended promptly after 4 hours by moving the fish into 9 
observation tanks (10 fish/tank) at 26 °C randomized between the treatments (1 
treatment/tank). Immediately after moving the fish, the exposure tank water was sampled 
(5 mL) again for another bacterial count. The abrasions and exposures created the 
following treatment groups: 
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Group 1.1: no abrasion, 4 hour exposure, 
Group 1.2: tool abrasion, 4 hour exposure, and 
Group 1.3: cotton abrasion, 4 hour exposure. 




) in sterile 




 dilutions were spread on separate Shieh agar 
plates incubated at 28°C and colonies counted after 44-48 hours. The fish were observed, 
fed and necropsied as described below for 12 days. On the final day all remaining fish 
were sacrificed and necropsied. 
5.3.4.2 Experiment 2: 2 versus 4 hour exposure 
The first experiment induced a high level of infection and found an abrasion was 
not necessary to induce consistent infections. In this experiment the same methods 
without an abrasion were used to compare between exposing the fish for 2 or 4 hours. We 
also replicated the 4 hour exposure using an 80L exposure tank to test if the model could 
be scaled down. 
This experiment used 90 fish acclimated in nine 80 L observation tanks (10 
fish/tank). After acclimation, 60 fish were moved from the observation tanks into a 240 L 
exposure aquarium (30 fish in 2 of 3 compartments).  Another 30 fish were moved into 
an 80L exposure aquarium (10 fish/compartment).  All of the fish added to each 
compartment were randomly selected from the 9 observation tanks. To start the 
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exposures, we lowered the water in exposure tanks, sampled the water for a pre-exposure 
bacterial count (as in Experiment 1) and added the F. columnare broth culture:  
240 L aquaria: 40 L water, 200 mL broth and 
80 L aquaria: 20 L water, 100 mL broth.  
After 2 hours at 28 °C, 30 fish were removed from 1 compartment in the 240 L 
exposure tank and placed into 3 randomly assigned observation tanks (10 fish/tank) at 26 
°C. At 4 hours the remaining fish in the 240 L exposure tank were moved to another 3 
observation tanks (10 fish/tank) and water sampled for a post-exposure bacterial count. 
The fish in the 80 L exposure were also moved to 3 additional observation tanks after 4 
hours. The exposures created the following treatment groups: 
Group 2.1: 240 L aquaria, 2 hour exposure, 
Group 2.2: 240 L aquaria, 4 hour exposure, and 
Group 2.3: 80 L aquaria, 4 hour exposure. 
The fish were observed, fed, and necropsied as described for 10 days. All 
remaining fish were sacrificed and necropsied on the final day. 
5.3.4.3 Experiment 3: Variance in fish density and bacterial concentration 
This experiment tested if reducing the fish density and/ or bacterial concentration 
in the bath exposure tank would slow the onset of infection to allow more time to feed the 
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fish in future experiments. We exposed for 4 hours since a 2 hour exposure (experiment 
2) induced mortality below our target level. 
The experiment used 90 fish divided into 2 trials.  After acclimation, the first trial 
exposed 30 fish (30 fish/treatment) with reduced density in the exposure (Group 3.1) and 
30 fish with reduced bacteria (Group 3.2).  The second trial exposed 30 fish with reduced 
density and reduced bacteria (Group 3.3). The fish were randomly moved into 80 L 
exposure tanks (10 fish/compartment), 1 for each treatment group. After all fish were 
moved, we lowered the water level, sampled the water for pre-exposure bacterial count 
and F. columnare broth culture added in the following volumes: 
Group 3.1: 30 L water, 150 mL F. columnare culture, 
Group 3.2: 20 L water, 50 mL F. columnare culture, and 
Group 3.3: 30L water, 75 mL F. columnare culture. 
After 4 hours at 28 °C, 10 fish in each exposure tank compartment were randomly 
moved into 3 corresponding observation tanks at 26 °C, and water sampled for a post-
exposure bacterial count.  The fish were observed, fed, and necropsied as described 
(Group 3.1 and 3.2: 11 days; Group 3.3: 9 days). On the final the day the remaining fish 
were necropsied. 
5.3.4.4 Experiment 4: Effect of binding ammonia and/or removing temperature 
stress to slow the onset of infection 
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Total ammonia levels increased dramatically during the static bath exposures. The 
unionized ammonia levels rapidly rose to near critical levels presumably creating stress. 
This experiment tested if removing ammonia and/or reducing the slight temperature 
increase during the exposure would slow the onset of the infection. 
Catfish were bath exposed to F. columnare (isolate 36490) for 2 hours in an 80 L 
aquarium as described in order to test if using an ammonia detoxifying solution used in 
aquariums will 1) reduce the ammonia level and 2) slow the onset of the infection. In 
addition, we also investigated if removing the slight temperature increase during the 
exposure would slow the infection with or without the ammonia detoxifying solution. We 
used a 2 hour exposure to be in-line with the methods used in experiments 5 and 6. 
104 fish were acclimated for 2 weeks. To begin exposure, the fish were randomly 
moved into five 80-L exposure tanks. After all fish were moved, the water level was 
lowered to 24 L (12 L for the negative control fish), tank heaters turned on, water 
samples collected for a bacterial count and water quality, and 7.9 mL of ammonia 
detoxifying solution (Ammo-Lock®) added as assigned.  The treatment groups were as 
follows: 
Group 4.1: 8 fish, Temperature increase (28 °C water) and no ammonia reducer 
(negative control – not exposed to F. columnare); 
Group 4.2: 24 fish, Temperature increase (28 °C water) and no ammonia reducer 
(positive control – same as previous exposures); 
Group 4.3: 24 fish, Temperature increase (28 °C water) and ammonia reducer;  
Group 4.4: 24 fish, No temperature increase (26 °C water) and ammonia reducer; 
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Group 4.5: 24 fish, No temperature increase (26 °C water) and no ammonia 
reducer. 
To begin the exposure, 180 mL of a 72-hour F. columnare broth culture was 
added to each exposure tank.  60 mL of un-inoculated broth media was added to the 
negative control tank.  After 2 hours, the fish in the negative control tank were moved 
into 1 observation tank at 26 °C and the fish in the other exposure tanks were randomly 
moved into 3 corresponding observation tanks (9 fish/tank, n=12) also at 26 °C. After 
moving the fish, we sampled the exposure tank water for bacteria counts and to test water 
quality. Water samples collected before and after exposures were analyzed for ammonia 
with the indophenol method in addition to Nessler method as stated above (Hach Inc., 
Loveland, Colorado). The fish were observed, fed, and necropsied for 4 days. On the 
final the day, the remaining fish were necropsied. 
5.3.4.5 Experiments 5 and 6: Disease induced by F. columnare that vary in their 
sensitivity to florfenicol 
We used the disease model to compare the ability of 6 F. columnare isolates to 
induce infections with a 2 hour bath exposure. We chose the shorter exposure to possibly 
improve observing mortality differences between the positive control and the test isolates. 
Two experiments were performed; Experiment 5 tested 3 F. columnare isolates with 
typical wild type susceptibility to the antimicrobial florfenicol based on laboratory testing 
and Experiment 6 tested 3 F. columnare isolates with decrease non-wild type 
susceptibility to florfenicol.  
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Each experiment used 150 fish (300 fish total). The experiments only differed in 
the F. columnare isolates tested.  After acclimating 2 weeks, 30 fish were moved into the 
first of five 80 L exposure tanks; 2 fish from each of the 15 observation tanks. After these 
fish were moved, the water level was lowered to 20 L, pre-exposure water samples 
collected for a bacterial count and water quality, tank heaters turned on, and 150 mL of 
broth culture added. Preliminary experiments determined that 150 mL of broth culture 
best approximated the target cell concentration of 10
6
 CFU/mL across all of the isolates. 
The remaining 4 groups of 30 fish were moved into corresponding exposure tanks. 
Movements and exposures were staggered by 20 minutes to allow time for fish 
movement after each exposure. The 5 treatment groups were as follows: 
Experiment 5 
Group 5.1: un-inoculated broth as a negative control, 
Group 5.2: Positive control isolate, 
Group 5.3: F. columnare isolate WT-1, 
Group 5.4: F. columnare test isolate WT-2, and 
Group 5.5: F. columnare test isolate WT-3. 
Experiment 6 
Group 6.1: un-inoculated broth as a negative control, 
Group 6.2: Positive control isolate, 
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Group 6.3: F. columnare isolate NWT-1, 
Group 6.4: F. columnare test isolate NWT-2, and 
Group 6.5: F. columnare test isolate NWT-3. 
A completely randomized design was used with 3 observation tanks for each of 
the 5 exposure scenarios (negative control, positive control and 3 test isolates). A table of 
random assignments was generated, with the restriction that no more than 2 replicates of 
each exposure in 1 of the 3 flow-through aquarium systems. Unblinded collaborators 
assigned the randomization and moved the fish from the exposure to observation tanks. 
The unblinded collaborators did not participate in observations following exposure. 
After a 2 hour static bath exposure at 28 °C, the fish were removed in a rotating 
sequence from each compartment in the exposure tank in groups of 10 with a bucket 
filled with water from the receiving observation tank. One exposure tank was moved at a 
time into the 3 corresponding observation tanks (10 fish/tank) at 26 °C. The water in the 
exposure tanks was sampled collected for a bacterial count and water quality immediately 
after moving the fish. The fish were observed, fed, and necropsied as described for 14 
days. On the final day the remaining fish were necropsied. The bacterial counts were 
performed as described in Experiment 1.  The water quality samples tested for ammonia 
and nitrite using spectrophotometric methods (Hach Inc., Loveland, Colorado).  
5.3.5 Observations/Feeding/Necropsy 
The fish were observed in the morning (prior to feeding) and afternoon for brown 
to yellowish lesions typical of columnaris disease (Durborow, 1998) on the skin, gills 
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and/or fins.  We set criteria to determine if a fish was moribund during the course of the 
experiments to develop the disease model. Moribund fish were defined as having met 2 
of 3 criteria: 1) lethargy, 2) listing unable to maintain vertical position and 3) have 
significant skin lesions. Dead fish were collected and moribund fish removed and 
sacrificed with an overdose of tricaine methanesulfonate (500-1000 ppm). 
In Experiments 1-3, the fish were fasted the day of the exposure and subsequently 
fed commercial catfish feed (Cargill, Inc., Franklinton, Louisiana) at 2% body weight 
once daily 7 days/week until the end of the experiment. In Experiment 3, the feed was re-
pelleted at described below. The last group in Experiment 3 (Group 3.3) was offered feed 
4 hours after exposure to test if medicated feed could be given at an earlier time point. All 
fish in Experiments 4-6 were fed re-pelleted commercial catfish feed (Zeigler Bros., 
Gardners, Pennsylvania) at 2% body weight 4 hours after exposure and subsequently fed 
once daily 7 days/week until the final day of the experiment. The re-pelleted feed was 
pulverized, 20% filtered water added, re-pelleted with a laboratory pellet mill (California 
Pellet Mill, Crawfordsville, Indiana), and dried at 32 °C for 4 hours. The re-pelleted feed 
was developed for a future drug effectiveness trial that will use the disease model 
described here. The feed amounts were adjusted based on the number of fish remaining in 
the tank. Feed consumption was assessed as 0, 25, 50, 75 or 100 percent approximately 
15 min. after feeding. 
Moribund and dead fish were necropsied and sampled for microbiology to 
confirm infections. Each necropsy noted the date of collection, tank number, weight and 
fork length. Wet preparations of skin lesions (or normal skin if no lesions are present) and 
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a gill biopsy were analyzed. Microbiology samples were taken from skin (just anterior to 
the dorsal fin or lesion if present), posterior kidney and spleen. Samples were cultured on 
Shieh agar (Shieh, 1980) and incubated at 28±1°C for approximately 48 hours. Yellow, 
rhizoid colonies strongly adhered to the agar were considered F. columnare. 
Representative F. columnare were frozen at -80°C. Some non-F. columnare isolates were 
identified using the Biolog® system (Biolog, Inc., Hayward, California).  Skin, gill, liver, 
spleen, and posterior kidney samples were collected for histopathology from 
representative fish, fixed in 10 % neutral buffered formalin, and stained with hematoxylin 
and eosin. Select tissues were special stained with the methods Gram, Periodic Acid 
Schiff (PAS), and Grocott’s Methenamine Silver (GMS) to better visual the bacteria and 
confirm a fungal infection of the eye. 
5.3.6 Calculations and Statistics 
Each sacrificed moribund fish was considered a death in order to calculate 
cumulative percent mortality for each experimental group. Fish left in the tanks because 
they minimally meant our moribund criteria always died by the next observation period 
(≤ 12 hours). The cumulative percent mortality at Day 14 post-exposure to each isolate 
was modeled for the disease induction experiments using a generalized linear model 
(GLIMMIX) procedure available in SAS assuming a binomial distribution and logit link. 
The model included isolate as a fixed effect. The estimated mean cumulative percent 
mortality for each disease induction experiment was calculated for each isolate along 
with 95% confidence intervals. 
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The experimental protocol was approved by the Animal Care and Use Committee 
at the Office of Research, Center for Veterinary Medicine, U.S. Food and Drug 
Administration, and all procedures were conducted in accordance with the principles 
stated in the Guide for the Care and Use of Laboratory Animals (2011) and the Animal 
Welfare Act of 1966 (P.L. 89-544), as amended. 
5.4 Results 
Table 2 lists the average weight and length of the fish, exposure duration, and F. 
columnare concentration at the end of the exposure for all of the experiments. The size of 
the fish was kept consistent by using different batches of fish for each experiment. The 
disease induction trials used the same batch of fish therefore the fish were larger in the 
second trial.  Table 3 lists the ammonia and nitrite levels in the exposure and observation 
tanks during experiments to develop the disease model (Experiments 1-3) and to compare 
how different isolates induce disease (Experiments 5-6). Table 4 lists the ammonia and 
nitrate levels in Experiment 4 that tested if removing the temperature and/or ammonia 
stress would slow the onset of infection.   
5.4.1 Development of the disease model 
5.4.1.1 Experiment 1: comparison of abrasion techniques 
The cumulative percent mortality (CPM) was consistent between the 3 abrasion 
techniques (Fig. 1). The abrasion with the motorized tool rapidly caused all of the fish to 
be moribund or dead within 1 day post-challenge (dpc). However, the cotton abrasion and 
non-abrasion also caused a similar level of moribund or dead fish by 2 dpc. The skin 
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lesions were associated with the motorized tool abrasion but not the dental cotton 
abrasion. The skin lesions observed on the fish abraded with dental cotton or fish not 
abraded were often associated with fins although many were randomly located. 
5.4.1.2 Experiment 2: 2 versus 4 hour exposure 
Reducing the exposure time to 2 hours only slowed the onset of infection slightly 
but the CPM was lower compared to the 4 hour exposure (43% and 70 % respectively for 
exposures using a 240 L tank). When scaled down with less fish and a smaller 80 L 
exposure tank, the infection onset and CPM was similar to the larger exposure conditions 
(Fig. 2). The fish became moribund or died mostly 1-2 dpc when exposed for 4 hours and 
2 dpc when exposed 2 hours.  
5.4.1.3 Experiment 3: Variance in fish density or bacterial concentration, or both 
Challenging the fish with fewer bacteria delayed the onset of disease signs 
slightly but not the CPM (Fig. 3). A majority of the fish did not appear moribund 1 dpc 
but died overnight. Lowering the fish density in the challenge bath did not delay the 
disease onset. When combined, less fish density and fewer bacteria also did not delay the 
disease.  
5.4.1.4 Experiment 4: Effect of binding ammonia and/or removing temperature 
stress on the onset of infection 
Increasing the temperature slightly to 28 °C during the exposure resulted in a 
lower CPM compared with exposures at 26 °C (54% versus 75 %, respectively; Fig. 4). 
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The ammonia binding solution did not lower the CPM either with or without the 
temperature increase during the exposure. Onset of infection was slightly delayed by 
holding fish at 28 °C without binding ammonia. 
5.4.1.5 Experiments 5 and 6: Disease induced by F. columnare that vary in their 
sensitivity to florfenicol 
One isolate (WT-3) with typical (wild type) florfenicol susceptibility did not 
induce infection (0% CPM). The other 5 F. columnare isolates (with typical or decreased 
florfenicol susceptibility) induced infections statistically similar to the positive control 
isolate used to develop the disease model. Table 5 lists the estimated CPM and 95% 
confidence intervals for each treatment group. All of the infectious isolates and the 
positive control induced a CPM ≥ 87 % (Fig. 5 and 6). 
5.4.2 Gross, Microbiological and Histological Observations 
Gross observations. Most of the moribund and dead fish examined had long 
filamentous bacteria on their gills and/or skin. These bacteria were often aggregated into 
columns that had a haystack appearance diagnostic of F. columnare (Fig. 7A). Skin 
lesions were often dull circular areas with a thin red margin on the circumference (Fig. 
7B). Aside from lesions formed on the motorized tool abrasion in Experiment 1, the skin 
lesions typically originated at the base of the fins, but were also randomly located on the 
body surface.  None of the surviving fish had lesions. 
Microbiological observations. Flavobacterium columnare were isolated from 
skin, posterior kidney, and spleen of most moribund or dead fish (Table 6). The 
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occurrence of F. columnare on the skin of survivors varied between the experiments. The 
bacterium remained on the skin of survivors in Experiments 1 -3 (50, 100, and 75 %, 
respectively), but was not isolated in Experiments 5 and 6. Internal bacteria were only 
isolated from the kidney and spleen in Experiment 2.  
We also consistently isolated cream-colored round colonies (not F. columnare) on 
Shieh media with smooth margins from the skin, kidney, and spleen of the fish in the 
disease induction experiments. This colony was also noted in earlier experiments but not 
consistently recorded. The colony was equally prevalent on the skin of moribund and 
surviving fish suggesting the bacteria were part of the normal skin flora. Representative 
colonies identified as Aeromonas hydrophila, A. veronii, A. bestiarum, A. sobria and 
Plesiomonas shigelloides. Internally these bacteria were more prevalent in the moribund 
fish versus the survivors, suggesting the bacteria entered following F. columnare. 
  Histological observations. The moribund fish had focal skin and gill lesions. On 
the skin, the epidermis was gone with bacteria in the dermal connective tissue causing 
necrosis and edema (Fig. 8A). More advanced lesions penetrated through the dermis into 
the muscle causing focal necrosis and mild inflammation. Some fish, usually near death 
or already dead, had more advanced lesions encompassing large areas of necrotic skin 
and muscle. A Gram stain clearly demonstrated the bacteria in the dense connective 
tissue layer of the dermis and in the fascia of the muscle of the advanced lesions (Fig. 
8B). 
Gill lesions ranged from mild hypertrophy of the gill lamellae to severe 
hyperplasia of lamellae with focal areas of necrosis (Fig. 8C). A Gram stain showed the 
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bacteria in the connective tissue of the gill arch. On occasion, the bacteria also infected 
the eye eroding the epidermis of the cornea and caused necrosis, edema, inflammation in 
the connective tissue and choroid rete (Fig. 8D). Some eyes were also co-infected with 
fungus as confirmed with PAS and GMS stains. 
Internally, in moribund fish, the lymphatic tissue of the splenic white pulp was 
depleted assumedly because lymphocytes were being mobilized into the blood (Fig. 9A). 
Many inflammatory cells, particularly monocytes, were in the blood vessels. Some of the 
vessels were also severely dilated in the spleen, liver and posterior kidney (Fig. 9B). A 
Gram stain of the internal organs did not show any bacteria. 
 Angular cyst-like pockets with clear lumens were also seen in the spleen in a few 
moribund and surviving fish (Fig. 9C). The tissue surrounding these pockets appeared to 
be compressed somatic tissue. In a few cases the pocket was filled with non-descript 
material perhaps of a parasite or dying somatic tissue (Fig. 9D). Except for the cyst-like 
pockets, all of the tissues from the surviving fish appeared normal. 
5.5 Discussion 
We successfully developed a model of columnaris disease in channel catfish. The 
experimental infections caused a rapid onset of disease following a 2 or 4 hour bath 
exposure to a known infective isolate of F. columnare. As intended, the model is very 
similar to the columnaris disease model used to generate evidence for the recent U.S. 
approval of Aquaflor® to control mortality in channel catfish (Gaunt et al., 2010). 
Similar to Gaunt et al. (2010), only crowding and exposure to the bacterium in a static 
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bath was needed to induce infection. Although both models were developed with the 
same F. columnare isolate at a similar concentration and exposure duration, the models 
differed in intensity and onset of infections. Our model had a faster onset with a higher 
percent mortality. The primary differences between the models were the hardness of the 
water, the fish, and the temperature in the exposure bath. 
We used filtered well water which was relatively soft (30 ppm as CaCO3) as 
opposed to the unfiltered pond water used by Gaunt et al. (2010) which had about 10 
times more hardness. Gaunt et al. could not induce F. columnare infections in channel 
catfish using their well water which had hardness similar to their pond water but less 
organic matter (Gaunt, personal communication). High water hardness and organic matter 
enhances the survival of F. columnare (Fijan, 1968). However, F. columnare grows 
relatively well in a wide range of water hardness including the moderately soft water used 
here (Chowdury and Wakabayashi, 1988; Cai et al., 2013). Of the salts that contribute to 
water hardness, F. columnare is most sensitive to calcium at high levels (200 to 2000 
ppm); however, no threshold was determined from 20 to 200 ppm (Chowdury and 
Wakabayashi, 1988). More recent research reports similar growth in 12 to 360 ppm 
calcium salts but significantly more biofilm at 360 ppm (Cai et al., 2013). Therefore, 
calcium could contribute to the difference in the onset and intensity of the infections 
between the models. High calcium levels in the water used by Gaunt et al. (2010) could 
limit growth of the bacterium requiring organic matter and/or cause biofilms to form on 
tank surfaces therefore slowing attachment and growth on the fish.  
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Our model uses larger catfish (~20 to 40 g) than Gaunt et al. (~8 g), although we 
maintained a similar density in the exposure and observation tanks. Another F. 
columnare infection model induced a similar rate and intensity of infection without 
abrasion as we describe with fish of similar size (~30 g; Bader et al., 2006). However, the 
model used a different F. columnare isolate at a higher dose (10
8
 CFU/mL) and a shorter 
duration (15 min.). Therefore, it is possible that larger juvenile catfish are more 
susceptible to infection, possibly being more affected by the handling and crowding 
required with laboratory models. Crowding is known to predispose fish to attachment and 
infection of F. columnare (Wakabayashi, 1991). 
Our second disease induction experiment demonstrated the importance of 
consistently crowding the fish in the exposure bath. Although the fish were bigger 
relative to the first experiment, we did not adjust the water level in the bath to maintain a 
similar density of fish (~ 30 g fish/ L water). The average density in the exposure bath in 
the first experiment was 36 g fish/ L water whereas in the second experiment the density 
averaged 57 g fish/ L water. Consequently, the infections developed faster compared to 
the first trial clearly suggesting that the increased crowding influenced the infection rate.  
We had to change fish suppliers during the study and found the catfish from the 
new supplier were more susceptible to infection. A shorter 2 hour exposure induced the 
same onset and intensity of infection as when the fish from the original vendor were 
exposed 4 hours. Separate families of channel catfish can have different susceptibility to 
columnaris disease (LaFrentz et al., 2012; Beck et al., 2012; Peatman et al., 2013). 
129 
Therefore, it is important to confirm the duration of exposure and/or inoculum 
concentration when working with fish from a different source. 
In order to induce a slight temperature stress, we raised the water temperature in 
our exposure 2 degrees. However, the warmwater catfish actually appeared to benefit for 
the temperature increase as we observed a slight delay in the onset of infections and less 
mortality. Therefore we used the temperature increase in the disease model.  
We also tried to bind the ammonia in the exposure tank in order to remove any 
stress from the elevated ammonia levels detected at the end of exposure. A proprietary 
chemical clearly bound the ammonia; however, in error, we exceeded the target dose by a 
factor of approximately 2.5. The overdose did not appear to cause toxicity since we did 
not observe any enhanced sensitivity to the infections. Binding ammonia during the 
exposure did not slow the onset of infections or reduce mortality; therefore, the binding 
agent was not added to the disease model. 
Five of the 6 F. columnare isolates compared for their ability to induce infections 
in our disease model caused a similar high level of infection. However, an isolate known 
to have low virulence did not induce any infection (Soto et al., 2008). Although 3 of the 
virulent isolates had decreased non-wild type florfenicol susceptibility, their ability to 
induce infections was not impaired. Similar results occurred when 3 different strains of 
the closely related bacterium, Flavobacterium psychrophilium, were injected into 
rainbow trout, Oncorhynchus mykiss (Bruun et al., 2003). Each strain was highly virulent 
although they differed greatly in their oxytetracycline susceptibility (MIC = 0.25, 4 or 8 
µg/mL). In some strains of pathogenic bacteria, decreased antimicrobial susceptibility has 
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correlated with a decreased virulence in animal infection models (Magnúsdóttir et al., 
2000; Chen et al., 2010); however, in other pathogenic bacteria decreased susceptibility 
does not associate with decreased virulence (Johnson et al., 2012). 
The 2 F. columnare isolates (94-060 and C003133K) with typical wild type 
florfenicol susceptibility are known to be virulent based on previous challenges of 
channel catfish (Soto et al., 2008). To our knowledge, this is the first time that virulence 
of the 3 non-wild type isolates (S03-517, S03-554B and S03-559) has been characterized. 
Other than isolates S03-517 and S03-554B, the virulent isolates all have unique PFGE 
patterns when analyzed with the method developed by Soto et al., (2008) using the mluI 
and pasI restriction enzymes (data not shown).  
Our study developed a repeatable disease model that begins by acclimating 
juvenile channel catfish (18-46 g) to the observation tanks and feed at low density (~2.5-
6 g fish/ L) in 26 °C water for at least 2 weeks prior to bacterial exposure. To induce F. 
columnare infections, the catfish are put into an exposure tank at a crowded density (~30 
g fish/ L water) in water at 28 °C, and then approximately 10
6
 CFU/mL of a virulent F. 
columnare isolate is added. After 2 or 4 hours, we move the catfish back into the 
observation tanks at the same conditions used for the acclimation. The fish readily eat the 
feed fed during acclimation as early as 4 hours after exposure therefore future studies on 
drug effects can begin treatment at this time. We also developed a 3-point scale to 
consistently assess when the fish are moribund and should be removed from the tank. 
This disease model and virulent F. columnare isolates provide materials and method to 
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study whether in vitro florfenicol susceptibility can accurately predict if an approved 
florfenicol treatment can control columnaris disease in channel catfish.  
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Table 5-1. Flavobacterium columnare isolate used to develop the disease model and 
isolates compared for the ability to induce disease and associated minimal inhibitory 
concentration (MIC) against florfenicol. (WT = wild type; NWT = non-wild type) 







Positve control not given Channel catfish n/a USA 2
WT-1 94-060 Channel catfish 1994 USA 2
WT-2 C003133K Channel catfish 2003 USA 2
WT-3 C91-20 Channel catfish 1991 USA 2
NWT-1 S03-517 Channel catfish 2003 USA 32
NWT-2 S03-554B Channel catfish 2003 USA 64




Table 5-2. Average size of the fish used in each experiment. Also reported is the duration 










at end of 
exposure 
(CFU/mL)
Development of Disease model
Exp. 1 – abrasion techniques 22.8 12.9 4 4.0E+06
Exp. 2 – 4 versus 2 hour exposure
60 gallon tank 21.3 12.6 2 not sampled
60 gallon tank 23.3 12.5 2.3E+06
20 gallon tank 21.8 12.3 2.2E+06
Exp. 3 – Variance in fish density and bacterial concentration
Fewer bacteria 22.2 12.4 4.7E+05
Lower fish density 17.9 12.1 2.2E+06
Fewer bacteria and lower density 24.7 13.1 6.7E+04*
Disease Induction
Exp. 5 - highly FFN susceptible F. columnare
negative control, media only 30.7 13.8 0.0E+00
postive control, 36490 21.3 12.7 1.0E+06
WT-1 23.0 13.0 5.3E+05
WT-2 21.8 12.8 1.9E+06
WT-3 23.7 13.0 2.0E+06
Exp. 6 - poorly FFN susceptible F. columnare
negative control, media only 46.1 15.4 0.0E+00
postive control, 36490 35.4 14.4 2.1E+06
NWT-1 39.0 14.9 1.4E+06
NWT-2 35.9 14.5 7.2E+05
NWT-3 34.8 14.3 8.2E+05
*Note: The tank water was released prior to taking the colony count samples, therefore only the residual water at the 








Table 5-3. Ammonia and nitrite levels measured in the exposure and observation tanks 
during Experiments 1-3 to develop the model and Experiments 4-5 to compare how 
different F. columnare induce disease. 
0 h 2 h 4 h 0 h 2 h 4 h
Development of Disease model
Exp. 1 – abrasion techniques 0.037 2.070 0.049 0.0026 0.0067 0.0029
Exp. 2 – 4 versus 2 hour exposure
60 gallon tank 0.024 1.299 1.847 0.0018 0.0060 0.0091
20 gallon tank 0.012 1.342 2.205 0.0031 0.0062 0.0124
Exp. 3 – Variance in fish density and bacterial concentration
Fewer bacteria 0.198 1.719 0.0057 0.0067
Lower fish density 0.187 1.523 0.0048 0.0061
Fewer bacteria and lower density 0.181 0.426 0.0019 0.0023
Disease Induction
Exp. 4 - highly FFN susceptible F. columnare
negative control, media only 0.199 1.379 0.0013 0.0027
postive control, 36490 0.227 2.242 0.0018 0.0056
WT-1 0.19 1.864 0.0024 0.0028
WT-2 0.142 1.976 0.0016 0.0037
WT-3 0.144 1.802 0.0015 0.0042
Exp. 5 - poorly FFN susceptible F. columnare
negative control, media only 0.548 2.106 0.0074 0.0107
postive control, 36490 0.278 2.83 0.0069 0.0169
NWT-1 0.326 2.823 0.0071 0.0171
NWT-2 0.206 2.108 0.0052 0.0173
NWT-3 0.263 2.109 0.0054 0.0151
* Data was pooled since we only monitored represenative tanks that did not include all treatments.
















Table 5-4. Ammonia and nitrite levels (mg/L) measured in the exposure and observation 
tanks when temperature and/or ammonia levels varied in the bath challenges (Experiment 
6). 
0 h 2 h 0 h 2 h 0 h 2 h 0 h 2 h 0 h 2 h
Control, non-exposed, no temperature increase, no 
ammonia reducer
0.002 0.003 0.07 0.15 0.03 0.02 0.08 0.22 0.00055 0.01518
Temperature increase, no ammonia reducer 0.003 0.003 0.11 0.2 0.03 0 0.14 0.26 0.00084 0.0156
No temperature increase, no ammonia reducer 0.004 0.003 0.9 0.19 0.03 0.03 0.08 0.2 0.00048 0.012
Temperature increase, ammonia reducer 0.004 0.002 0.38 0.17 0.02 0.03 0 0.01 0 0.00069





































Figure 5-1. Percent mortality of catfish experimentally infected with F. columnare using 























2hr - 60 gal
4hr - 60 gal
4hr - 20 gal
 
Figure 5-2. Percent mortality of catfish experimentally infected with F. columnare. A 
repeat of the 4 hour non-abrasion exposure in a 60 gallon exposure tank, the 4 hour 

























less density & bacteria
 
Figure 5-3. Percent mortality of catfish experimentally infected with F. columnare 
comparing exposures with less fish density, less bacteria, or both less density and less 
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No temp. inc., no ammo-lock
Temp. inc., ammo-lock
No temp. inc., ammo-lock
 
Figure 5-4. Percent mortality of catfish experimentally infected with F. columnare 





























Figure 5-5. Percent mortality of catfish experimentally infected with F. columnare (2 
hour exposure at 28 °C, ~10
6
 CFU/mL) comparing 3 isolates with high susceptibility to 





























Figure 5-6. Percent mortality of catfish experimentally infected with F. columnare (2 
hour exposure at 28 °C, ~10
6
 CFU/mL) comparing 3 isolates with low susceptibility to 
florfenicol based on antimicrobial susceptibility testing. 
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Table 5-5. Least squares mean cumulative percent mortality at day 14 for both trials of 
the disease induction experiment. 
Trial








Negative control - plain broth   0.0 (SE =0.01) (0.0, 100)
Positive control isolate 93.3 (SE = 4.01) (76.9, 98.3)
Isolate WT-1 86.7 (SE = 5.47) (69.4, 94.9)
Isolate WT-2 86.7 (SE = 5.47) (69.4, 94.9)
Isolate WT-3   3.3 (SE = 2.89) (0.5, 20.2)
Negative control - plain broth  0.0 (SE =0.00) (0.0, 0.0)
Positive control isolate 100 (SE = 0.00) (100, 100)
Isolate NWT-1 100 (SE = 0.00) (100, 100)
Isolate NWT-2 100 (SE = 0.00) (100, 100)
Isolate NWT-3 100 (SE = 0.00) (100, 100)
Phase I - F. columnare 
highly susceptible to 
florfenicol
Phase I - F. columnare 
poorly susceptible to 
florfenicol




Figure 5-7. Gross observations of F. columnare infection. (A) Wet preparation of 
aggregate columns (arrows) of F. columare (scale bar = 50 µm); (B) Spreading skin 




Table 5-6. Condition of the fish at necropsy and percent of F. columnare colonies and 
contaminating cream colonies isolated from the skin, kidney or spleen. 
skin kidney spleen skin kidney spleen
Moribund/Dead 41 100 100 98
Survivors 6 50 0 0
Moribund/Dead 22 100 95 95
Survivors 9 100 22 33
3 Moribund/Dead 30 97 90 93
Survivors 4 75 0 0
Moribund 45 98 84 76 100 64 76
Survivors 48 0 0 0 89 14 11
Moribund 50 94 80 84 100 68 74
Survivors 9 0 0 0 100 22 44
Microbiology was not collected in experiment 6.
4 - FFN susceptible isolates
5 - FFN resistant isolates
N












Figure 5-8. Skin, gill and eye changes associated with F. columnare infection. (A) Skin 
missing its epidermis with dermal connective tissue (d) frayed and necrotic at the surface. 
Underlying muscle has mild focal inflammation (arrow) (20x); (B) Gram stain of the 
dermal connective tissue infected with F. columnare (arrows) and underlying blood and 
inflammatory cells in the hypodermis (40x); (C) Gill filaments with hypertrophic (h) and 
necrotic (n) lamellae; (D) Gram stain of F. columnare infecting the sclera (s) of the eye 





Figure 5-9. Spleen and kidney changes associated with F. columnare infection. (A) 
Splenic corpuscles (s) of the white pulp depleted of lymphatic cells with edema seen as 
white space in the tissue (20x); (B) Dilated blood vessel (bv) in the posterior kidney filled 
with many blood (white arrows) and lymphatic cells (black arrows) (40x); (C) Angular 
cyst-like pockets (po) in the spleen (20x); (D) Cyst-like pocket filled with possible 
parasite (pa) or decaying somatic tissue (20x). 
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Chapter 6: Effect of differences in florfenicol susceptibility on the 
ability of an approved treatment to control Flavobacterium columnare 
infections in channel catfish, Ictalurus punctatus. 
 
Gieseker, C M, Hasbrouck, N R, Crosby, T C, Evans, E R, Stine, C B, Parker, A J, 
Reimschuessel, R, Woods, L C. In Preparation. 
 
6.1 Abstract 
We experimentally infected channel catfish Ictalurus punctatus with either 
Flavobacterium columnare isolate 94-060 or isolate S03-559, then treated the fish with 
an approved florfenicol treatment. The isolates differed in their florfenicol susceptibility. 
Our goal was to determine if the approved treatment could protect catfish from infections 
caused by a F. columnare (S03-559) which had tested as less susceptible to florfenicol 
than a wild type (WT) F. columnare such as isolate 94-060. One hundred eighty catfish 
were exposed to either: 1) F. columnare isolate 94-060, 2) F. columnare isolate S03-559, 
or 3) uninoculated media (negative control) in a 2 hour static bath at 28±1º C. After 
exposure, the fish were randomly distributed among 6 tanks per exposure (10 fish/tank, 
18 tanks total) and held at 25±1º C to observe for moribund fish. We fed the fish an 
approved dose (10 mg drug/kg fish body weight) of florfenicol-medicated catfish feed or 
a non-medicated feed beginning 4 hours post-exposure once a day. After 10 days, all of 
the fish were fed the non-medicated feed for an additional 8 days. Any moribund fish that 
had at least 2 of 3 defined signs (lesions, lethargy, and listing) was sacrificed and 
necropsied. We conducted 3 blinded replicate experiments with 540 catfish. The 
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medicated feed successfully protected fish from infections induced with the WT isolate 
94-060 but not isolate S03-559. The cumulative mortality of fish exposed to isolate 94-
060 was 16 % for the fish fed the medicated feed and 83 % for the fish fed the non-
medicated feed. The mortality of fish exposed to the isolate S03-559 was 82 % when 
treated versus 90% without treatment. This data shows significantly improved survival if 
catfish infected with susceptible isolate 94-060 are treated with a 10-day dose of 10 
mg/kg dose florfenicol. Survival did not improve among catfish infected with the less 
susceptible isolate S03-559. Our results will help set clinical breakpoints so veterinarians 
can used the results of a standardized susceptibility test to interpret if florfenicol 
treatment will control F. columnare in channel catfish. 
6.2 Introduction 
In the United States (U.S.), columnaris disease caused by the nutritionally 
fastidious gliding bacterium Flavobacterium columnare is a leading pathogen in the 
channel catfish industry and is emerging in the rainbow trout industry (Wagner et al., 
2002; Evenhuis et al., 2014). In 2007, the U.S. Food and Drug Administration (FDA) 
conditionally approved the use of the drug Aquaflor® (active ingredient = 50 % 
florfenicol) to control columnaris disease in farmed channel catfish Ictalurus punctatus 
under the Minor Species Minor Use Act of 2004 (Federal Register, 2007). Aquaflor® is 
new to the U.S. aquaculture industry as of 2005 when it was originally approved to 
control enteric septicemia of channel catfish (Federal Register, 2005). Recently the U.S. 
FDA officially approved the use of florfenicol to treat columnaris disease expanding it to 
include all freshwater-reared finfish and adding a dosage range of 10-15 mg drug /kg 
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body weight (Federal Register, 2012, 2014). These new approvals will increase the use of 
Aquaflor® to treat columnaris disease. Therefore, the industry must use this antimicrobial 
as prudently as possible to limit the possibility that F. columnare isolates develop 
decreased susceptibility to florfenicol. 
In order to facilitate prudent use, an antimicrobial susceptibility test was 
standardized for F. columnare (Chapter 4: Gieseker et al., 2012).The standardized 
method provides laboratories with the same methods and quality control measures to 
monitor for changes in susceptibility among F. columnare isolates. Criteria to interpret 
test results to predict treatment outcomes are still needed. These criteria, called clinical 
breakpoints, help guide veterinarians to decide which antimicrobial to use. Clinical 
breakpoints are particular drug concentrations that categorize the results of standardized 
susceptibility testing based on the likely success of treatment (susceptible, intermediate, 
or resistant).  Isolates in the susceptible category are likely controlled by the treatment 
while resistant isolates are not. Treatment may control isolates in the intermediate 
category, but in some cases a higher dosage may be necessary. 
Setting clinical breakpoints requires field effectiveness data and in vitro 
susceptibility testing data with pharmacokinetic /pharmacodynamic data used as an 
interpreting factor (CLSI, 2008). Recent tests of 134 F. columnare with the standardized 
susceptibility test method found a small group of isolates that have decreased 
susceptibility to florfenicol (Chapter 4: Gieseker et al., 2012). Wild type (WT) isolates 
(with typical susceptibility) were inhibited by ≤ 4 µg/mL florfenicol. Five non-wild type 
(NWT) isolates required ≥ 16 µg/mL florfenicol before growth was inhibited. These 
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florfenicol concentrations could represent potential susceptible and resistant cutoff points 
that could potentially define clinical breakpoints. However, such cutoffs must be 
correlated with the outcome of treatment from clinical use in the field. Only minimal 
field effectiveness data is available for columnaris disease which has not been correlated 
with the standardized susceptibility test. 
Fortunately, a columnaris disease model that experimentally infected channel 
catfish with F. columnare generated effectiveness data for the recent approval of 
Aquaflor® in the U.S. (Gaunt et al., 2010). A similar model would be a good way to 
study whether infections induced with F. columnare with decreased florfenicol 
susceptibility withstand treatment with the approved dose of Aquaflor®. To facilitate this 
study, we developed a columnaris disease model with channel catfish similar to the one 
used by Gaunt et al. (2010) and tested the ability of 6 F. columnare to induce infections 
(Chapter 5). Two isolates with typical (WT) florfenicol susceptibility were highly 
virulent along with 3 isolates with decreased (NWT) susceptibility. In the present study 
we infected catfish with either a wild type F. columnare isolate or a non-wild type 
isolate, and then treated the infected fish with the approved dose of florfenicol. The 
results provide critical evidence on effectiveness of Aquaflor® treatment of F. columnare 
with various florfenicol susceptibilities.  
6.3 Materials & Methods 
6.3.1 Experimental design 
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Three replicate experiments used a randomized block design in which 3 separate 
aquarium systems each had 6 observation tanks (18 tanks total) randomly assigned to a 
set of 3 exposures: 
1) un-inoculated broth, 
2) F. columnare isolate (94-060) with WT florfenicol susceptibility, or 
3) F. columnare isolate (S03-559) with decreased NWT susceptibility. 
The 2 tanks assigned to each exposure were fed either: 1) non-medicated fish feed 
or 2) florfenicol-medicated feed at 10 mg/kg for 10 days. Treatments began 4 hours post-
exposure. After 10 days all of the fish were fed non-medicated feed for another 8 days. 
6.3.2 Fish and rearing conditions 
We obtained a single batch of 540 juvenile channel catfish (mean weight = 3.6 g, 
SD = 2.4; mean length = 6.7 cm, SD = 1.3) from the USDA Catfish Genetics Unit 
(Stoneville, Mississippi). The catfish were maintained in 240 L aquaria constantly 
supplied with supplemental aeration and 26±1 °C freshwater flowing at approximately 1-
2 L/min. The fish were fed commercial catfish feed with at least 35 % protein (Zeigler 
Bronze, Zeigler Bros., Gardners, PA) at 2% body weight once daily 5 days/week and 
grown to approximately 20g prior to the experiments. The mean weight (SD) prior to the 
3 replicate experiments weighed in groups of 10 fish was 16.8 g (2.7), 24.8 g (3.8) and 
30.2 g (2.9), respectively.  
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The aquaria were fed conditioned well water from a 50-gal head tank. The 
calcium, magnesium and sodium levels in the water just prior to the study were 16, 12 
and 18 mg/L, respectively. The water hardness estimated using the calcium and 
magnesium levels was 89.2 (as mg/L CaCO3). A digital temperature controller controlled 
the hot water input into the head tank and float valves controlled the cold water input. 
Water was delivered by gravity flow, controlled by a valve, for each aquarium. Each tank 
also had supplemental aeration. A water quality monitoring system (Water Management 
Technologies, Baton Rouge, Louisiana) continuously recorded the dissolved oxygen 
(DO), pH and temperature in representative 240 L and 80 L tanks. Water samples 
collected from the observation and exposure tanks were tested for ammonia and nitrite 
using the Nessler and Diazotization spectrophotometric methods, respectively (Hach Inc., 
Loveland, Colorado).  
The observation tanks consisted of 3 separate systems with eight 80 L aquaria fed 
water at 26±1 °C at a rate of approximately 500 ml/min. These tanks housed the fish 14 
days prior to the exposure (acclimation) and 18 days after the exposure 
(treatment/observation). The mean water quality values (SD) during the acclimation 
period for the entire study were temperature = 25.7 °C (0.4), DO = 6.9 mg/L (0.6) and pH 
= 7.3 (0.2). Ammonia and nitrite were not monitored as historically the levels in our 
aquaria with continuous water flow are well below the toxicity thresholds for unionized 
ammonia (0.05 mg/L) and nitrite (0.10 mg/L; Francis-Floyd et al., 1990). The mean water 
quality values (SD) post-exposure for the entire study were temperature = 25.5 °C (0.4), 
DO = 7.0 mg/L (0.6), pH = 7.4 (0.3), ammonia = 0.08 mg/L (0.07) and nitrite = 0.008 
mg/L (0.008).  
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The bath exposure tanks were part of one system with four 240 L aquaria fed 
water at 28±1 °C at about 1-2 L/min. Each tank (n=3) was divided into 3 equal 
compartments with a slotted acrylic divider that allowed the compartments to share 
water. The water flowed until the start of each exposure. Afterwards, 100-watt aquarium 
heaters (Aquarium Systems, Sarrebourg, France) maintained the water temperature. After 
shutting off the water flow, the water level was lowered to maintain a fish density of 30 g 
body weight/L water. The water level was the same in each exposure tank calculated 
from the average fish weight measured when the fish were moved for acclimation, the 
number of fish in the exposure tank (n=60), and divided by the fish density. The water 
levels in the exposure tanks for the 3 replicate experiments were 33.5, 50 and 60 L, 
respectively. The mean temperature, DO and pH (SD) from 1 representative exposure 
tank for the entire study was 27.8 °C (0.9), 4.0 mg/L (0.9) and 6.9 (0.3), respectively. 
6.3.3 Custom Catfish Feed 
The custom feed was made using methods of Li et al. (1993) adapted from 
previous drug effectiveness and pharmacokinetic studies (Gaunt et al., 2010, 2012, 2013). 
Each batch of custom feed was made using the same lot of commercial fish feed as a base 
(Zeigler Bronze, Ziegler Bros., Gardiner, PA). This was the same type of feed used to 
grow the fish prior to the study. A commercial laboratory found no detectable levels 
(limit of detection) of the antimicrobials florfenicol (< 0.100 ppm), oxytetracycline (< 
0.100 ppm), ormetoprim (< 0.100 ppm) or sulfadimethoxine (< 0.100 ppm) in the base 
feed (Central Analytical Laboratories, Eurofins Scientific, Metairie, Louisiana). 
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The feed was pulverized with a mini grinder (Retsch, Haan, Germany). 
Approximately 10L of pulverized feed filled a 16 quart shell of a laboratory V-Blender 
(Kelly-Paterson, East Stroudsburg, PA). The V-Blender mixed the dry powder for 20 
minutes with a combination of tumble mixing (25 rpm) and an internal intensifier bar 
(3500 rpm). With the V-Blender drive running, 2 L of purified water (20%) was added 
through a siphon tube and the mixture blended for an additional 10 minutes. Afterwards, 
the mixture was pelleted with a CL5 laboratory pellet mill (California Pellet Mill, 
Crawfordsville, IN) using 3/32” pelleting die. The pellets were then spread on racks and 
dried with a commercial food dehydrator (Cabela’s, Sidney, NE) at 32 °C (90 °F) for 4 
hours. The dried feed pellets were mixed, sampled for testing (below) and placed in 
plastic storage container and held at 4 °C until used. 
Separate batches of non-medicated and medicated feed were made prior to each of 
the 3 replicate experiments. The non-medicated feed was always made first. The 
medicated feed was made by weighing the ground feed (~10 L) and adding 500 mg 
florfenicol/kg of feed (454 g florfenicol/ ton) in the V-Blender shell just prior to mixing. 
All of the components of the V-blender, pellet mill and food dehydrator were washed 
following each feed preparation session. After each replicate experiment, all of these 
components were further washed in a commercial glassware washer. Preliminary 
experiments verified the florfenicol was evenly distributed in the medicated feed and that 
the drug was stable in the feed for at least 2 months when held at 4 °C (tested 7, 14, 35 
and 63 days after manufacture).  
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Each batch of non-medicated or medicated feed was tested for florfenicol 
concentration using the methods of Hayes (2013) by a commercial laboratory (Lancaster 
Lab, Eurofins Scientific, Portage, MI). No florfenicol was found in any of the non-
medicated control feed. The average florfenicol concentration (ppm) from 3 replicate 
tests for each experiment was 502, 500, and 513 respectively. A commercial forage 
laboratory tested the moisture, protein, fat, fiber, ash, calcium, and phosphorus of the 
custom prepared feeds (Cumberland Analytical Laboratories, Hagerstown, MD). The 
mean (SD) moisture level was 11.1 (2.1) %. The other mean (SD) levels as % dry matter 
were as follows: protein = 38.7 (0.2), fiber = 6.9 (1.0), fat = 8.7 (0.1), ash = 9.0 (0.4), 
calcium = 1.8 (0.04), and phosphorus = 1.2 (0.03). 
6.3.4 Bacteria and culture conditions 
Dr. Mark Lawrence and Dr. Tim Santucci (Mississippi State University) supplied 
the 2 F. columnare isolates used in the bath exposures. The isolates were collected from 
channel catfish in the U.S. in 1994 (94-060) or 2003 (S03-559). We confirmed the 
identity of the isolates with F. columnare specific PCR (Darwish et al., 2004; Welker et 
al., 2005). The minimal inhibitory concentration (MIC) against florfenicol, determined 
with recently standardized testing methods (CLSI, 2014), was 2 µg/mL for isolate 94-060 
and 32 µg/mL for isolate S03-559. Previous experiments found both isolates are highly 
virulent to channel catfish Ictalurus punctatus in our challenge model (Chapter 5). 
To prepare the broth inoculums for each experiment, each isolate was subcultured 
twice in Shieh broth (Shieh, 1980) at 28 °C for 24 hours starting from frozen cultures 
kept at ≤ -70 °C in 20% glycerol. The second subculture was adjusted with sterile saline 
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to a 1.0 McFarland turbidity measured with a colorimeter (Hach Company, Loveland, 
Colorado, USA).  Fifteen mL of each suspension was inoculated into a corresponding 
sterile flask containing 2 L of Shieh broth. An additional 2 L flask of Shieh broth was not 
inoculated. The flasks were incubated at 28°C for approximately 72 hours while stirring 
at 100 rpms. Afterwards, the flasks were stirred and amount of inoculum removed 
(Experiment 1 = 251 mL, Experiment 2 = 375 mL and Experiment 3 = 450 mL). 
Preliminary experiments found 150 mL of the inoculum in 20 L of exposure tank water 
best approximated the target level of 10
6 
CFU/mL F. columnare in the bath exposure. 
Therefore, we calculated the inoculum volume by multiplying the 150 mL inoculum/20 L 
water ratio by the water level in the exposure tank. 
6.3.5 Fish Movements and Exposure 
Two weeks prior to each experiment, 180 fish in groups of 10 were netted from 
the holding tanks, weighed and added to 1 of the 18 observation tanks. The fish were fed 
the custom non-medicated feed at 2% body weight once daily 7 days/week. 
Just prior to exposure, 3 groups of 20 fish were moved from the observation tanks 
into the 3 compartments of an exposure tank. A randomization list (nQuery, Statistical 
Solutions, Cork, Ireland) assigned the fish from the observation tanks to an exposure tank 
compartment. After all fish were moved the water flow was stopped, the water level 
lowered, tank temperature measured, tank heaters turned on, water sampled for a 
bacterial count and for water quality (pre-inoculum ammonia and nitrite), and the broth 
inoculum added (un-inoculated broth). The process was repeated for the 2 other exposure 
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tanks (2 F. columnare inoculums). The start times of the fish movements and exposures 
were staggered 20-30 minutes to allow time for post-exposure movements and samples. 
Each exposure was 2 hours at approximately 28 °C. To end each exposure, 10 fish 
were moved from each exposure tank, weighed in a bucket of water and gently poured 
into the receiving observation tank. A separate bucket for moving fish was assigned to 
each observation tank. A randomization list (nQuery, Statistical Solutions, Cork, Ireland) 
assigned 2 observation tanks (non-medicated or medicated feed) in each block to 1 of the 
3 exposure tanks. Unblinded collaborators generated the assignments and moved the fish. 
The unblinded collaborators did not participate in observations following exposure. 
Immediately after removing the fish, the exposure tank water was sampled for a 
bacterial count and water quality (post-inoculum ammonia and nitrite). The colony count 









 dilutions were spread on separate Shieh agar plates incubated at 28°C and F. 
columnare colonies counted after 44-48 hours. The water quality samples were tested for 
ammonia and nitrite using methods listed above immediately following each exposure. 
Table 1 lists the mean ammonia and nitrite values for the treatment groups just prior to 
and immediately after each exposure and the F. columnare levels at the end of each 
exposure.  No F. columnare was cultured from the bath exposure water sampled just prior 
to adding the broth inoculum. 
6.3.6 Observations/Feeding/Necropsy 
The fish were observed at least twice a day in the morning (prior to feeding) and 
afternoon for brown to yellowish lesions typical of columnaris disease (Durborow, 1998) 
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on the skin, gills and/or fins and to assess their health status (healthy, moribund or dead). 
Healthy fish had either no clinical signs of disease, or early signs not meeting the criteria 
for moribund. Moribund fish were defined as meeting 2 of 3 criteria: 1) lethargy, 2) 
listing unable to maintain vertical position and 3) have significant skin lesions defined as 
1 or more lesions ≥ 1 cm. Dead fish were collected and moribund fish removed and 
sacrificed with an overdose of tricaine methanesulfonate (500-1000 ppm). 
The fish were fed either custom non-medicated or florfenicol-medicated fish feed 
at 2% body weight based on the weight measured when the fish were moved post-
exposure. Once daily feeding began 4 hours after exposure and subsequently in the 
morning 7 days/week until the final day of the experiment. Each day the feed was 
weighed for each observation tank from an assigned feed bottle. The amount of feed 
given was adjusted based on the number of fish remaining in the tank after removing any 
dead fish. Prior to each experiment, an unblinded collaborator filled the bottles with 
either non-medicated or florfenicol-medicated feed based on the randomization list used 
to move the fish post-exposure. The fish were fed from these bottles for 10 days. 
Afterwards, the bottles were filled with non-medicated feed and feeding continued until 
the final day. Feed consumption was assessed as 0, 25, 50, 75 or 100 percent 
approximately 15 min. after feeding. In order to track feeding, the number of fish in the 
tank was multiplied by the feed score then averaged within treatments and across 
experiments to calculate an average daily feed score for each treatment for the entire 
study.  
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Each day post-exposure, up to 3 moribund fish/observation tank were examined 
with a full necropsy. Each necropsy noted the date of collection, tank, weight and fork 
length, and classified the condition as dead, moribund or healthy (no clinical signs). The 
external appearance was noted and lesions described. We prepared and analyzed wet 
preparations of skin (lesions if present) and a gill biopsy. Gills, skin, posterior kidney, 
and spleen were cultured on non-selective Shieh agar (Shieh, 1980) and incubated at 
28±1°C and observed at approximately 24 and 48 hours. Yellow, rhizoid colonies 
strongly adhered to the agar were considered F. columnare. Representative colonies of F. 
columnare and other bacteria were frozen at -80°C. Skin, gill, liver, spleen, and posterior 
kidney samples were collected for histopathology from representative fish, fixed in 10 % 
neutral buffered formalin, and stained with hematoxylin and eosin. Select histopathology 
slides were stained with Gram’s method to characterize bacteria and Masson’s trichrome 
method to view the connective tissue in the splenic corpuscles. 
All other dead and moribund fish were examined with an abbreviated necropsy. 
We noted the date, tank, weight, fork length and condition. Only the gills and skin were 
cultured on selective Shieh medium containing 5 µg/mL neomycin and 200 units/mL 
polymyxin B (Hawke and Thune, 1992) and incubated at 28±1°C and observed at 
approximately 24 and 48 hours.  
Representative isolates from each treatment group were re-identified with F. 
columnare specific PCR (cited above). The relatedness of representative F. columnare 
from each treatment group was compared with pulsed-field gel electrophoresis using the 
mluI restriction enzyme (PFGE; Soto et al., 2008). We also re-tested the florfenicol 
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susceptibility of F. columnare collected from the fish with in-house frozen broth 
microdilution 96-well plates prepared following CLSI guidelines with 11 dilutions of 
florfenicol (64-0.06 µg/mL) (CLSI, 2014) with 4 g/L CAMHB (Becton, Dickinson and 
Company, Sparks, Maryland). 
6.3.7 Statistics 
Each sacrificed moribund fish was considered a death in order to calculate 
cumulative percent mortality for each experimental group. In previous experiments to 
develop our columnaris disease model, catfish which were not sacrificed because they 
only minimally met the moribund criteria always died by the next observation period (≤ 
12 hours). The cumulative percent mortality at Day 18 was calculated post-exposure to 
each treatment was modeled using a generalized linear mixed model (GLIMMIX) 
procedure available in SAS, assuming a binomial distribution and using a logit link.  The 
model included isolate, feed type (non-medicated vs. medicated), and the isolate by feed 
type interaction as fixed effects. Since trials were pooled, trials and blocks nested within 
trials were included as random effects. The isolate by feed type interaction was tested at 
α = 0.05. The estimated mean cumulative percent mortality for each treatment group was 
calculated from back-transformed least squares mean estimates along with 95% 
confidence intervals. 
The experimental protocol was approved by the Animal Care and Use Committee 
at the Office of Research, Center for Veterinary Medicine, U.S. Food and Drug 
Administration, and all procedures were conducted in accordance with the principles 
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stated in the Guide for the Care and Use of Laboratory Animals (2011) and the Animal 
Welfare Act of 1966 (P.L. 89-544), as amended. 
6.4 Results 
6.4.1 Mortality 
The fish exposed to F. columnare isolate 94-060 with WT florfenicol 
susceptibility or to NWT isolate S03-559, and then fed non-medicated feed had a 
cumulative mortality of 83 % and 90 %, respectively (Fig. 1). Similarly, the fish exposed 
to the isolate S03-559 and treated with medicated feed had 82 % cumulative mortality. In 
contrast, the cumulative mortality was only 16 % for the fish exposed to isolate 94-060 
and treated with medicated feed. None of the non-exposed fish fed either non-medicated 
or medicated feed became moribund or died.  
The fish died from 1 to 18 days post-challenge (dpc) with most deaths occurring 
from 1 to 4 dpc. Both non-medicated treatment groups had a similar onset of illness. 
Mortality following challenge with the wild type isolate 94-060 from 1 to 4 dpc was 11, 
54, 81, and 81 %.  Mortality following challenge with the NWT isolate S03-559 from 1 
to 4 dpc was 26, 81, 88, and 90 %. 
The onset of illness was very different between the 2 medicated treatment groups. 
Mortality from 1 to 4 dpc following challenge with NWT isolate S03-559 was 9, 43, 61, 
and 76 %. Although the mortality was similar to the non-medicated groups, florfenicol 
treatment appeared to slow the rate of infection on day 3 and 4 dpc. On the other hand, 
mortality of the fish challenged with the WT isolate 94-060 was 1, 6, 6, and 12 %. After 
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day 4, the fish had no signs of infection until 12 dpc when 1 fish in the second 
experiment became moribund. Another fish in the same tank became moribund at the end 
of the experiment at 18 dpc. The delayed mortality occurred again in the third experiment 
with 1 fish becoming moribund at 18 dpc. 
The percent mortality for the unexposed, non-medicated group was not 
significantly different from the medicated group (df = 40, t = -0.13, P = 0.9006). 
Likewise, the percent mortality for the S03-559 exposed, non-medicated group was not 
significantly different from the medicated group (df = 40, t = 1.51, P <= 0.1378), 
indicating the bacterium was apparently not affected by the treatment. However, the 
percent mortality for the 94-060 exposed, non-medicated group was significantly higher 
than the medicated group (df = 40, t = 8.17, P < 0.0001), indicating the treatment was 
effective. 
6.4.2 Fish and Feeding 
Mean weight (SD) of the fish in the 3 replicate experiments was 25.9 g (9.8), 32.6 
g (12.7), and 42.0 g (14.1) respectively. Mean length (SD) was 13.3 cm (1.7), 13.7 cm 
(1.7), and 14.9 cm (1.6) respectively. 
Most of the treatment groups ate well when offered food 4 hours after exposure. 
Only 2 of 54 observation tanks (18/experiment) only ate 75 % of the feed whereas all of 
the other tanks ate all of the feed. The 2 non-exposed treatment groups (non-medicated 
and medicated) ate most of their feed throughout the study; the weighted average ranged 
from 3.8 to 4.0. Feeding rates dropped on day 1 amongst the fish exposed to isolate 94-
060 and fed non-medicated feed, and both treatment groups exposed to isolate S03-559 
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(non-medicated and medicated). Surviving fish in these groups resumed eating at least 75 
% of the feed within 4 to 10 days post challenge, after we removed the last moribund 
fish. 
The fish exposed to isolate 94-060 and fed medicated feed only ate about half of 
the feed on day 1 but began eating at least 75 % of the feed by day 3. Otherwise these 
fish ate all of the feed throughout most of the study with a daily weighted average that 
ranged from 3.4 to 3.8. 
6.4.3 Gross lesions 
Most of the moribund fish examined with a full necropsy had long rod-shaped 
bacteria on their gills and/or skin. These bacteria aggregated into columns that had a 
haystack appearance diagnostic of F. columnare (Fig. 2A). Skin lesions often began at 
the base of the fins, appearing as dull circular areas with a thin red outer margin (Fig. 
2B). More advanced infections had multifocal skin lesions. Some fish became moribund 
without skin lesions but had pale necrotic area in the gill filaments. Some of these fish 
had a small skin lesion on the outside margin of the operculum on the side near the pale 
area.  None of the surviving fish had lesions. Internally, some moribund fish had enlarged 
spleens that were either pale or dark in color. 
6.4.4 Histopathology 
The moribund fish had focal skin and gill lesions. Skin lesions were missing 
epidermis with bacteria in the dermal connective tissue causing necrosis and edema (Fig. 
3A). Focal necrosis was just under some lesions but did not extend further into the 
muscles. Occasionally the muscles also had mild hemorrhage and inflammation. On 
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occasion, the bacteria also infected the eye and nares eroding epidermis and causing 
necrosis, edema, and inflammation in the connective tissue and muscles. Gill lesions 
ranged from mild hypertrophy of the gill lamellae to severe hyperplasia (Fig. 3B) that 
fused lamellae. Heavily infected gills also had focal areas of necrosis with long rod-
shaped gram negative bacteria present.  
Internally, the spleens of moribund fish had mild to severe depletion of lymphatic 
white pulp that matched the severity of lesions observed in the gills and skin (Fig. 3C). 
Many inflammatory cells, particularly monocytes, were in congested blood vessels of the 
spleen, liver, and posterior kidney. No bacteria were seen in the organs or congested 
blood vessels. Some moribund and surviving fish had angular cyst-like structures with 
clear lumens in their spleens.  Occasionally the pockets contained non-descript tissue 
most likely of a parasite (Fig. 3D), and thus these structures are likely an incidental 
finding. Except for the structures, all of the tissues from the surviving fish appeared 
normal. 
6.4.5 Microbiology 
The F. columnare-like isolates sampled from the fish re-identified as F. 
columnare by PCR. Most moribund fish examined with a full necropsy had F. columnare 
on or in their skin, gills, posterior kidney, and spleen regardless of exposure isolate or 
type of feed (Table 2). The bacterium was also present on skin and gills of moribund fish 
examined with an abbreviated necropsy. 
We did not find F. columnare on any of the surviving unexposed or exposed fish 
given non-medicated feed.  We did culture a few F. columnare colonies on the gills of 2 
168 
unexposed, medicated fish. We also cultured F. columnare from some survivors in both 
exposed, medicated groups. One of 15 (7%) surviving fish exposed to isolate S03-559 
had F. columnare on its gills. Sixteen of 78 (20 %) fish that survived exposure to isolate 
94-060 following treatment had F. columnare on their skin and 15 of these 78 (19%) fish 
had F. columnare on its gills. One of these fish also had F. columnare in its posterior 
kidney in addition to its skin and gills.  
We also consistently isolated other bacteria (round colonies with smooth margins) 
from the skin and gills of most of the fish, regardless of treatment. These bacteria were 
equally prevalent on the skin of moribund and surviving fish. We cultured fewer of these 
bacteria on the skin and gills of fish examined with an abbreviated necropsy because the 
selective isolation media inhibited their growth. Internally, we cultured a lower 
prevalence of these bacteria from the spleen and kidneys of the unexposed and exposed 
non-medicated fish. In general, the prevalence in the internal organs was similar except 
for the exposed medicated fish, which had less of these bacteria in the survivors versus 
the moribund fish. 
The 2 F. columnare used in this study had different PFGE patterns (Fig. 4).  F. 
columnare isolates collected from the fish formed two main groups with each having the 
same pattern as the original exposure isolate. The single F. columnare isolate cultured 
from an unexposed fish had the same pattern as the wild type isolate 94-060. When re-
tested with the standardized susceptibility test, the F. columnare isolated from the fish 
post-exposure all had the same MIC of 1 µg/mL regardless of treatment group.   
6.5 Discussion 
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Treatment of channel catfish with 10 mg florfenicol/kg body weight once daily 
for 10 days following exposure to a F. columnare isolate with typical WT florfenicol 
susceptibility (isolate 94-060) significantly reduced the cumulative percent mortality as 
compared to fish not treated following the exposure. Based on florfenicol susceptibility, 
isolate 94-060 grouped together with most F. columnare (n=129) tested with a recently 
standardized antimicrobial susceptibility test (Chapter 4: Gieseker et al., 2012). The 
minimal inhibitory florfenicol concentration of the isolate (MIC = 2 µg/mL) was in the 
upper part of the group’s MIC frequency distribution which had a median of 1 µg/mL 
that ranged from 0.25 to 4 µg/mL. In contrast, the approved treatment did not reduce 
mortality following exposure to NWT F. columnare isolate S03-559 which had decreased 
florfenicol susceptibility (MIC = 32 µg/mL). This isolate was 1 of 5 F. columnare 
isolates that had an MIC ≥ 16 µg/mL clearly separate from most of the F. columnare 
isolates.  
Both F. columnare isolates induced an onset and intensity of disease similar to 
our experiments to develop the model and to another published columnaris disease model 
(Bader et al., 2003, 2006). However, infections developed faster and with greater 
mortality than the infection model used to study Aquaflor® treatment’s ability to control 
columnaris disease (Gaunt et al., 2010). Due to the faster onset of our infections, we 
started feeding our fish 4 hours after exposure. All of the fish ate immediately after 
exposure (day 0). Therefore all of our fish had at least 1 feeding prior to the time some 
fish stopped eating on the day after exposure (day 1). The treatment schedule used by 
Gaunt et al. (2010) resulted in a similar number of doses prior to mortality. They started 
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treatment 1 day after exposure and their fish began to die on day 2 with most dying from 
day 3 to 5.  
We included two unexposed treatment groups (medicated or non-medicated) to 
identify any possible influence of our custom feed. The feeds had no unwanted 
antimicrobials and, based on general nutrient levels, had the same composition as the 
base commercial feed. Both groups ate well and had no mortality indicating the feed had 
no influence on the results other than delivering the antimicrobial. The feeds were made 
using the same methods used to study the efficacy and pharmacokinetics following single 
and multiple 10 mg/kg doses (Gaunt et al., 2010, 2012, 2013). 
The signs and external erosions on the skin and gills of the moribund fish using 
our disease model were consistent with typical signs of columnaris disease (Davis, 1922; 
Foscarini, 1989; Pacha and Ordal, 1967; Durburow et al., 1998). The lesions typically 
started at the base of the fins, particularly on the pectoral and anal fins. Scrapes of the 
lesions had a long rod-shaped bacterium that formed columnar aggregates typical of F. 
columnare (Durburow et al., 1998). Skin lesions were missing epidermis with long rod-
shaped bacteria in the dermal connective tissue, similar to saddle-back lesions F. 
columnare causes on young Atlantic salmon Salmo salar (Morrison et al., 1981). The F. 
columnare also affected the gill epithelium causing the cells to enlarge. In more 
chronically affected fish, the gill epithelial cells proliferated causing occlusion and 
clubbing, often associated with necrosis of the secondary lamellae. These changes 
presumably impaired the ability of oxygen to diffuse from water to blood (Foscarini, 
1989).  
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Most of the moribund fish consistently had skin lesions; however, some became 
moribund with minimal signs of infection. These fish had some gill necrosis that was 
sometimes associated with small skin lesions on edge of the operculum. Highly virulent 
strains of F. columnare may cause mortality by causing systemic infections that enter 
through the gills without causing skin lesions (Pacha and Ordal, 1967).  However, we did 
not consistently observe moribund fish lacking skin lesions suggesting these fish were 
part of the natural variation in the pattern of lesion production.  
The moribund fish clearly had systemic infections because F. columnare was 
isolated from the spleen and/or posterior kidney. The spleen was also consistently 
enlarged and dark. The most notable histological changes were depletion of the lymphatic 
white pulp in the spleen and the vasculitis observed in congested blood vessels. Chen et 
al. (2011) found similar changes in farmed channel catfish with an acute septicemia 
caused by Streptococcus iniae. Their findings included severe inflammation in the spleen 
with reduced lymphoid tissue in the white pulp and blood vessels congested with many 
inflammatory cells. We did not observe inflammation in the spleen of our fish but did 
note lymphocyte depletion. 
Our PFGE results clearly show that the F. columnare isolate added to the 
exposure bath was the same isolate collected back from the fish. We isolated other non-F. 
columnare bacteria; however, these bacteria did not appear to be primary pathogens as 
they were equally present on the moribund and surviving fish. Conversely, F. columnare 
was highly prevalent both in and outside of the moribund fish whereas it was not isolated 
from most surviving exposed fish. Interestingly, the non-wild type isolate S03-559 did 
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not retain its decreased florfenicol susceptibility when re-isolated from the fish. The 
isolate had to be regrown multiple times to get an uncontaminated culture; therefore its 
susceptibility may have changed as subsequent generations of the isolate were cultured 
on the microbiological media. 
Determining clinical breakpoints begins with defining the susceptible MIC 
breakpoint.  Infections caused by any F. columnare in the susceptible category should be 
controlled by treatment. Our results suggest setting the susceptible florfenicol breakpoint 
at ≤ 2 µg/mL, similar to the provisional wild type cutoff determined from testing 134 F. 
columnare using our standardized testing method (Chapter 4: Gieseker et al., 2012). The 
cutoffs comprising 99.0 and 99.9 % of the wild type isolates were 2 and 4 µg/mL, 
respectively. Recent susceptibility testing with a similar unstandardized susceptibility test 
of another 100 F. columnare isolates had florfenicol MICs ≤ 2 µg/mL (DeClercq et al., 
2013). Since these potential clinical and wild type cutoffs agree, official breakpoints can 
be set without further influence from a cutoff based on PK/PD data (CLSI, 2008). 
However, the pharmacokinetics of florfenicol in channel catfish following the same 
treatment further supports our provisional breakpoint. The florfenicol concentration in the 
blood maintained a steady state at 2.5 µg/mL during the 10 day treatment (Gaunt et al., 
2013). 
Three of the 129 F. columnare isolates with wild type florfenicol susceptibility 
based on recent tests with the standardized method had a MIC of 4 µg/mL (Chapter 4: 























When possible, standard-setting organizations (e.g. CLSI) avoid setting a 
susceptible clinical breakpoint that splits the wild type MIC distribution (CLSI 2008). 
Considering that MICs inherently vary by ± 1 drug dilution (Turnidge and Patterson, 
2007), these few F. columnare may still be controlled by the approved 10 mg/kg 
florfenicol treatment. However, it may be best to have these isolates in the intermediate 
category which suggests they may be controlled by a higher dose. The US FDA recently 
increased the maximum daily dose of Aquaflor® to provide a dosage range of 10-15 
mg/kg (Federal Register, 2012; 2014). This higher dose would presumably increase the 
peak and steady state blood concentrations, therefore increasing the likelihood that 
treatment at the higher dose would control F. columnare isolates in the upper part of the 
wild type MIC distribution. However, little knowledge is publicly available on the 
pharmacokinetics of the 15 mg/kg dose in fish over the treatment period; therefore, it is 
not clear how much the drug serum concentration would increase compared to 10 mg/kg 
dose (Reimschuessel et al., 2005). 
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We clearly show the approved 10 mg/kg florfenicol treatment fails to control 
infections caused by the F. columnare (isolate S03-559) with decreased florfenicol 
susceptibility (MIC = 32 µg/mL). The amount of florfenicol needed to inhibit the isolate 
is well above the peak blood concentration following a single 10 mg/kg dose of 
florfenicol (7.6 µg/mL) in channel catfish Ictalurus punctatus and 20 mg/kg dose in 
Korean catfish Silurus asotus (9.6 µg/mL), and is an order of magnitude higher than 
steady state blood concentrations of the approved 10 mg/kg dose treatment (Park et al., 
2006; Gaunt et al., 2012; Gaunt et al., 2013). Based on this data, the approved treatment 
will likely fail to inhibit any of the 5 F.columnare isolates found in recent testing with a 
florfenicol susceptibility ≥ 16 µg/mL (Chapter 4: Gieseker et al., 2012). Hence these 
isolates appear to define a resistant susceptibility breakpoint for the standardized broth 
microdilution testing of F. columnare. 
Our effectiveness data reported here and the florfenicol MIC frequency 
distribution from recent in vitro testing provide some of the necessary data needed to set 
clinical breakpoints for the recently standardized in vitro test (Chapter 4: Gieseker et al., 
2012; CLSI, 2014). Setting breakpoints will give prescribers the ability to interpret test 
results needed to judiciously use the approved florfenicol product to control columnaris 
disease. 
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Table 6-1. Ammonia and nitrite levels in the tanks at the beginning (0 h) and end (2h) of 
the bath exposures, and F. columnare level at the end of the exposure. 
0 h 2 h 0 h 2 h
1 Negative control 0.16 1.36 0.003 0.013 0
Isolate 94-060 0.22 2.69 0.004 0.012 3.5 x 10
6
Isolate S03-559 0.27 2.81 0.004 0.014 1.9 x 10
6
2 Negative control 0.19 1.18 0.008 0.016 0
Isolate 94-060 0.20 2.61 0.005 0.016 2.6 x 10
6
Isolate S03-559 0.19 2.65 0.009 0.012 1.0 x 10
6
3 Negative control 0.18 1.28 0.009 0.014 0
Isolate 94-060 0.19 2.84 0.006 0.020 8.3 x 10
6































wild type 94-060, non-medicated
wild type 94-060, medicated
non-wild type S03-559, non-medicated
non-wild type S03-559, medicated
 
Figure 6-1. Cumulative percent survival of channel catfish challenged with F. columnare 
then treated with 10 mg florfenicol/kg body weight once daily for 10 days.  The fish were 
non-exposed, exposed to an isolate with high florfenicol susceptibility or exposed to an 
isolate with poor florfenicol susceptibility.  
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Figure 6-2. (A) Wet preparation of a skin lesion with aggregates of F. columnare (arrows, 
scale bar = 20 µm); (B) Circular skin lesion around pectoral fin of a channel catfish. The 
fin at the lesion’s center has eroded spine (s) and fin rays (r). Skin has a dull appearance 




Figure 6-3. Skin, gill and spleen changes caused by F. columnare infection. (A) Dermal 
connective (d) tissue of the skin missing most of its epidermis (arrow, scale bar = 20 µm); 
(B) Gill filament with hyperplastic epithelium occluding the spaces between secondary 
lamellae (arrows, scale bar = 20 µm); (C) Spleen with white pulp (wp) deplete of 
lymphatic cells (arrows, scale bar = 50 µm);); (D) Amorphous tissue of a possible 
parasite in cyst-like pockets observe in the spleen (p, scale bar = 100 µm). 
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Table 6-2. Percent of channel catfish with F. columnare or non-F. columnare colonies 
isolated from the skin, gill, posterior kidney or spleen.  Separate results are given for the 
full and abbreviated necropsies. 
skin gill kidney spleen skin gill kidney spleen
Unexposed, non-medicated feed
Survivors F 28 0 0 0 0 100 100 25 18
Survivors A 61 0 0 66 41
Unexposed, medicated feed
Survivors F 27 0 0 0 0 93 96 22 19
Survivors A 62 0 3 69 69
Wild type isolate 94-060, non-medicated feed
Moribund F 50 100 98 98 94 96 96 34 22
Moribund/Dead A 26 92 96 54 65
Survivors F 14 0 0 0 0 100 100 29 0
Wild type isolate 94-060, medicated feed
Moribund F 11 100 100 100 82 100 100 64 55
Survivors F 27 22 19 7 0 96 93 4 22
Survivors A 51 20 20 49 31
Non-wild type isolate S03-559, non-medicated feed
Moribund F 44 98 98 98 95 93 95 36 36
Moribund/Dead A 37 97 62 81 38
Survivors F 9 0 0 0 0 100 100 44 22
Non-wild type isolate S03-559, medicated feed
Moribund F 53 96 96 94 90 98 98 34 35
Moribund/Dead A 21 100 71 81 57
Survivors F 15 0 7 0 0 100 100 0 7
* F = Full necropsy; A = Abbreviated necropsy
Treatment n







Figure 6-4. Dendrogram of PFGE patterns of F. columnare isolates collected from the 
catfish after bath exposure to F. columnare isolate 94-060 or isolate S03-559.  Isolates 
C7, C27, C68, C191, C192, C226, C232, C265, C371, C392 and C418 were isolates from 
fish exposed to isolate 94-060. Isolates C1, C3, C60, C187, C189, C204, C225, C255, 
C362, and C420 were isolated from fish exposed to S03-559. Isolate C334 was isolated 
from the unexposed medicated treatment group. 
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Chapter 7: Discussion and Summary 
The use of antimicrobials in farmed fish to control infections caused by the 
aquatic bacterial pathogens Flavobacterium columnare and Flavobacterium 
psychrophilum created an important need for reliable test methods and for research to 
guide therapy. Standard antimicrobial susceptibility testing is one key strategy to monitor 
the development of antimicrobial resistance, and it is essential that laboratories all use the 
same methods and interpretive criteria (Leung et al., 2011). Up to now, no test method 
had been standardized for the nutritionally fastidious F. columnare and F. psychrophilum. 
In addition, there was very little data regarding changes in antimicrobial susceptibility of 
F. columnare nor data regarding decreased florfenicol susceptibility that could limit 
treatment of this common, but fastidious pathogen. 
7.1 Standardized Testing 
The research described in this dissertation developed test methods and adaptions 
specific for the unique growth characteristics of these two yellow-pigmented gliding 
bacteria. Both F. columnare and F. psychrophilum grow well in liquid media; therefore, 
broth dilution was the best test to standardize. Fortunately, when we began there was 
already a basis for developing a broth method since researchers had recently determined 
4 g/L dilute Mueller-Hinton media worked well for broth microdilution testing F. 
columnare (Farmer et al., 2004; Darwish et al., 2008). However, some aspects of the 
media were not known, such as the effects of supplementing the broth with cations, as 
typically done for routine susceptibility tests, or adding serum as done to enhance growth 
in previous disk diffusion and agar dilution tests (Hawke and Thune, 1992; Bruun et al., 
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2000; Michel et al., 2003). In the end, we needed to add dilute cations so the method 
would work for F. psychrophilum but found that serum should not be added since growth 
either stayed the same or actually declined.  
By far, the biggest challenge was making consistent cell suspensions. The 
precision of susceptibility tests relies on testing a similar number of bacteria each time 
(Wiegand et al., 2008). Most F. columnare isolates adhere strongly to agar; therefore, 
suspensions are best made from broth cultures. In addition, F. psychrophilum isolates 
vary a lot in their growth rate and cultures can have a lot of dead cells that make turbidity 
readings used to standardize the suspension inaccurate (Michel et al., 1999). Fortunately, 
our adaptations for making cell suspensions from static broth cultures worked well for F. 
columnare; however, we still get a lot of variation with F. psychrophilum. Therefore, 
additional work will be needed to improve the consistency of F. psychrophilum 
suspensions. 
 To validate our method, we conducted a multi-laboratory trial. The trial 
developed quality control (QC) ranges for a standard strain of Escherichia coli and 
Aeromonas salmonicida subsp. salmonicida against 9 antimicrobial drugs commonly 
used in aquaculture. Laboratories could test these strains alongside F. columnare or F. 
psychrophilum to validate if the drug concentrations were correct or if a mistake was 
made in setting up the test. Moreover, the QC ranges allow laboratories to make their 
own plates when their needs prevent buying commercial plates. QC bacteria provide a 
means to validate the drug concentrations in laboratory prepared plates, made in a 96-
well format or 8-well strips, using the VET04 guideline (CLSI, 2014). 
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In collaboration with other members of the CLSI Aquaculture Working Group 
(within the Veterinary Antimicrobial Susceptibility Testing Subcommittee), sections 
specific for broth microdilution testing of F. columnare and F. psychrophilum (based on 
chapter 2) were recently added to the latest edition of the VET04 guideline (CLSI, 
2014a). A separate supplement for performance standards was also created which 
includes the quality control ranges developed in chapter 3 (CLSI 2014 b). With standard 
methods in place, the data developed in chapters 4-6 will help develop interpretive 
criteria to complete standardized testing of F. columnare so researchers and clinicians 
can evaluate test results in the same manner. 
7.2 Monitoring for antimicrobial resistance 
Our research clearly shows there are F. columnare isolates with decreased 
susceptibility to multiple antimicrobials used in aquaculture. The antimicrobials we tested 
represent 7 drug classes: 3 quinolones, 2 potentiated sulfonamides, and 1 representative 
each from the beta-lactam, macrolide, aminoglycoside, phenicol and tetracycline classes. 
Twenty-two of our 134 (17%) F. columnare isolates had susceptibility above our 
provisional epidemiological cutoff values (ECVs). Most notable were F. columnare 
isolates with decreased susceptibility to florfenicol, erythromycin and ampicillin. All 
previous research that tested the florfenicol susceptibility of F. columnare reported 
isolates with relatively low susceptibility similar to our wild type (WT) isolate group 
(Michel et al, 2002; Suomalainen et al 2006a; Darwish et al., 2008, Gaunt et al., 2010; 
Declercq et al., 2013). Our finding about florfenicol is especially important since some of 
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the non-wild type (NWT) isolates came from channel catfish farmed in the US (Federal 
Register, 2007a/b, 2012, 2014) 
The multiple isolates we found with NWT susceptibilities to ampicillin and 
erythromycin also confirmed recent broth microdilution testing that found a single F. 
columnare isolate with decreased ampicillin or erythromycin susceptibility (Darwish et 
al., 2008; Declercq et al. 2013). All previous F. columnare tested by disk diffusion or 
agar dilution reported all isolates as highly sensitive to erythromycin. Of 3 studies that 
tested F. columnare against ampicillin by disk diffusion (Amin et al., 1988; Michel et al., 
2002; Suomalainen et al 2006a), one study did report some isolates that were “slightly 
sensitive” to ampicillin (Amin et al., 1988). 
Nine of the 22 isolates we found with decreased antimicrobial susceptibility had 
elevated minimal inhibitory concentrations (MICs) to more than 1 antimicrobial drug 
class. Our isolates with decreased erythromycin and florfenicol susceptibility all 
classified as NWT against multiple drugs representing 4 to 5 drug classes. Whereas 
decreased ampicillin susceptibility was singular in some cases and multi-drug in others. 
As recently reported from testing with a similar but unstandardized broth microdilution 
method, we also found decreased susceptibility to enrofloxacin, flumequine and/or 
oxolinic acid (all quinolones), or oxytetracycline that was also either singular or multi-
drug (Declercq et al., 2013). Five of the isolates with non-typical phenotypes in our study 
were also in the study by Declercq et al. (2013). The phenotypes of these isolates were 
very consistent between the 2 studies which provide strong evidence validating the test 
and these isolate’s NWT susceptibilities. 
189 
Future research should investigate the genetic origins of these non-typical 
phenotypes. In chapter 4 some MIC frequency distributions had clearly separate WT and 
NWT isolates but these groups overlapped for other drugs. Therefore, if certain genes 
only associate with the NWT phenotypes, then those genotypes could help confirm that 
the ECVs are set on the correct drug concentration. Secondly, discovering genotypes 
could also lead to faster antimicrobial susceptibility tests. A major challenge is the time it 
takes to run susceptibility tests, especially for slow growing bacteria from cold-blooded 
animals like fish. If genotype can reliably predict NWT antimicrobial phenotypes, then 
whole genome sequencing could speed up the time it takes to give aquatic veterinarians 
susceptibility results. Thirdly, if resistance genes are present then, whether they are 
located on chromosomal DNA or mobile elements such as plasmids should be 
investigated.  Suomalainen et al. (2006b) did not find plasmids in 7 F. columnare isolates 
collected from Finnish fish disease outbreaks and 1 type strain; however, plasmids are 
found in F. psychrophilum (Madsen and Dalsgaard, 2000). Recent broth microdilution 
testing with Anacker and Ordal broth recently found F. psychrophilum with elevated 
MICs against flumequine and oxolinic acid which were associated with mutations in the 
quinolone resistance determining region of the gyrA gene (Shah et al., 2012). However, 
no plasmid-mediated qnr genes were found. A consistent method for testing the different 
isolates will help research target which isolates to investigate by sequencing. 
Additional F. columnare testing by other laboratories using our standard method 
is needed so the Aquaculture working group can incorporate some inter-laboratory 
variation into the provisional ECVs. Dr. Turnidge, who is on the CLSI VAST committee, 
has advised that including at least some inter-laboratory testing is desired for setting 
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official ECVs. The similarity in results between our study and the one by Declercq et al. 
(2013) suggests the standard method should have good precision between laboratories. 
7.3 Judicious use of florfenicol for columnaris disease 
It is important to note that decreased susceptibility as determined by an ECV does 
not necessarily mean that the bacterium cannot be inhibited by treatment (CLSI, 2011). 
For example, an isolate with low-level resistance can still be inhibited as long as 
treatment can achieve an effective drug concentration at the infection site for the 
appropriate duration. In regards to aquaculture, some scientists suggest laboratories 
advise clinicians on whether to initiate treatment based on if ECVs classify isolates as 
WT or NWT (Smith, 2008). This approach provides clinicians with the best information 
available until enough data on clinical outcomes and drug kinetics develops to set clinical 
breakpoints. However, fish with curable infections from a bacterium with low level 
resistance might go untreated, allowing the bacterium to persist and possibly develop a 
higher level of resistance. Therefore, our work to supplement limited clinical data with an 
experimental disease model is a very justifiable approach to move along setting 
interpretive clinical breakpoints for aquaculture. 
In developing our disease model, we found that some F. columnare with 
decreased florfenicol susceptibility have an increased virulence. Other studies of 
pathogenic bacteria in animal infection models have associated decreased antimicrobial 
susceptibility with decreased virulence (Magnúsdóttir et al., 2000; Chen et al., 2010). All 
5 of our F. columnare isolates induced a similar level of mortality regardless of 
differences in susceptibility. Similar results were found in a study that intraperitoneally 
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injected rainbow trout, Oncorhynchus mykiss, with 1 of 3 F. psychrophilum strains that 
had different oxytetracycline susceptibility (Bruun et al., 2003). All 3 isolates killed most 
fish even though they had different oxytetracycline MICs (0.25, 4 and 8 µg/mL). 
We have shown in chapter 6 that experimental infections with non-wild type F. 
columnare (florfenicol MIC = 32 µg/mL) are not controlled by treatment with 10 mg/kg 
dose of florfenicol given once daily for 10 days. Since broth microdilution results usually 
vary by ± 1 drug dilution (Turnidge and Patterson, 2007), the same florfenicol treatment 
will likely fail to control infections caused by any of the 5 of isolates found in chapter 4 
with a florfenicol MIC between 16 and 64 µg/mL. Similarly, Bruun et al. (2003) found a 
100 mg/kg dose of oxytetracycline for 10 days failed when rainbow trout were infected 
with F. psychrophilum strains with low susceptibility (MICOTC = 4 or 8 µg/mL) as 
determined by an unstandardized agar dilution test (Bruun et al., 2000).The treatment 
prevented deaths when trout were infected with a strain with high susceptibility (MICOTC 
= 0.25 µg/mL). 
Unexpectedly, our isolate with non-wild type florfenicol susceptibility did not 
retain its elevated MIC when re-isolated from the moribund fish after exposure. The 
isolate had to be sub-cultured multiple times to re-purify it; therefore, the multiple growth 
cycles could have changed its susceptibility. The results of chapter 6 support our original 
test; however, more research is needed to determine if the decreased susceptibility varies 
and what parameters of storage could affect this. Future studies to evaluate this could 
include infecting catfish with the isolates recovered from the challenge fish to test 
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whether their change in susceptibility makes the isolates susceptible to florfenicol 
treatment. 
In addition to florfenicol, clinicians also use oxytetracycline to control mortalities 
caused by F. columnare in rainbow trout (Pulkkinen et al., 2010; Federal Register, 2008). 
Therefore, future studies with our disease model should study if differences in OTC 
susceptibility affect the approved treatment. LaFrentz et al. (2012) recently developed a 
columnaris disease model with rainbow trout fry to investigate virulence. The model uses 
a bath immersion without abrasion similar to our catfish model. Therefore, methods 
already exist to help adapt our model to trout or to possibly facilitate a collaboration. 
Further study with channel catfish is also valuable since it would help veterinarians 
responsibly use OTC when requirements are meant for extra-label use. 
The MIC frequency distributions and provisional ECVs determined in chapter 4 
meet most requirements for setting ECVs for F. columnare. In addition, the comparison 
of drug effectiveness between 2 F. columnare isolates with different florfenicol 
susceptibility, in combination with the MIC distributions, offers good evidence that 
should expedite setting clinical breakpoints.   
7.4 Conclusion 
In summary, the studies reported here have standardized an antimicrobial 
susceptibility test specific for 2 nutritionally fastidious gliding bacteria that continue to be 
important disease problems in many aquaculture industries (Wagner et al., 2002; 
Evenhuis et al., 2014). This work has already stimulated additional research as a multi-
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laboratory testing trial recently used our methods to generate proposed ECVs for F. 
psychrophilum (Smith et al., 2014). Hopefully, our research will stimulate continued 
improvements in monitoring for changes in antimicrobial susceptibility among these 
pathogens on individual farms and regions. Overall, we hope our research will help 
improve the prudent use of antimicrobials in aquaculture for the benefit of public health 
by limiting development of antimicrobial resistance and by helping the veterinarians 
effectively manage fish health so the aquaculture industry can provide people with 




Amin N E, Abdallah I S, Faisal M, Easa M EL-S, Alaway T, Alyan S A. 1988. 
Columnaris infection among cultured Nile tilapia Oreochromis niloticus. Antonie van 
Leeuwenhoek 54:509-520. 
Bruun M S, Schmidt A S, Madsen L, Dalsgaard I. 2000. Antimicrobial resistance patterns 
in Danish isolates of Flavobacterium psychrophilum.  Aquaculture 187-201-212. 
Bruun M S, Madsen L, Dalsgaard I. 2003. Efficiency of oxytetracycline treatment in 
rainbow trout experimentally infected with Flavobacterium psychrophilum strains having 
different in vitro antibiotic susceptibilities. Aquaculture 215:11-20. 
Chen J-H, Siu L K, Fung C-P, Lin J-C, Yeh K-M, Chen T-L, Tsai Y-K, Chang F-Y. 
2010. Contribution of outer membrane protein K36 to antimicrobial resistance and 
virulence in Klebsiella pneumoniae. Journal of Antimicrobial Chemotherapy 65:986-990. 
CLSI – Clinical Laboratory Standards Institute. 2011. Generation, Presentation, and 
Application of antimicrobial susceptibility test data for bacteria of animal origin; A 
report. Document X08-R. CLSI, Wayne, Pennsylvania. 
CLSI – Clinical Laboratory Standards Institute. 2014a. Methods for broth dilution 
susceptibility testing of bacteria isolated from aquatic animals: Approved guideline – 
second edition, Document VET04-A2. CLSI, Wayne, Pennsylvania. 
CLSI – Clinical Laboratory Standards Institute. 2014b. Performance Standards for 
Antimicrobial Susceptibility Testing of Bacteria Isolated From Aquatic Animals; Second 
Informational Supplement. Document VET03/VET04-S2. CLSI, Wayne, Pennsylvania. 
Darwish A M, Farmer B D, Hawke J P. 2008. Improved method for minimum inhibitory 
concentration testing of Flavobacterium columnare. Journal of Aquatic Animal Health 
20:185-191. 
Declercq A M, Boyen F, Van den Broeck W, Bossier P, Karsi A, Haesebrouck F, 
Decostere A. 2013. Antimicrobial susceptibility pattern of Flavobacterium columnare 
isolates collected worldwide from 17 fish species. Journal of Fish Diseases 36:45-55. 
Evenhuis J P, LaPatra S E, Marancik D. Early life stage rainbow trout (Oncorhynchus 
mykiss) mortalities due to Flavobacterium columnare in Idaho, USA. Aquaculture 418-
419:123-131. 
195 
Farmer B D. 2004. Improved methods for the isolation and characterization of 
Flavobacterium columnare. Master Thesis, Louisiana State University, Baton Rouge, 
Louisiana. 
Federal Register 2007. New Animal Drug; Florfenicol; Conditional approval of the use of 
florfenicol by veterinary feed directive for the control of mortality in catfish due to 
columnaris disease associated with Flavobacterium columnare, 72 Federal Register 194 
(9 Oct 2007), pp. 57199-57200. 
Federal Register 2007b. New Animal Drug For Use In Animal Feeds, 72 Federal Register 
76 (20 April 2007), pp. 19797-19798. 
Federal Register 2008. New Animal Drug For Use In Animal Feeds; Oxytetracycline; 73 
Federal Register 153 (7 August 2008), pp. 45874-45875. 
Federal Register 2012. New Animal Drug; Altrenogest; Dexamethasone; Florfenicol, Part 
558-New Animal Drugs for Use in Animal Feeds, 77 Federal Register 105 (31 May 
2012), pp. 32010-32013. 
Federal Register 2014. New Animal Drugs; Amprolium;Bambermycins; Ceftiofur; 
Deslorelin; Florfenicol; Florfenicol and Flunixin;Paclitaxel; Phenylbutazone; 
Pimobendan; Salinomycin; Tilmicosin;Tiludronate; Change of Sponsor, Part 558- New 
Animal Drugs for Use in Animal Feeds, 79 Federal Register 79 (1 April 2014), pp. 
18156-18159. 
Gaunt P S, Gao D, Sun F, Endris R. 2010. Efficacy of florfenicol for control of mortality 
caused by Flavobacterium columnare infection in channel catfish. Journal of Aquatic 
Animal Health 22:115-122. 
LaFrentz B R, LaPatra S E, Shoemaker C A, Klesius P H. 2012. Reproducible challenge 
model to investigate the virulence of Flavobacterium columnare genomovars in rainbow 
trout Oncorhynchus mykiss. Diseases of Aquatic Organisms 101:115-122. 
Leung E, Weil D E, Raviglione M, Nakatani H. 2011. The WHO policy package to 
combat antimicrobial resistance. Bulletin of the World Health Organization 89:390-392. 
Madsen L, Dalsgaard I. Comparative studies of Danish Flavobacterium psychrophilum 
isolates: ribotypes, plasmid profiles, serotypes and virulence. Journal of Fish Diseases 
23:211-218. 
Magnúsdóttir A, B, Hermansson A, Melhus Å. Experimental study of the virulence of 
Streptococcus pneumoniae with reduced susceptibility to penicillin. International Journal 
196 
of Pediatric Otorhinolaryngology 55:1-9. 
Michel C, Antonio D, Hedrick R P. 1999. Production of viable cultures of 
Flavobacterium psychrophilum: approach and control. Research in Microbiology 
150:351–358. 
Michel C, Messiaen S, Bernardet J-F. 2002. Muscle infections in imported neon tetra, 
Paracheirodon innesi Myers: limited occurrence of microsporidia and predominance of 
severe forms of columnaris disease caused by an Asian genomovar of Flavobacterium 
columnare. Journal of Fish Diseases 25:253-263. 
Michel C, Kerouault B, Martin C. 2003. Chloramphenicol and florfenicol susceptibility 
of fish-pathogenic bacteria isolated in France: comparison of minimum inhibitory 
concentration, using recommended provisory standards for fish bacteria. Journal of 
Applied Microbiology 95:1008-1015. 
Pulkkinen K, Suomalainen L-R, Read A F, Ebert D, Rintamäki P, Valtonen E T. 2010. 
Intensive fish farming and the evolution of pathogen virulence: the case of columnaris 
disease in Finland. Proceedings of the royal society B. 277:593-600. 
Shah S Q A, Nilsen H, Bottolfsen K, Colquhoun D J, Sørum H. 2012. DNA gyrase and 
topoisomerase IV mutations in quinolone-resistant Flavobacterium psychrophilum 
isolated from diseased salmonids in Norway. Microbial Drug Resistance 18:207-214. 
Smith P. 2008. A cost-benefit analysis of the application of 
pharmacokinetic/pharmacodynamics-based approaches to setting disc diffusion 
breakpoints in aquaculture: a case study of oxolinic acid and Aeromonas salmonicida. 
Aquaculture 284:2-18. 
Smith P, Endris R, Kronvall G, Thomas V, Verner-Jeffreys D, Wilhelm C, Dalsgaard I. 
2014. Epidemiological cut-off values for Flavobacterium psychrophilum MIC data 
generated by a standard test protocol. Journal of Fish Diseases, published online 
December26. 
Suomalainen L-R, Kunttu H, Valtonen E T, Hirvelä-Koski V, Tiirola M. 2006a. 
Molecular diversity and growth features of Flavobacterium columnare strains isolated in 
Finland. Diseases of Aquatic Organisms 70:55-61. 
Suomalainen L-R, Tiirola M, Valtonen E T. 2006b. Chondroitin AC lyase is related to 
virulence of fish pathogenic Flavobacterium columare. Journal of Fish Diseases 29:757-
763. 
197 
Turnidge J, Paterson D L. 2007. Setting and revision antibacterial susceptibility 
breakpoints. Clinical Microbiology Reviews 20:391-408. 
Wagner B A, Wise D J, Khoo L H, Terhune J S. 2002. The epidemiology of bacterial 
diseases in food-size channel catfish. Journal of Aquatic Animal Health 14:263-272. 
Wiegand I, Hilpert K, Hancock E W. 2008. Agar and broth dilution methods to determine 
the minimal inhibitory concentration (MIC) of antimicrobial substances. Nature Protocols 
3:163-175. 
 
